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Abstract 
Macular pigment (MP) is the shared term for three xanthophyllic- carotenoids: 
lutein, zeaxanthin, and meso-zeaxanthin, which, relative to human serum 
concentrations, are highly concentrated in the central macula.  The term macular 
pigment optical density (MPOD) refers to a quantifiable (typically in log units) 
value of the peak optical absorption density of MP in the central retina.  MP alters 
the spectral composition of incident light due to its anatomic position relative to 
the photoreceptors.  In addition to its short wavelength filtering properties, MP 
also exhibits potent antioxidant properties that have become the subject of 
interest for a wide range of retinal conditions, most notably, age-related macular 
degeneration. 
 
Recently, a number of studies have focused their efforts on the spectral 
properties of MP and its relationship with visual performance.  These studies 
have demonstrated a correlation between central MPOD and visual performance 
measures including contrast sensitivity (Hammond et al., 2012 and Loughman et 
al., 2012), glare disability (Hammond et al., 2012 and Loughman et al., 2010), 
temporal sensitivity function (Renzi et al., 2010),  glare discomfort (Stringham et 
al., 2011), and photostress recovery time (Stringham et al., 2007 and 2008).  All 
of these visual performance metrics were measured at central fixation. 
 
No published studies have examined the relationship between visual 
performance and MPOD at parafoveal locations where MP levels are lower.  The 
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objectives of this project were to explore the relationship of the MPOD spatial 
profile with measures of contrast sensitivity, specifically glare sensitivity, at foveal 
as well as parafoveal locations out to 60 of eccentricity in order to better 
understand the role of the MPOD spatial profile on measures of visual 
performance.   
 
In pursuit of demonstrating the parafoveal relationship of MPOD and visual 
performance, a novel device capable of measuring MPOD across the central 160 
of retina along 8 principle meridians using customized heterochromatic flicker 
photometry (cHFP) to determine MPOD (e.g., Bone et al., 2004) at foveal 
eccentricities of 0o, 2o, 4o, 6o and 8o using a 1o stimulus diameter was built.  
MPOD was calculated as five different values: 1) Stimulus center discrete value, 2) 
Stimulus center integrated across 1o, 3) Stimulus point at highest retinal sensitivity 
integrated across 1o, 4) area under the curve (AUC) using stimulus center across 
16o and 5) AUC using stimulus point at highest retinal sensitivity across 16o.  
 
Visual performance was assessed as contrast sensitivity (CS), glare disability 
(GD), relative glare disability (RGD) and intraocular scatter. CS was measured 
using vertical grating stimuli presented at foveal eccentricities of 0o, 2o, 4o, 6o and 
8o using a 1o stimulus diameter. GD was calculated as a difference in CS 
between glare and no glare conditions (CSNo Glare – CSGlare) using the same 
vertical grating stimuli presented at the same foveal eccentricities. RGD [(CSNo 
Glare – CSGlare) / CSNo Glare] was calculated to isolate the glare attenuation effects 
P a g e  | 23 
 
of MPOD by controlling for CS variability among the subject sample. Intraocular 
scatter was assessed through a direct compensation method using a 
commercially available device. Statistical analysis of the discrete and integrated 
MPOD associations with CS, GD, RGD and intraocular scatter were evaluated. 
 
Macular Pigment Spatial Distribution 
The cHFP identified reliable MPOD spatial distribution maps demonstrating a 1st 
order exponential decay curve as a function of increasing eccentricity with a r2 
value of 0.886 when fit to stimulus center and a r2 value of 0.907 when fit to 
stimulus point at highest retinal sensitivity. Correlation values at each foveal 
eccentricity were highly significant (2o r = 0.955-0.968, p<0.001 / 4o r = 0.928-
0.947, p<0.001 / 6o r = 0.875-0.929, p<0.001) suggesting symmetrical MPOD 
distribution along the four measured meridians. OriginPro9 software was used to 
create a Lorentzian distribution across the 16o macula for each subject. Individual 
Lorentzian distributions were also integrated across the 1o stimulus diameter at 
each measured retinal loci and across the 16o macula assuming both stimulus 
center and stimulus point of highest retinal sensitivity. Kurtosis calculations for 
each MPOD spatial distribution were calculated showing a range of -0.763 
(highly platykurtic) to 7.154 (highly leptokurtic). Although overall MPOD spatial 
distribution shows a Lorentzian distribution, substantial variability exists among 
individual distributions. 
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Contrast Sensitivity and Glare Disability across the Macula 
CS and GD were measured and RGD was calculated at 0o, 2o, 4o and 6o of 
foveal eccentricity for vertical grating stimuli of 3, 6 and 9 cycles per degree (cpd) 
along nasal, temporal, superior and inferior meridians. CS for all three spatial 
frequencies showed consistent trends as a function of eccentricity. Stimuli at 
3cpd showed the highest CS with the lowest variability at all retinal loci 
measured. Stimuli at 9cpd showed the lowest CS with the highest variability at all 
retinal loci measured. Among all spatial frequencies measured, significant 
differences between horizontal and vertical meridians were identified. GD 
showed a general trend with increasing foveal eccentricity. At each spatial 
frequency, GD increased as a function of increased foveal eccentricity with more 
subjects following the expected trend using 9cpd stimuli (25 of 33 subjects) than 
3cpd stimuli (21 of 33 subjects). When glare attenuation effects were isolated by 
calculating RGD, the trend of increasing RGD as a function of increased foveal 
eccentricity was higher using 9cpd stimuli (28 of 33 subjects) than 3cpd stimuli 
(24 of 33 subjects) supporting a possible influence of spatial frequency on 
resulting RGD. 
 
Relationship between MPOD, CS, GD and Intraocular Scatter 
Overall, no significant correlation between MPOD and CS was demonstrated 
using 3, 6 or 9cpd stimuli. Quartile analysis of CS at 0o, 2o, 4o and 6o using 3, 6 
and 9cpd stimuli showed non-significant differences between the highest and 
lowest peak foveal MPOD values. 
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Using 3cpd stimuli, non-significant correlations were demonstrated between peak 
foveal measures of MPOD and both GD and RGD at 0o, 2o, 4o and 6o of foveal 
eccentricity. Non-significant correlations were also found between corresponding 
retinal loci of calculated MPOD and both GD and RGD (i.e. 2o MPOD vs. 2o GD 
and RGD). However, quartile analysis found significant differences at 2o and 4o 
RGD between the highest and lowest peak foveal MPOD values. 
 
Using 6cpd stimuli, significant correlations were demonstrated between peak 
foveal measures of MPOD and RGD at 0o and 2o of foveal eccentricity. Non-
significant correlations were found between corresponding retinal loci of 
calculated MPOD and both GD and RGD. Quartile analysis found significant 
differences 0o, 2o and 4o RGD between the highest and lowest peak foveal 
MPOD values. 
 
Using 9cpd stimuli, significant correlations were demonstrated between peak 
foveal MPOD measures and GD at 0o and 2o foveal eccentricities and RGD at 0o, 
2o and 4o foveal eccentricities. Significant correlations were also identified 
between corresponding retinal loci of calculated MPOD measures and both GD 
and RGD at 2o and 4o foveal eccentricities. Quartile analysis found significant 
differences 0o, 2o and 4o GD and RGD between the highest and lowest peak 
foveal MPOD values. 
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Intraocular scatter correlations between peak foveal MPOD measures and 
integrated MPOD across 16o macula demonstrated non-significant values. 
However, quartile analysis of intraocular scatter showed a significant difference (t 
= -2.715, p=0.015) between the highest and lowest peak foveal MPOD 
measures.  
 
In summary, peak foveal MPOD revealed the highest correlation coefficients with 
RGD using 9cpd stimuli. These results possibly support a spatial frequency 
association on the glare attenuation effects of MP. Further support of a spatial 
frequency association may be seen form the significant correlations between 
corresponding parafoveal MPOD measures and both GD and RGD at 2o and 4o 
of foveal eccentricity. Additionally, all calculated measures of peak foveal MPOD 
shared similar significant correlation coefficients with both GD and RGD using 
6cpd and 9cpd stimuli. These results indicate that discrete and integrated 
measures of MPOD are similar in regards to their association with glare 
attenuation effects across the macula. Intraocular scatter resulting from incident 
light is primarily induced at the cornea and lens before reaching the retina. The 
ocular media influences prior to absorption by MP are the likely explanation for 
non-significant correlations between peak foveal MPOD measures and 16o 
integrated measure across the macula with intraocular scatter. However, the 
significant differences in intraocular scatter values between the highest and 
lowest peak foveal quartiles indicate MPOD may minimize scattered intraocular 
short-wavelength light albeit to a lesser degree than the cornea and lens. 
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I. MACULAR PIGMENT 
A. Composition and Anatomic Location 
Macular pigment (MP) is the shared name for 3 isomeric carotenoids: lutein (L), 
zeaxanthin (Z), and meso-zeaxanthin (MZ) which characterizes roughly 36%, 
18%, and 18% of total retinal carotenoid content, respectively (Beatty et al., 
1999). The remaining 28% of macular carotenoids are comprised of metabolic 
isomers including 3’-oxolutein and 3-methoxyzeaxanthin (Landrum et al., 1997).  
The level of carotenoids comprising MP within the retina rises more than 1000X 
above levels found in serum (Landrum et al., 1997), suggesting a specific role in 
human vision. 
 
MP is distributed across the retina with a peak density in the central 10 of the 
macula with an exponential decay function falling to optically undetectable levels 
around 8o of foveal eccentricity (Hammond et al., 1997). Trieschmann et al. 
(2008) found that the density and distribution of MP differs among individuals and 
that spatial distribution measurements did not show a significant relationship with 
peak MP density found at the fovea. This finding may underscore the importance 
that any MP measurement method must account for the density of foveal MP 
levels as well as the spatial distribution profile. 
  
Within the retina, L and Z are localized predominantly in the outer and inner 
plexiform layers of the retina (Snodderly et al., 1984) and in the outer segments 
of the photoreceptors (Sommerberg et al., 1999 and Rapp et al., 2000). MP 
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location and distribution within the retina was later confirmed by Trieschmann et 
al. (2008): L and Z are incorporated at the location of the fovea within the outer 
plexiform layer, or Henle fiber layer, which is comprised of cone receptor axons 
and in the parafovea within the inner plexiform layer of the retina. Gass et al. 
(1999) postulated that a layer of Müller glial cells exists between the internal 
limiting membrane and the Henle fiber layer specifically at the base of the foveal 
depression. Recently, work performed by Reichenbach et al. (2013) identified a 
relationship between Müller glial functions and MP deposition and transport 
within the central macula. A paper published by Westrup et al. (2014) posited 
that it is an association between Müller glial cells in the foveola and cone axons 
in the fovea extending to the macula which produces the spatial distribution 
pattern of MP. 
 
L is found in greater levels within the peripheral retina as the ratio of L:Z changes 
from approximately 1:2.4 at the fovea to 1.8:1 in the parafovea to 2.7:1 in the 
peripheral retina (Bone et al., 1988 and Bone et al., 1997). The inversion of the 
L:Z ratio with eccentricity parallels the rod:cone ratio demonstrated by Osterberg 
(1935) and Curcio et al. (1990) suggestive of a possible underlying process 
which promotes structure-specific accumulation (Bone et al., 1988). Bone et al. 
(2007) suggested that MP spatial distribution is highly correlated with cone 
photoreceptor distribution possibly indicating a role in cone function.  Nolan et al. 
(2008) proposed that foveal anatomical structure directly influences L and Z 
distribution. Their results found that foveal levels of MP integrated under the 
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spatial distribution curve shared a significant relationship with foveal width 
measured as both foveal crest to foveal crest (r = 0.32, p <0.05) and absence of 
nerve fiber layer (r = 0.41, p<0.01). Westrup et al. (2014) hypothesized that the 
density differences of photoreceptor axons at the foveal center versus the 
parafovea underlies the spatial distribution pattern of MP. Their findings support 
that the foveal peak of MP is due to the Müller glial cells and the spatial 
distribution decline of MP is a result of the higher density of photoreceptor axons 
within the Henle fiber layer creating an integration of two structures incorporating 
L and Z: Müller glial cells in the foveal center and the Henle fiber layer in the 
parafovea producing a monotonous, exponential decline with eccentricity. 
 
Proposed xanthophyll-binding proteins demonstrating a presence in cones as 
well as rods were explored by Handelman et al. (1991). Their findings supported 
a L and Z specific deposition process within primate retinal tissue using high 
performance liquid chromatography techniques compared against 
microdensitometry. Bhosale et al. (2004) confirmed a selective biologic 
mechanism in Z integration within the retina. Their work demonstrated the pi-
isoform of glutathione S-transferase (GSTP1) as a Z-specific binding protein 
showing the highest levels within the outer and inner plexiform layers of the 
human retina. Bhosale et al. (2009) identified and later confirmed by Li et al. 
(2011), a membrane-associated lutein-binding protein (StARD3) and showed 
specific presence of this lutein-binding protein within the rod and cone inner 
segments along with an increased occurrence within the Henle fiber layer. 
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The only other xanthophyll existing at substantial levels within the macula region 
is meso-zeaxanthin (MZ) (Bone et al., 1993 and Landrum et al., 2001).  MZ is a 
stereoisomer of zeaxanthin that is not found in significant amounts within a 
traditional Western diet and is not readily detectable in the serum through 
conventional HPLC assays.  Bone et al. (1997) proposed that a process may be 
found in cone axons which may allow L to undergo isomeric conversion to MZ 
and was later confirmed by Bhosale et al. (2007) demonstrating that MZ is a 
metabolic isomer of L in primate models.  This pathway may help to explain the 
prevalence of Z relative to L at the fovea supported by a nearly 1:1 
foveal:peripheral ratios of (L+MZ)/Z originally identified by Bone et al. (1997).   
 
L and Z are not produced de novo and therefore only available through dietary 
intake. The bioavailability of xanthophyllic carotenoids depends on their chemical 
matrix within the dietary source and ester bonds at xanthophyll hydroxyl groups 
(Schalch et al., 2007). A number of studies have evaluated the MP response to 
oral supplementation with L and Z (Bone et al., 2003, Schalch et al. 2007, 
Trieschmann et al., 2007, Richer et al., 2011). Although serum levels of L and Z 
generally correlated with MP, differences in retinal L and Z concentrations within 
the population may offer further support of specific physiologic pathways that 
regulate the retinal uptake of L and Z. For example, L is the dominant xanthophyll 
relative to Z in almost all food sources with only a few rare exceptions including 
orange and red peppers (Perry et al., 2009). However, studies have shown that 
this abundance of dietary L is almost never reflected within central retinal 
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measures of MP (Bone, 1997). It is likely that individual metabolic processes 
such as specific protein binding, serum lipoprotein profiles and body composition 
account for the L and Z levels of MP distribution.    
 
B. Function 
Proposed functions of MP are derived from the anatomical characteristics and 
the specific biochemical structure of L and Z. The effects of L and Z on short 
wavelength (SW) visible light absorption and their respective antioxidant 
properties have been investigated in a number of studies. Within the realm of 
current literature, three primary roles for the function of MP have been described:  
Protection, Optical, and Neural Efficiency. All three proposed functions derived 
their hypotheses directly from structural attributes and physiological 
characteristics MP. 
 
1. Protection Hypothesis 
The proposed protective hypothesis of MP depends upon its chemical structure 
as well as its spectral absorption properties. Carotenoids in general are 
recognized for their antioxidant and free radical scavenging properties (Krinsky, 
1989). The exact pathogenesis of age related macular degeneration remains 
uncertain although current models implicate a combination of cumulative damage 
from reactive oxygen intermediates (ROIs) created through metabolic processes 
and high energy, short wavelength light and chronic inflammation (Hollyfield et 
al., 2008). O’Connell et al. (2006) provided a review of the two primary roles of 
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macular carotenoids of specific importance in terms of their recognized tissue 
protective effects: 1) Antioxidant function and 2) SW light filtration. 
 
Antioxidant Function 
Carotenoids, including L and Z, have demonstrated the ability to reduce singlet 
oxygen (Krinsky et al., 1989), moderate ROIs (DiMacio et al., 1989), inhibit cell 
membrane perioxidation (Lim et al., 1992) and reduce lipofuscin formation 
(Sundelin et al., 2001). The presence of L and Z within the photoreceptor outer 
segments and retinal pigmented epithelium offers further support of the ROI and 
singlet oxygen reducing properties of MP (Sommerburg et al., 1999 and Rapp et 
al., 2000). 
 
Khachik et al. (1997) were able to provide the first evidence of oxidative products 
of MP within retinal tissue indicating metabolic oxidation-reduction events. These 
results showed definitive L and Z antioxidant activity within retinal tissue. L and Z 
antioxidant properties are derived from their ability to quench singlet oxygen and 
inhibit peroxyl radicals (Paiva et al., 1999). These antioxidant functions are based 
on the number of conjugated double bonds and hydroxyl end groups. L and Z 
have been confirmed to inhibit light-induced oxidative damage within retinal 
tissue (Beatty et al., 1999). Their study showed that metabolic oxidative products 
including singlet oxygen, free peroxyl radicals, and ROIs are attenuated in the 
presence of L and Z.     
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Krinsky et al. (2003) and Stahl et al. (2003) further explored the antioxidant 
mechanism of L and Z. They identified various free radicals are created under 
oxidative stress conditions found in retinal tissue and of these, xanthophyllic 
carotenoids show the greatest efficiency with reactions involving peroxyl radicals.  
These peroxyl radicals are the result of lipid peroxidation and the free radical 
scavenging abilities of L and Z attenuates the progression of damage to lipophilic 
structures (Landrum, 2013). In a number of animal models, SW light exposure 
may lead to the development of ROIs which have the potential to damage 
biologic tissues at a molecular level and negatively affect subcellular structures, 
cells and tissues (Polidori et al., 2001 and Krutmann, 2000). 
 
Carotenoids can quench the destructive properties of free radicals by either 
providing an electron to the free radical itself or incorporating the free radical into 
its own molecular structure through a covalent bond to pair the single electron.  
The molecular nature of the carotenoid structure attracts free radicals ultimately 
providing protection from oxidative damage to cellular lipids, proteins, and DNA 
(Stahl et al., 2003). 
 
Yeum et al. (2004) furthered the understanding of the antioxidant efficacy of 
xanthophyllic carotenoids. Their study, along with results from Semba et al. 
(2003), identified the polar end-groups of L and Z as a primary source of their 
effectiveness. These polar end-groups project outside the cell membrane into 
both the intracellular and extracellular plasma allowing enhanced interaction with 
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ROIs. This unique membrane insertion enhances the antioxidant properties of L 
and Z within the photoreceptor outer segment which has a significant membrane 
surface area subject to oxidative reactions (Semba et al., 2003). L and Z show a 
high affinity to lipid containing structures and, along with their efficiency in peroxyl 
radical mitigation, carotenoids may serve a critical role in cell membrane 
protection and oxidative damage (Stahl et al., 2005). 
 
Short Wavelength Light Filtration 
SW light damage at high intensity within the retinal tissue has been extensively 
documented (Ham et al., 1976). At wavelengths of 450nm, nearly 100X less 
energy is required to produce retinal injury compared to wavelengths greater 
than 590nm. Ham et al. (1979) demonstrated the severity of light-induced injury 
to retinal cells. Their work revealed that the severity of retinal damage caused by 
high energy, SW light can be expressed as a function of wavelength. They 
described an exponential increase in the severity of retinal damage as the 
wavelength of the source decreased. Ham et al. (1984) and Noell (1980) 
evaluated a bandwidth for visible SW light induced retinal damage. Their studies 
identified increased risk of retinal injury at wavelengths between 400-450nm.  
This action spectrum bandwidth for SW induced damage shows considerable 
overlap with the previously established absorption spectrum of MP of 400-
500nm.   
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SW light generated by an intraocular operating biomicroscope has been 
recognized to create retinal lesions that demonstrate a lesser degree of injury in 
affected areas corresponding to higher levels of MP (Michels et al., 1992) and 
identified macular sparing from light-induced retinal lesions relative to 
surrounding non-macular retinal tissue (Jaffe et al., 1988).    
 
Snodderly et al., (1984a) proposed three reasons that L and Z are capable of 
providing an optical filter of SW visible light: 1) the absorbance spectrum of 
macular pigment has a peak at 460nm which falls within the short wavelength 
portion of the visible light spectrum. 2) MP is at its highest levels within the cone 
axon layers (primarily Henle’s fiber layer) of the retina. This prereceptoral 
anatomic location allows MP to employ its absorptive properties on SW visible 
light prior to incidence on the photoreceptors. 3) MP is found not only within the 
axon layers of the retina but also within the outer segments of the photoreceptor 
membrane itself. The presence of MP within the photoreceptor membranes may 
provide additional SW light optical filtration to adjacent cells as a result of the 
anatomic path followed by the axon projection to more anterior layers (Whitehead 
et al., 2006). Using the absorbance formula applied with spectroscopy 
measurements [A=log10(Io/I)], Snodderly et al. (1984b) postulated that macular 
carotenoids are capable of decreasing incident blue light by approximately 40%,  
assuming their study sample mean central MPOD.   
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Sujak et al. (1999) demonstrated that L and Z are incorporated into the liposome 
bilayer at different orientations. Z was identified in a vertical orientation with 
respect to the membrane layer while L was incorporated in both a vertical and 
horizontal orientation. Differences in both SW absorption and antioxidant 
properties may be attributed to these differences in orientation. Junghans et al. 
(2001) identified L as a superior filter of SW light relative to Z. They posited that 
the higher optical filtration efficiency of L was a result of the both parallel and 
perpendicular orientations found within photoreceptor membranes compared to Z 
which has only a perpendicular membrane orientation. A likely result of the two 
orthogonal orientations of L within the lipid membrane is an improved capture of 
incident SW light. L and Z are located in an anatomically ideal location to 
attenuate incident SW light and may preclude the photosensitization of retinal 
tissue and the formation of ROIs. The SW attenuation provided by L and Z can 
be viewed as an indirect protective function (Bernstein et al., 2010). 
 
The Protection Hypothesis is comprised of two primary elements: antioxidant 
functions and SW light filtration. These two elements are not mutually exclusive 
and likely act in a synergistic fashion. Clinical conditions resulting in annular 
maculopathy including maculopathy resulting from use of photosensitizing drugs 
are described by central retinal degeneration in an annular pattern which 
surrounds but spares the 1o foveal region corresponding to the diameter of 
highest MPOD (Weiter et al., 1988). Foveal sparing may be a result of the free 
radical scavenging and oxidative damage inhibition properties demonstrated by 
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MP. Foveal sparing has also been documented in advanced cases geographic 
atrophy associated with AMD (Schatz et al., 1989 and Sunness et al., 1999).   
 
Haegerstrom-Portnoy (1988) published results documenting a loss of SW cone 
sensitivity with age. Their study identified less SW sensitivity loss in the fovea 
where MP is at the highest levels compared to non-foveal areas. Hammond et al. 
(1998) also found photopic sensitivity was related to MP in subjects aged 60-84 
years. Their study demonstrated a significant relationship for both 550nm 
(p<0.01) and 440nm (p<0.001). However, older individuals (ages 60-84) with the 
highest levels of MP had visual sensitivity levels that were not significantly 
different from younger individuals (ages 24-36). Older individuals with the lowest 
levels of MP had significantly different visual sensitivity levels than younger 
subjects. Their results support a visual sensitivity relationship and suggest that 
potential retinal protection may be offered by MP. 
 
A case-control study performed by Bone et al. (2001) utilized donor retinas from 
56 individuals diagnosed with age-related macular degeneration (AMD) and 56 
control donors without evidence of AMD. Three concentric regions of retina, an 
inner region of 0° to 5°, a middle region of 5° to 19° and a peripheral region of 
19° to 38° were analyzed for L and Z concentration using high performance liquid 
chromatography (HPLC). The differences in L and Z content between controls 
and AMD donors were greatest at the inner region and decreased with 
eccentricity.  A logistic regression analysis showed that individuals with the 
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highest levels of L and Z concentrations had an 82% risk reduction for AMD than 
those with the lowest levels when controlling for both age and gender. The Lutein 
Antioxidant Supplementation Trial (LAST) (Richer et al., 2004) was one of the 
first large scale prospective placebo controlled trials to identify a significant link 
between AMD, lutein supplementation, and visual performance. Treatment 
groups received one of three possible conditions: lutein, lutein plus antioxidants 
or a placebo. MPOD measured at the end of a 12-month trial showed a mean 
increase of nearly 0.09 optical density units from baseline measurements and 
improved visual acuity as well as contrast sensitivity. The NIH-sponsored Age-
Related Eye Disease Study 2 (AREDS2) is the largest multi-center, longitudinal, 
placebo-controlled, randomized clinical trials performed using lutein and 
zeaxanthin supplementation. The study encompasses 2 of the 3 hypotheses of 
MP by using a primary outcome measure as rate of progression to advanced 
AMD (Protection Hypothesis) and a secondary outcome measure of cognitive 
function (Neural Hypothesis). Results for the AREDS2 indicated a 10% reduction 
in progression to advanced AMD when L and Z were added to the original 
AREDS formula. When L and Z were substituted in place of β-carotene, results 
identified an18% risk reduction in advanced AMD within 5 years and a 22% risk 
reduction in neovascular AMD within 5 years. The authors of AREDS2 
acknowledged that a potential competitive inhibition of carotenoids may have 
occurred when both beta-carotene and L and Z were incorporated within the 
original AREDS formulation.   
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Growing evidence indicates that the Protection Hypothesis is better supported by 
the shape of the MP spatial distribution rather than the MP peak density (Wenzel 
et al., 2006 and Stringham et al., 2010). Peak MPOD is typically measured at the 
fovea or central 10 of retina. Large variations in spatial distribution across the 
remaining macula are not reported in foveal measurements which may overlook 
important differences in a total integrated MP versus a single peak MP value. As 
both an antioxidant and SW visible light filter incorporated into the photoreceptor 
axon membrane, L and Z would likely confer greater benefits distributed across 
the macula as opposed to a single, central, isolated peak. Evidence of an 
association between MPOD spatial distribution and an increased risk of age-
related macular degeneration has been described in the literature (Kirby et al., 
2010). The characteristics of L and Z that confer protective benefits in retinal 
disease may be the same characteristics that are able to confer optical benefits 
to both foveal and parafoveal areas.   
 
2. Optical Hypotheses 
The origins of the Optical Hypothesis were first posited by Walls and Judd (1933) 
in reference to ‘oil-droplet filters of a carotenoid nature’ which were associated 
with cone photoreceptors. The ellipsoid containing the oil droplet is located at the 
distal end of the inner segment which covers the outer segment. This positioning 
allows a majority of incident light to pass through it before reaching the visual 
pigment. Later, Nussbaum et al. (1981) advanced the Optical Hypothesis in 
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which MP is specifically referenced. Both summaries shared common ideas for 
the principle functions of an “Optical Hypothesis”. These principle functions are: 
 
1) The improvement visual acuity by a reduction of chromatic aberration 
2) The promotion of comfort by a reduction of glare  
3) The improvement of detail by atmospheric blue-haze absorption 
4) The enhancement of contrast by selective short wavelength light attenuation 
 
Separate, but not mutually exclusive from the Protection Hypothesis, the Optical 
Hypothesis posits MP filters SW visible light causing an attenuation of chromatic 
aberrations and SW light scatter. Related to the SW attenuation properties, MP 
has been described as a dichroic filter exhibiting selective absorption of plane 
polarized light.   
 
The primary focus of the Optical Hypothesis is the theory that MP enhances 
visual potential through optical filtration effects due to its pre-receptoral location 
within the inner layers of the macula. The multi-faceted theory of the Optical 
Hypothesis of MP encompasses several mutually dependent physiological and 
optical roles. In general, the Optical Hypothesis can be broken down into 
separate, interrelated components: the Acuity Hypothesis, the Glare Hypothesis, 
and the Visibility Hypothesis. 
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i. Acuity Hypothesis 
Engles et al. (2007) provided a review of the origins of the Optical Hypothesis.  
First formally proposed in 1866 by German anatomist Max Schultze, the Optical 
Hypothesis postulated that MP may enhance visual acuity by facilitating a 
reduction of short wavelength aberrations through absorptive properties.  
Schultze contended that the selective wavelength absorption of MP helped to 
limit chromatic aberration.  Discussed as the “Acuity Hypothesis” by Wooten et 
al. (2002), it was been proposed that MP improves acuity by screening both 
scattered and aberrated SW visible light that would otherwise degrade image 
quality.   
 
The first empiric measurements to review Shultze’s theory were conducted by 
Reading and Weale (1974). They initially calculated the resulting blur circle due 
to the chromatic aberration of natural sunlight. Using the derived aberration data, 
they were able to derive the spectral transmission of an ideal filter that would 
diminish the SW portion of visible light to near threshold levels at the same time 
maximizing remaining light transmission. The resulting transmission 
characteristics closely resembled the spectral absorption of MP. Reading and 
Weale then used the resulting filter combined with psychophysical data 
associated with chromatic aberration and visual thresholds. From this, they 
determined levels of macular pigment sufficient to decrease the violet (SW) 
portion of a white disc to subthreshold levels and theoretically improve visual 
acuity. 
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Campbell and Gubisch (1966) also measured visual acuity using broadband light 
versus monochromatic light under photopic conditions and found that chromatic 
aberration accounts for ~50% of the variance between physical and 
psychophysical assessments of the human eye’s optical quality. Yoon and 
Williams (2002) repeated the Campbell and Gubisch experiment using strict 
controls and measuring acuity as well as contrast sensitivity. Their results 
demonstrated that at spatial frequency greater than 6cpd, using narrow-band 
light increased acuity measurements by a factor of approximately 1.2-1.5.  
However, neither experiment measured associated MPOD. Therefore, if normal 
optical density of a subject is assumed, the initial contention of Reading and 
Weale (1974) is supported and any additional reduction in SW visible light would 
be largely superfluous and additional improvement in visual acuity would be non-
significant. This same interpretation has been documented in numerous studies 
that document specific bandwidth filters (e.g. yellow filters) in general, may 
improve contrast sensitivity and decrease glare but do not improve spatial 
resolution (Wooten et al., 2002 and Eperjesi et al., 2002). 
 
Engles et al. (2007) reviewed chromatic aberration effects and summarized that 
refractive error with a wavelength dependence will affect retinal image quality of 
a polychromatic stimulus to the greatest degree at wavelengths below 500nm.  
The authors cited Howarth et al. (1986) which stated SW light defocus can reach 
1.6D at 420nm and approximately 1.2D defocus at 460nm. The characteristics of 
chromatic aberration are wavelength dependent image degradation (e.g. 
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longitudinal chromatic aberration) and wavelength dependent image position 
(e.g. lateral chromatic aberration). Each of these components decreases the 
retinal image quality, however; longitudinal chromatic aberration tends to be the 
dominant component in a typical eye. Empirical studies performed by Kaiser 
(1988) show that for each additional diopter of retinal image degradation, visual 
acuity falls by a factor of nearly two.   
 
Engles et al. (2007) created an empiric evaluation of the Acuity Hypothesis by 
direct comparison of macular pigment optical density and both resolution acuity 
and hyperacuity. Previous studies (Yoon et al., 2002 and Wooten et al., 2002) 
had evaluated resolution acuity but Engles et al. extended the hypothesis to 
include hyperacuity. The authors’ position to include hyperacuity was that it 
characterizes the highest level of spatial discrimination and may be the first to 
exhibit improvements with the elimination of image degradation. Their study 
utilized solid black targets presented on a white background with a peak 
wavelength of 460nm or a yellow background with a peak wavelength of 570nm. 
Results revealed no significant correlations between MP and acuity, either 
resolution or hyperacuity, in either background condition.  Engles et al. also 
evaluated a standard observer’s V(λ) curve as it related to optical defocus 
centered on 565nm. They found only a 12% difference in defocus of greater than 
0.25D in the 430nm to 510nm region. The authors concluded that macular 
pigment is not related to resolution acuity or hyperacuity. 
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ii. Glare Hypothesis 
The human visual system is adept at detecting at luminance levels that span 
approximately 8 orders of magnitude (e.g. Pokorny et al., 2006). Retinal 
adaptation adjusts the range of visual sensitivity to prevailing luminance.  
Perceptual difficulties occur when the visual system must adapt to changes 
across this range. Glare is caused by light entering the eye that does not aid 
vision and is most commonly luminance that is too intense or variable across the 
visual field (Mainster et al., 2012). Glare can be evaluated as three distinct forms: 
disability glare, discomfort glare and dazzling glare. Vos (2003) provides a 
comprehensive review of the types of glare.   
 
Disability Glare 
Disability glare has been defined as loss of retinal image contrast resulting from 
veiling illuminance or intraocular scatter. Decreased visual performance follows 
the loss of retinal image contrast as a consequence of increased forward scatter 
within the eye. Diminution in visual potential may result from both veiling 
illuminance that reduces the object contrast as well as photopigment depletion 
and regeneration rates. The origins of disability glare support a dependence on 
the overall luminance and wavelength created by a glare source (Aslam et al., 
2007). Forward scattering or straylight is not the primary cause of disability glare 
symptoms in all cases.  At smaller angles of incidence, neural inhibition at the 
level of the retina can add to disability glare through retinal gain models (van den 
Berg et al. 1991). 
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Increased MPOD will not affect glare disability when the wavelength of the 
stimulus and the wavelength of the background are the same (Stringham et al., 
2007).  If MP absorbs SW light from the stimulus and background in equivalent 
amounts, the ratio will remain comparable regardless of the MP density level.  In 
this instance, high MPOD may diminish visual discomfort but it will not increase 
stimulus visibility (Renzi et al., 2010a and Wenzel et al., 2006).  Strictly speaking, 
MP filters the veiling luminance of the target at the retinal plane proportional to 
the MPOD for SW light. 
 
Discomfort Glare 
Discomfort glare has been characterized as exacerbation or generation of pain 
as a consequence of light exposure which does not necessarily impair object 
visibility. Digre and Brennan (2012) defined photophobia as ‘a sensory state in 
which light causes discomfort in the eye or head possibly involving an avoidance 
reaction without overt pain’. The authors also drew a distinction with the term 
photo-oculodynia used to describe light-induced pain from a normally non-painful 
source such as ambient lighting.  According to Lapid-Gortzak et al. (2011), 
clinical complaints of photophobia resulting from a small posterior capsulotomy 
following a cataract procedure were associated with increased straylight values.  
The authors concluded that, in some case, photophobia may be a result of 
increased intraocular scatter. 
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Stringham et al. (2003) and Stringham et al. (2004) evaluated the effects of MP 
on glare discomfort.  Together these two studies showed the degree of visual 
discomfort was significantly higher if the glare source contained SW light 
compared to mid and long wavelength visible light.  Their results further identified 
that in subjects with higher levels of MPOD, a greater intensity of SW light was 
required to produce an avoidance response.  In retinal eccentricities greater than 
100 where MP levels are non-significant, significantly less intensity of SW light 
was required to elicit the same avoidance response. 
 
Dazzling Glare 
Dazzling glare is a form of discomfort glare associated with disability glare. 
Sheehy (1989) reported the loss in visual performance resulting from 
wavelengths within the visible spectrum and detailed the characteristics of eye 
protection necessary based on visual performance. It is commonly encountered 
as high retinal illuminance across the visual field in scenarios such as expanses 
of snow or water and facing the sun when it is low in the horizon (Vos 2003).  
Dazzling glare typically results in a light avoidance behavior and is related to 
photostress (high retinal illuminance leading to bleaching of photopigments, 
afterimages and temporary, reduced retinal sensitivity) and scotomatic glare 
(transient visual disturbances usually associated with minimal discomfort). 
 
The Glare hypothesis is derived from the selective filtering properties of MP on 
short wavelength light (Stringham et al., 2007). SW light as a significant 
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contributor to the ocular discomfort and disability related to exposure from a glare 
source has been identified in the literature (Stringham et al., 2003 and Mainster 
et al. 2012). A 2007 study by Stringham et al. defined the origins of disability 
glare as the ‘forward scattering of light resulting from illumination at the retina 
that directly reduces image contrast ’. Their results supported a significant 
dependence of disability glare on the overall luminance created by a glare 
source. Stringham et al. inferred that the global effects produced by MP optical 
filtration are greater under broadband, achromatic  light sources in contrast to 
narrow-band SW light sources. Importantly, Stringham et al. (2007) recognized 
that MP effects on glare disability result from the spectral characteristics of the 
light source. Their technique involved the use of a 10 grating with a spatial 
frequency of 5cpd at 100% contrast as a central stimulus. A xenon arc annulus 
with an inner diameter of 11o was adjusted by the subject and the radiance of the 
glare source was recorded when the subject reported that the grating was no 
longer visible. Their findings demonstrated significance at 440nm (r = 0.36, p = 
0.032) and 460nm (r = 0.34, p = 0.039) but non-significance at 550nm and 
580nm. Overall, the authors were able to explain 58% of the variance of target 
visibility through subject differences in MPOD. MP will not decrease glare 
disability if the source does not contain a substantial amount of SW visible light 
(Stringham et al., 2007).   
 
These studies support the idea that MPOD plays a role in visual discomfort due 
to glare reduction but do not address whether improvements in visual 
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performance occurs. Stringham and Hammond et al. (2007) performed an 
empiric study of both photostress and glare disability as they relate to MPOD.  
Their results revealed a significant correlation of visual thresholds under glare 
conditions with MP density (r = 0.76, p<0.0001) and photostress recovery time, 
after exposure to xenon-white light, was significantly lessened for subjects with 
higher MP levels (r = -0.79, p<0.0001). Results of the study also found that MP 
displayed a stronger correlation coefficient to both glare disability and 
photostress recovery in the broadband white testing conditions compared to 
narrow-band short-wavelength light. 
 
iii. Visibility Hypothesis 
The Visibility Hypothesis has its origins from Luria (1972) who demonstrated that 
resolution threshold for a yellow stimulus on a blue surround is improved when 
observed through SW-selective filters. The result was later confirmed by 
Wolffsohn et al. (2000) using contrast sensitivity measurements. A SW specific 
filter reduces the luminance of blue backgrounds resulting in increased visibility 
of the yellow stimulus. 
 
The basic theory of the visibility hypothesis was summarized by McCartney 
(1976). At every point along a line of sight to a point on a distant object, light 
reflected from the object will interact with particles within the atmosphere and 
consequently increase light scatter towards the observer. Husar et al. (2000) 
suggested that, separate from the optical and neurological status of the subject, 
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scatter due to atmospheric composition is the primary determinant of visual 
discrimination and range at large distances.   
 
Visibility was defined by Wooten et al. (2002) as the clearness with which objects 
in the atmosphere stand out from their surroundings. It is the atmospheric 
composition that guides the visibility hypothesis when considering the physics of 
light scatter. Light scattering results from particle interactions that occur along an 
electromagnetic wave path that simultaneously removes energy from the incident 
wave and emits that energy at a solid angle from the particle. Scattering only 
occurs when the particle’s refractive index differs from the surrounding medium 
(e.g. smog, haze, and vapor). The amount of scatter depends on the particle type 
and concentration within the atmosphere. This particle-dependent scatter largely 
dictates the quality of vision in an outdoor environment. Rayleigh (elastic / small 
particle) and Mie (inelastic / large particle) scattering are essential theories for 
describing the effects SW light within the environment (Wooten et al., 2002).   
 
If scatter within the eye is wavelength dependent as it is in the clear atmosphere, 
then MP may increase the resolution of the retinal image by selectively screening 
the highly scattered SW visible light. Straylight from the cornea and lens 
increases with decreasing wavelength showing a Rayleigh type of scattering (van 
den Berg, 1997) and straylight from fundus reflectance and transillumination  
decreases with decreasing wavelength (van den Berg et al., 1991). Coppen et al. 
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(2006) suggested the presence of significant forward scatter of SW light and 
relatively less backward scatter of SW light to be absorbed by MP.   
 
The Visibility Hypothesis posits that the resolution of a distant object is affected in 
primarily two ways: 1) Light reflected from an object demonstrates increased 
scatter along the sight path and 2) Background light energy is scattered into the 
eye, not directly reflected from the target. Considering the object’s visibility 
against the horizon, an underlying theory of the Visibility Hypothesis suggests 
that atmospheric scattering reduces the relative contrast of objects (Wooten et 
al., 2002). Wavelength dependence of object background and wavelength 
dependence of object are critical components of determining MP influences on 
the scatter resulting from atmospheric particle interactions referred to as the 
atmospheric haze coefficient by Wooten and Hammond. 
 
Wooten et al. (2002) summarize the mathematical derivation of the atmospheric 
haze coefficient by integrating the CIE photopic luminosity function and the 
spectral energy of the natural illuminant. They proposed that the non-image 
forming portion of atmospheric light acts as a veiling luminance with respect to 
the targets seen through it. In addition, Rayleigh scattering influences the 
atmospheric background wavelength causing SW light to become the dominant 
wavelength as the viewing distance increases. MP absorbs wavelengths 
primarily in the 410-520nm range and will have a quantitatively different effect on 
the SW dominant background versus object wavelength (Snodderly et al., 1984).   
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The increased retina image resolution described by the Visibility Hypothesis may 
have its origins in the dichroic properties of MP due to its fundamental anatomic 
orientation features. Linear dichroism is defined as a difference in absorption of 
light linearly polarized parallel and perpendicular to an orientation axis (Bengt, 
1997). In a 1980 paper, Bone briefly reviewed existing experimental evidence 
that partial symmetry of L orientation within the retina was created dichroic 
properties. His work proposed a ‘dichroic ratio’ investigating the absorption of 
incident polarized light parallel and perpendicular to the molecule axis. The 
presence of linear dichroic properties exhibited by the MP supports that a portion 
of the L orientation must be arranged tangential with respect to the fovea 
(Mission, 1993).  Bone et al. (1985) speculated that Haidinger’s brush 
phenomena are a result of the dichroic properties of L and Z. These identified 
dichroic properties are likely derived from the perpendicular arrangement of Z 
and the non-orthogonal positioning of L within the lipid membrane layer 
referenced above (N’Soukpoe-Kossi et al., 1988). Work by Hemenger (1992) 
agreed that MP exhibits these dichroic properties and may reduce glare disability 
through selective absorption of polarized light. Sujak et al. (2000) provided 
further support that the cone axons projections from the central fovea to form the 
outer plexiform layer or Henle fiber layer  causes both L and Z to display dichroic 
properties. The perpendicular membrane orientation of both L and Z within the 
radial projections of the Henle fiber layer may allow specific absorption of plane-
polarized light.   
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3. Neural Hypothesis 
L and Z have been studied extensively for their roles in singlet oxygen 
scavenging and ROI neutralization within retinal tissue (Krinsky et al., 1989 and 
Khachik et al., 1997 and Paiva et al., 1999). L and Z models have proposed anti-
inflammatory properties through modulation of lipoxygenase activity and 
decrease oxidative stress in high metabolic environments including the RPE 
(Krinsky et al., 2005).   
 
Anatomically, the retina is an extension of the brain consisting of axons which 
form the optic nerve and project to both cortical and subcortical locations. Like 
the CNS, the retina also displays physiologic and immune responses similar to 
those found within the brain. The brain, like the retina, is susceptible to lipid 
peroxidation, increased production of ROI and increased levels of oxidative 
stress as a result of a high metabolic rate. Craft et al. (2004) identified that 
approximately 66-77% of the total carotenoids found in the brain were L and Z.  
These concentrations of L and Z were highest within the pons and medulla and 
cortical structures such as the frontal and occipital lobe. The preferential 
accumulation of L and Z within CNS tissue supports a potential role in neural 
function.   
 
Vishwanathan et al. (2012) assessed a primate model of the retinal L and Z 
levels compared to brain L and Z levels. Their findings showed retinal L was 
significantly associated with levels of L in the pons, cerebellum and occipital 
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cortex with marginal significance in the frontal cortex.  Macular Z was significantly 
associated with levels of Z in the cerebellum and frontal cortex with marginal 
significance in the pons and occipital cortex. The authors suggested that an 
integrated measure of MPOD has the potential to serve as a biomarker for brain 
L and Z level. 
 
Early investigation into L and Z by Bernstein et al. (1997) showed that, within 
neural tissue, L and Z accumulate at the location of the microtubules forming the 
cytoarchitecture of retinal axons. Crabtree et al. (2001) identified the role of 
tubulin as a potential binding protein that specifically accumulates L and Z within 
axon cell membranes. Stahl et al. (2002) recognized that, in addition to structural 
roles, microtubules can also influence gap junction communication and neural 
transmission. Gap junction transmission is an important mediator between glial 
cells and neuron within the retina propagating action potentials. Gap junction 
communication has also been connected to the transfer of metabolites and 
electrolytes within the sensory retina. Wieslaw et al. (2004) identified positive 
metabolic effects of L and Z on the structure and equilibrium of neural 
membranes through the protein lattice structures formed from tubulin. Hammond 
et al. (2008) proposed that the physiologic and structural elements of L and Z 
combined with their conspicuous positioning within the CNS may influence neural 
processes. Zimmer and Hammond (2007) identified data showing the inverse 
relationship between MP density and rod-mediated (scotopic) noise hypothesized 
to originate at the level of the retina.  
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Akbaraly et al. (2007) identified a link between serum levels of Z and cognitive 
functioning. Using a Mini-Mental State Examination, Akbaraly et al. showed that 
participants with cognitive functioning in the lowest quartile had a significant 
probability of having plasma Z levels in the lowest quartile (OR: 1.97, CI:1.21-
3.20). Johnson et al. (2008) demonstrated a significant relationship between L 
and both verbal fluency and memory scores in women ages 60-80 years in a 
placebo-controlled trial. Johnson et al. (2013) recognized serum L and Z were 
related to cognitive function including memory, processing speed, attention, and 
executive function. In brain sample, L was related lower dementia severity 
(p<0.05). Feeny et al. (2013) identified lower foveal MPOD with reduced 
performance in individuals over 50 years of age on a range of cognitive tasks 
including the Montreal cognitive assessment (p = 0.011) and a mini mental state 
assessment (p = 0.026). 
 
Decreased L and Z serum levels have also been associated with mild cognitive 
impairment (MCI) and Alzheimer’s disease (AD). Rinaldi et al. (2003) identified 
decreased levels of serum L in MCI (p<0.01) and AD (p<0.0001) and decreased 
levels of Z in MCI (p<0.01) and AD (0.0001). Nakagawa et al. (2011) 
hypothesized that the xanthophyllic carotenoids, specifically L, may inhibit 
amyloid-β damage to red blood cells and decrease the oxidative injury caused to 
the brain.   
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C. Measurement Methods 
Widely accepted as the “gold standard” of MP measurement, high performance 
liquid chromatography (HPLC) has been employed in spatial distribution and 
quantitative analysis studies (Gellerman, 2004; Brown, 1990). HPLC is used 
extensively within biochemistry and analytical chemistry to identify and quantify 
individual components of a substance (Brown, 1990). Unfortunately, the ex vivo 
nature of HPLC measurement prevents application of this technique to a clinical 
population.   
 
At the very core of an in vivo MP measurement lies the matching of spectral 
absorption curves from L and Z to any method, objective or subjective. The 
difficulty of this proposition is replicating the in vivo environment in an accurate, 
quantifiable ex vivo situation. For example, L and Z show a change in spectral 
absorption when isolated within ethanol versus lipid-rich preparations (Bone, 
1985; Handelman, 1991). The orientation of these molecules also differ in their 
proposed role in spectral filtration and antioxidant properties, underscoring the 
importance of understanding the in vivo versus ex vivo data (Sujak, 1999). 
 
The more recent development of in vivo techniques of MPOD measurement has 
shown great promise using both objective and subjective methods. Objective 
methods include fundus reflectometry, fundus autofluorescence, resonance 
Raman spectroscopy, and visually evoked potentials (Howells, 2011). Each of 
these techniques share the common advantage that all objective measurements 
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share: Objective results that require minimal patient participation. However, the 
previously listed objective measurement devices also share significant 
disadvantages such as minimum required pupil diameter, media opacity 
considerations (lens clarity), imaging artifacts, need for retinal bleaching to limit 
photopigment absorption, significant expense and, in the case of resonance 
Raman spectroscopy, no comparative data (Hammond, 2005).  
 
Subjective methods of in vivo MPOD measurement are also commercially 
available. These include threshold spectral sensitivity, color matching, dichroism-
based measurements, minimum motion photometry, apparent motion 
photometry, and heterochromatic flicker photometry (HFP) (Hammond, 2005). 
Threshold spectral sensitivity targets the difference spectrum of MP by 
comparing the spectral sensitivity of the M cone mechanism in the foveal and 
parafoveal region by isolating a single photoreceptor sensitivity range (Pease et 
al., 1983). Color matching techniques involves two separate color matches: one 
performed at the fovea and another performed at 5o of eccentricity. The 
reference stimulus contains 490nm wavelength desaturated by 650nm 
wavelength. The reference stimulus is then matched by combining spectral 
primaries of 460nm, 530nm and 650nm wavelengths. The ratio of the 00:5o 
eccentricity color match determines the MPOD (Davies et al., 2002). Dichroism 
measurements rely on the partial plane polarization effects created by the shared 
distribution of L and Z orientations within the retinal layers. Dichroic 
measurements compare the foveal and parafoveal sensitivity against a 
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dichroism-based spectrum and difference measurements reflect the level of MP 
(Bone et al., 1992). Minimum motion photometry and apparent motion 
photometry share underlying perceptual principles: Moving square wave gratings 
are creating using alternating wavelengths with one wavelength strongly 
absorbed by MP and the other minimally absorbed by MP. The radiance of the 
longer wavelength is adjusted by the subject until the motion appears to slow 
(minimum motion photometry) or reverse (apparent motion photometry).  The 
square wave target is presented at foveal and parafoveal locations and a log 
ratio of these values determine MPOD (Moreland, 2004).  
 
HFP is the most common and widely studied method of measuring MP 
(Hammond, 2005). Within existing literature, over 50 publications utilized HFP in 
their studies of MPOD. This large collection of peer-reviewed work allows for the 
scrutiny of existing assumptions and further experimental evaluation. For these 
reasons, effort and resources were focused on HFP.   
 
1. Heterochromatic Flicker Photometry 
The ideal method of measuring MPOD depends on the specific application and a 
consideration of the limitations and assumptions underlying the use of each 
method. Preferably, the method employed should be capable of generating a 
spectral curve that can be compared with ex vivo template data. Provided below 
is a macular pigment spectral curve created from data by Wyszecki and Stiles 
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(1982) Bone et al. (1992), Ruddock (1963), and Pease et al. (1967) identifying 
optical density as a function of wavelength 
 
Figure 1 
A fitted macular pigment spectral curve created from data by Wyszecki and Stiles (1982) Bone et al. (1992), Ruddock 
(1963), and Pease et al. (1967) identifying optical density as a function of wavelength. 
 
Like many of the techniques described above, HFP utilizes the known spectral 
absorption properties of L and Z in combination with the presumed anatomic 
location of MP.  HFP determines MPOD by presenting a stimulus of two 
alternating narrowband wavelengths at the fovea and a parafoveal location. The 
peak wavelengths are selected specifically to maximize macular pigment 
absorption (458-476nm) and to minimize macular pigment absorption (530-
575nm). When the two alternating colors are presented at a proper frequency, a 
dissimilar luminance of the two wavelengths will be perceived as a flickering light 
with a mixture of the two source wavelengths. The radiance of the blue 
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wavelength is increased by the observer until the flicker is minimized and 
equiluminance of the blue and green wavelengths is achieved.  This procedure is 
presented at the foveal location then a parafoveal reference location to measure 
a maximum of MP absorption and a minimum of MP absorption. The tenet of 
HFP is dependent upon the retinal location and absorption spectra of macular 
pigment. MP has peak absorption at 460nm and demonstrates its highest density 
at the fovea diminishing with eccentricity at ~7o where negligible MP is identified 
through HPLC. Using this approach, a greater intensity of blue light will be 
required at the fovea where MP is the highest relative to a parafoveal location.  
The log ratio of blue light radiance at the fovea compared to parafoveal location 
is the measured MPOD.   
 
One type of HFP device utilizes a Maxwellian optical system with a bite bar for 
head stabilization. These complex designs require considerable training to 
operate and require considerable training associated with their set-up. Free-
viewing devices have offered an alternative to the more complex Maxwellian 
system. Several studies has established the strong correlation between device 
results and determined that accuracy is not compromised (Wooten, 1999 and 
Beatty et al., 2000).    
 
Of critical importance to measurement procedures are size of the testing fields, 
flicker rates of stimulus, and background luminance. First, the testing field is 
viewed a near-working distance using a 1o central stimulus. Exceptions to these 
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parameters exist but all fall within a similar range. The stimulus wavelength is 
determined to maximize MP absorption centered at 460nm and deviation from 
this peak must be corrected for during final determination of MPOD. Bandwidth of 
stimulus source may also be adjusted recognizing that the more narrow the 
bandwidth, the more accurate the MPOD measurement but at the cost of 
luminance. In the first HFP device described by Wooten et al. (1999), the LED 
source with peak energy at 458nm had a half-bandwidth of 20nm. As a result, the 
measured MPOD was corrected by a 15% constant. Parafoveal reference 
locations used by HFP devices range from 4o (Hammond, 200) to 12o (Werner, 
2000) eccentric from the fovea. As alluded to above, the parafoveal reference 
locations are used under the assumption that no MP exists at these points. 
Accurate selection of the parafoveal retinal locus is critical for accurate MPOD 
measurement. Negligible MP has been identified at outside 7o of eccentricity by 
HPLC (Bone, 1992). Incorrect assumption of absent MP will lead to significant 
underestimation of true optical density.  
 
Secondly, the selected flicker rates for alternating blue/green wavelength 
stimulus rely on individual subject’s flicker sensitivity. If flicker rate is set too low, 
the subject will have trouble correctly identifying a point of null flicker. If the flicker 
rate is set too high, the subject will show a large range of null point variability 
creating variations in measurements. Ideally, the approach is to create a 
repeatable, customized flicker rate for each subject at both the foveal and 
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parafoveal locations. Parafoveal reference locations employ the same flicker 
stimulus with a properly calibrated flicker rate for a non-foveal point.   
 
Finally, the background field that the stimulus is presented upon must both 
suppress the S-cone contribution and provide photopic conditions in order to 
suppress rod pathway interaction. Previous designs have utilized either a blue 
wavelength background or high luminance white background. The size of the 
background field that the stimulus is presented upon has also been reported in 
the literature from 4o to 30o. Small background fields of 4o present difficulty when 
parafoveal reference points require at least 7o of eccentricity to ensure absent 
macular pigment. Large fields of 30o however, present their own challenges with 
subject accuracy and sensitivity to a 1o stimulus within a high luminance field.   
 
Interference of MPOD measurement from ocular media absorption or scattering 
is controlled in HFP by using the parafoveal reference location. For example, 
crystalline lens brunescence would influence MPOD values but is controlled for 
by using the equally-affected measure outside the fovea during calculations. 
Unequal intrasubject retinal distribution of L and M photoreceptors and their 
differing spectral sensitivities are also controlled for through an invariant 
background field with a superimposed stimulus measured at a foveal and 
parafoveal location. 
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II. Visual Performance 
A. Spatial 
Measurement of spatial visual acuity can be accomplished in several different 
ways. The more conventional measurements include a confirmation of the 
presence of an object (minimum visible), or the distinction between two point 
sources (minimum resolvable), or the detection of the minimum offset of position 
(hyperacuity) (Wyszecki and Stiles, 1982). In the case of all three measurements 
of acuity, both physical and physiological factors determine visual performance.  
These physical and physiological factors include the optics of the eye, the quality 
of the retinal image, the structure and function of the retina, and the capacity of 
the neural stages of transmission of visual information (Westheimer, 1964). 
 
Resolution acuity (RA) is defined as the minimum perceivable angular distance 
subtended by the centers of two point sources that can reliably identified as two 
points as opposed to one (Westheimer, 2001 and 2003a). This threshold is 
determined by at least two of the above mentioned factors: 1) Ganglion cell 
packing density and receptive field convergence of the photoreceptor input and 
2) the quality of the image dictated by the optical constituents of the eye.   
 
Building on the established principle of cone receptor density and ganglion cell 
convergence, Virsu and Rovamo (1979) proposed the invariance principle. They 
suggested an equivalent resolution of visual stimuli existing at any point within 
the visual field if the stimuli are compared in terms of cortical projection or M-
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scaled. The cortical magnification scaling, suggested by Virsu and Rovamo 
(1979), is designed to balance the area of V1 neurons stimulated so that cortical 
projection becomes independent of retinal location within a receptive field. The 
values of calculated cortical projection used in their scaling were directly related 
to the square root of retinal ganglion cell receptive field density. The orderly 
composition of V1 (Hubel and Weisel, 1977) allows M-scaling to keep the 
number of stimulated cortical neurons constant. Using equivalent quantities of 
stimulated retinal ganglion cells and cortical cells, Virsu and Rovamo (1979) 
further suggested that it was possible to generalize to other points within the 
visual pathway. 
 
The spatial modulation transfer function (SMTF) is a measure of the object:image 
contrast ratio as a function of spatial frequency (Van Nes et al., 1967). Their work 
determined that when longitudinal chromatic aberration effects are controlled for, 
photopic contrast sensitivity function is equivalent across the visible spectrum.  
Van Nes et al also reported that low retinal illuminance followed the de Vries-
Rose Law: under dim illumination, variations inherent in a background source 
largely determine threshold.  At higher retinal illuminance, threshold modulation 
followed the Weber-Fechner Law: As the background illumination is increased, 
the intensity of the stimulus must also be increased so that the ratio of 
stimulus:background remains constant.    
 
The SMTF describes the quality of an optical image produced by an optical 
system.  The determination of the visual system SMTF utilizes a spatial grating 
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pattern of a known contrast to serve as the object. As the light from the object 
passes through the optical system, some degradation of the image occurs. The 
contrast of the resulting image is measured and the ratio of object:image contrast 
can be calculated. By performing this technique to a range of low to high spatial 
frequencies, a SMTF is produced and is commonly referred to as the contrast 
sensitivity function (CSF). Loughman et al. (2010b) reported a theoretical 
improvement of resolution acuity up to 0.1 log units by correction for chromatic 
aberration due to the characteristic short wavelength absorption. This theoretical 
refinement is in line with earlier published work involving the limiting effects of 
chromatic aberration on the SMTF (Thibos et al., 1991). 
 
Thibos (1990) stated that an image-forming optical system exhibits chromatic 
aberration if its focal length is not independent of wavelength. Although 
differences in focal length among different wavelengths define chromatic 
aberration, SW light appears to be the principle contributor to reduced image 
quality when regarding the composition of the visible spectrum. The level of 
defocus due to chromatic aberration in addition to the typical diffraction pattern 
would operate in concert to widen Airy’s disc. According to the hypothesis 
originally proposed by Schultze (Magnussen et al., 2001), the filtering effect MP 
on SW light would sacrifice a small amount of retinal illumination for a more 
narrow diffraction pattern resulting in increased contrast and potentially improved 
resolution acuity.   
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Engles et al. (2005a/b) used bandpass filters that provided a comparable spectral 
absorption profile of the human lens and macular pigment equivalent to 0.7 log 
optical density unit. Engles et al. demonstrated an improvement in visual acuity 
as measured by Landolt C (2005a) and contrast sensitivity (2005b) using the 
simulated SW filter under broadband illumination. Engles et al. (2007) later 
performed an empiric study of the Acuity Hypothesis involving human subjects.  
Using MP as a study variable and resolution and vernier acuity as visual 
performance measure, their group was unable to correlate MPOD with either 
resolution acuity or hyperacuity drawing the predictions of the Acuity Hypothesis 
into question.   
 
Wooten and Hammond (2002) proposed that optical mechanisms separate from 
chromatic aberration may hypothetically improve visual performance under the 
type of conditions where most yellow filters show enhancement. The authors 
termed this improvement the Visibility Hypothesis of macular pigment proposing 
the idea that macular pigment may improve vision by reducing the forward 
scatter caused by short wavelength dominant light and reducing veiling 
luminance through selective absorption. Thibos et al. (1991) determined that the 
influences from chromatic aberration on the SMTF were relatively small, 
estimated at approximately 0.15D of defocus. Effects of chromatic aberration are 
most likely encountered at the upper resolution limits of visual acuity although the 
luminous efficiency curve predicts that wavelengths near the edges of the V(λ) 
curve will have less effect on human visual sensitivity (Thibos et al., 1991).   
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B. Temporal 
Neural transmission efficiency within the visual system, like other neural 
structures, is limited by a number of conditions including processing speed and 
conduction rate (Vaney et al., 1998). A review by Hammond (2005) outlined a 
method of determining variations the speed of temporal processing by calculating 
the temporal modulation transfer function (TMTF). Spatial visual function can be 
described by the contrast sensitivity function, or SMTF, (sensitivity versus spatial 
frequency) just as temporal vision can be described by the TMTF (sensitivity 
versus temporal frequency) (Regan, 1982). Several studies have explored the 
high frequency portion of the TMTF (Rovamo et al., 1984, Mayer et al. 1988 and 
Hammond et al., 2005). One of the methods available involves a counter-phased 
square wave and is known as the critical flicker fusion (CFF) threshold. Mayer et 
al. (1988) found significant differences in the TMTF thresholds related to age 
supporting a decline in temporal sensitivity with increasing age. Hammond et al. 
(2005) found a positive relationship between MP and CFF and identified that this 
association was independent of age. The authors suggested that L and Z could 
theoretically improve neural signaling efficiency throughout the visual system.   
Renzi and Hammond (2010) measured a comprehensive temporal contrast 
sensitivity function (TCSF) using a 1o circular stimulus at the fovea and a 7o 
parafoveal location. MPOD was measured using HFP and a 1o circular stimulus 
and found a significant relationship between MP and the full TCSF at the foveal 
location (p<0.01) but not the parafoveal location (p=0.07). Their results also 
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identified a significant, positive correlation between foveal MPOD and foveal CFF 
(r = 0.21, p<0.001). 
 
Renzi et al. (2010) summarize results from a number of sources including Curran 
et al. (1990) and Parrot (2008) which indicate that CFF is likely determined post-
receptorally and CNS function has a direct influence on CFF thresholds. Hawken 
et al. (1996) reviewed the temporal response characteristics between LGN 
neurons, which receive direct input from the retinal ganglion cells, and V1 
neurons. Their work showed V1 response characteristics with reduced sensitivity 
to CFF rates indicating a possible loss of temporal information within the LGN.  
Hawken et al. concluded that intracortical mechanisms likely influence V1 
temporal response dynamics because their temporal properties are not derived 
from the LGN and significant variability in temporal tuning exists. As described 
above in the Neural Hypothesis, L and Z have been shown to improve gap 
junction transmission efficiency and improvements in signal transduction velocity 
(Stahl et al., 2002) both of which may improve temporal processing speed within 
the visual system.   
 
C. Differences across the Visual Field 
Robson and Graham (1979) described a probability summation hypothesis which 
involved 2 underlying assumptions: a target will be detected by a subject when 
any one receptive field is activated by the target within the visual field and that 
receptive field activation is independent of the likelihood that any other receptive 
P a g e  | 68 
 
field will also be activated. They further hypothesized that the relationship 
between contrast sensitivity and spatial frequency can be explained by the 
probability summation across the stimulated area if variation in sensitivity across 
the visual field is accounted for. 
 
Virsu and Rovamo (1979) described the effects of target area and spatial 
frequency on contrast sensitivity depends on a central integrator which sums the 
activity of a receptive field over large cortical areas. They determined that CS 
may be a result of extensive summation across a number of spatial frequency 
channels that have differing levels of sensitivity and specificity. Further, targets 
presented at different positions across the visual field will have equal sensitivity 
responses if they share equivalent cortical projections: contrast sensitivity is 
direct function of the number of stimulated receptive fields. 
 
Pointer et al. (1989) measured differences in contrast sensitivity along each of 
the four principle meridians using horizontal grating targets. They determined that 
contrast sensitivity is highest for all spatial targets of 0.5-24cpd and parafoveal 
reduction in sensitivity can be conveyed as a linear function is contrast sensitivity 
is expressed in relative units such as periods of the target. 
 
Previous psychophysical studies have explored the theoretical link between 
visual performance and underlying retinal ganglion cell density (Thibos et al., 
1987, Anderson et al., 1991 and Thibos et al., 1996). Thibos et al. (1987) 
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provided findings that grating resolution in the peripheral retina is defined by the 
ganglion cell density. The authors referred to the underlying neural performance 
limitation as sample-limiting performance and further defined the resolution limit 
and its relation to aliasing.  Further work by Anderson et al. (1991) concluded 
that for achromatic targets, peripheral spatial resolution is limited by both an 
underlying ganglion cell density and a post-receptoral mechanism.   
 
Thibos et al. (1996) provided a brief review of two separate measures of visual 
performance across the visual field described as resolution thresholds and 
detection thresholds. Resolution thresholds are referred to as the highest spatial 
frequency at which orientation can be recognized and signifies the spacing of the 
retinal ganglion cells and the resulting Nyquist limit. Detection threshold is the 
highest spatial frequency at which contrast can be recognized and is determined 
primarily by the optics of the eye. Thibos et al. (1996) reported that the shape of 
the SMTF, or contrast sensitivity function, can be determined by whether a 
resolution threshold or detection threshold was used offering further support that 
resolution thresholds are restricted by the underlying retinal density of the 
ganglion cell receptive fields. 
 
D. Interaction of Visual Performance Measures 
A decrease in visual performance may be caused by the loss of retinal image 
contrast due to surface reflections or bright luminance sources creating 
increased forward scatter of light within the eye (De Waard et al., 1992). 
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Intraocular scatter has an inverse relationship to the glare angle squared. Vos 
(1984) suggested that visual effects experienced in disability glare, as defined by 
the CIE, are similar to visual effects experienced in intraocular scatter. The 
resulting disability glare can decrease visual performance by two primary means, 
direct reduction in the contrast of the retinal image and a veiling luminance at the 
retinal plane caused by peripheral intraocular scattering. According to a review 
by Vos (2003), at smaller angles of incidence, inhibitory neural interactions at the 
retinal level can add to disability glare. 
 
Franssen et al. (2006) discussed intraocular scatter as a measure of the effects 
caused by the inhomogeneities of the eye’s optical elements on incident light 
arriving at the cornea. Backward light scatter will primarily reduce the amount of 
light reaching the retina while forward scatter will reduce contrast (both chromatic 
and achromatic) at the retina by increasing the spread of light. This forward 
scattering may cause a veiling luminance across the retina leading to a decline of 
resulting image contrast (van den Berg, 1995). Puell et al. (2008) found that inter-
subject differences in foveal MPOD showed a significant correlation with 
intraocular scatter in healthy, non-cataractous eyes. It has been identified by both 
Stringham et al. (2011) and Hammond et al. (2012) that MPOD has a positive 
effect on disability glare which suggests that MPOD may also have a role in the 
reduction of intraocular straylight. 
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Reading and Weale (1974) first introduced the role of MP on longitudinal 
chromatic aberration and Thibos (1987) found that, in reference to lateral 
chromatic aberration, selective filtering by MP increased target contrast by a level 
that increases with spatial frequency to a factor of ~1.5 at the spatial resolution 
limit. Hemenger (1992) introduced the proposed role the MP’s preferential 
absorption of plane polarized light may be related to lower root-mean-square 
aberrations. The dichroic nature of MP (Bone et al., 1992), with its major axis of 
absorption oriented tangential to a circle centered on the fovea support a 
potential absorption property of plane polarized light.   
 
III. Existing Evidence of Macular Pigment Role in Visual Performance 
One of the first experiments to evaluate the association between MPOD and 
visual performance under glare conditions was published by Stringham and 
Hammond (2007). Thirty-six (36) subjects (age range: 18 to 41), using HFP with 
a free-view macular densitometer, developed individual spatial distribution 
profiles of MPOD. Photostress recovery times and grating target visibility under 
glare conditions were measured in a Maxwellian-view optical system. For glare 
disability assessments, subjects fixated a 1° target utilizing a 100% contrast 
grating target. The radiometric power of an annulus (which served as the glare 
source) with an 11°/12° inner/outer diameter was adjusted until the grating target 
was no longer visible. Thresholds under glare conditions revealed significant 
correlation coefficients related to MPOD (p< 0.001) when using a broadband 
xenon light source. The authors concluded that an increase in MPOD is related 
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to decreases in glare disability and photostress recovery times consistent with 
known established spectral absorption characteristics and spatial distribution 
profile of MPOD. 
 
The Stringham and Hammond investigation (2008) assessed the relationship of 
MP to improvements in glare disability and photostress recovery time after 
supplementation with lutein and zeaxanthin for 6 months. Forty (40) subjects 
(mean age 23.9) were evaluated by HFP to create spatial MPOD profiles at 
baseline, 1, 2, 4, and 6 months.  Both disability glare and photostress recovery 
were assessed with a Maxwellian-view optical system.  For assessments of 
disability glare, a 100% contrast, 1°grating stimulus of 5cpd was used and the 
intensity of an 11 °inner/12 °outer annular xenon-white source was adjusted until 
the grating stimulus could no longer be resolved. Photostress recovery employed 
the same target using a 5o central disc delivering 5.5 log Trolands of retinal 
illuminance for a 5 second duration. At baseline, visual performance as assessed 
by glare disability and photostress recovery showed high correlation with MPOD. 
After 6 months of L and Z supplementation, mean central MPOD increased 
nearly 40% and glare disability (r = 0.59, p < 0.0001) and photostress recovery ( r 
= -0.66, p < 0.0001) were found to be significantly related to increases in MPOD.   
 
Loughman et al. (2010) evaluated the association between MPOD and visual 
performance. One hundred forty-two (142) subjects (mean age: 41 with SD of +/-
6) were assessed to determine the spatial profile of their MPOD through HFP. 
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Visual performance measurements included best corrected visual acuity, contrast 
sensitivity, glare disability, and photostress recovery time. Glare disability was 
measured under medium and high glare conditions assessed at 42 lux and 84 
lux, respectively. Psychophysical measurements of best corrected visual acuity 
and central contrast sensitivity showed a positive correlation (p < 0.05) with 
MPOD. Photostress recovery time and glare disability showed no significant 
correlation to MPOD (p>0.05). Important to note, the glare source output utilized 
by Loughman et al. did not contain a significant amount of SW light. The source 
utilized for the glare disability and photostress recovery were tungsten-based 
sources. These sources provide substantially more spectral irradiance between 
520-750nm than between 410-520nm where the spectral absorbance of MP is 
greatest.   
 
Nolan et al. (2011) evaluated the augmentation effects of macular pigment (MP) 
and potential resulting enhancement of visual performance measured by best 
corrected visual acuity, contrast sensitivity, glare disability, photostress recovery 
time, and subjective questionnaire related to visual function. One hundred 
twenty-one (121) subjects were randomly divided into active (12mg L and 1mg Z 
oral supplement) and non-active (placebo oral supplement) group. Subjects were 
evaluated at baseline, 3, 6, and 12 months through HFP determination of their 
MPOD spatial profile and psychophysical measurements of visual performance.  
At 12 months, a statistically significant rise in MPOD was measured in the active 
group but this increase in MPOD was not linked with a corresponding 
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improvement in visual performance measures. Nolan et al. (2011) did report 
statistically significant differences in mesopic contrast sensitivity at high spatial 
frequencies and in mesopic contrast sensitivity at low spatial frequencies under 
high glare conditions. Important to note, the glare source output utilized by Nolan 
et al. was identical to the 2010 Loughman et al. study. The spectral output of the 
tungsten-based source created markedly greater LW visible light (520-750nm) 
than SW visible light (410-520nm). The lack of a SW light component within the 
glare source accompanied by the absence a significant correlation between 
MPOD and both glare disability and photostress recovery may offer further 
support of the wavelength dependence of MP-related improvements on visual 
function.  
 
Stringham et al. (2011) evaluated 3 types of visual performance under glare 
conditions: photostress recovery time, disability glare, and discomfort glare.  
Twenty-six (26) subjects were measured to determine the spatial profile of their 
MPOD through HFP. Visual performance measurements for the photostress 
recovery and glare disability were determined through correct orientation 
identification of a Gabor patch. Discomfort glare was assessed during glare 
testing with a visual discomfort scale. Glare was produced using high intensity 
white LEDs. MP was shown to be significantly (p<0.05) associated with all 3 
measures of visual performance. Importantly, this study utilized natural viewing 
that involved the effects of pupil diameter allowing a greater generalization to 
typical, environmental viewing. 
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Hammond et al. (2012) performed the first direct test of the Visibility Hypothesis 
originally proposed by Wooten and Hammond (2002). Five (5) young, healthy 
subjects experienced with psychophysical testing procedures were evaluated.  
MPOD was assessed with HFP and visibility was evaluated by measuring 
contrast sensitivity at 8cpd using a xenon source optical system which created a 
sine wave grating target. Natural sunlight and atmospheric haze was simulated 
using a broad-spectrum filter and alterations to MPOD were replicated by a 
variable path length filter that represented the absorption spectrum of MP. 
Results showed that a simulated increase in MPOD of 0.25 density units lowered 
the average contrast sensitivity threshold approximately 25% and an additional 
0.25 density units lowered the threshold an additional 10% with an effect plateau 
at 0.50 density units.  Their results suggested that the greatest improvements in 
CS are associated with modest increases in MPOD. 
 
A 2013 study by Hammond et al. investigated the relationship of serum lutein and 
zeaxanthin with MPOD, glare disability, photostress recovery, and chromatic 
contrast. One hundred fifty (150) healthy subjects were assessed using cHFP to 
measure MPOD and a Maxwellian-view broadband light source to measure 
visual performance. Glare disability was evaluated by increasing the radiometric 
power of an annulus until it caused a loss of resolution for a 4cpd grating central 
target. Photostress recovery was recorded as the time elapsed before the subject 
was able to recognize a foveal target following a 5 second exposure to a glare 
source. Chromatic contrast was measured as the intensity of a 460nm 
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background which resulted in a loss of visibility of a 4cpd grating central target 
with a wavelength of 600nm. Their results showed a significant relationship 
between MPOD and glare disability (r = 0.24, p < 0.01), photostress recovery (r = 
0.18, p = 0.01) and chromatic contrast sensitivity (r = 0.46, p < 0.001). MPOD 
was also found to be significantly related to combined serum L/Z (r = 0.31, p < 
0.01). 
 
To date, a majority of previous studies have focused on the establishment of 
central visual function with foveal MPOD measurement. A number of 
investigations have demonstrated the distribution profile of MP within the sensory 
retina (Loughman et al., 2010 and Nolan et al., 2011 and Stringham et al., 2011) 
and all used measures of central visual performance. Where the deficits can be 
found in the literature is in defining the role of parafoveal MPOD and its relation 
to visual performance. Also important is the relationship between visual 
performance and foveal MPOD versus integrated MPOD. Robson et al. (2003) 
and Trieschmann et al. (2006) reported that foveal measures of MPOD show low 
correlations with total amount of MPOD measure across the spatial distribution.  
Wenzel et al. (2006) also hypothesized that an integrated measure of MPOD is 
potentially more important than a measure at a single eccentricity. This 
underscores the importance of determining the complete spatial distribution 
profile of MPOD: Certain spatial distributions may show significantly different 
foveal versus parafoveal measurements and quantification of foveal MPOD 
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levels in isolation may poorly reflect the potential role of MP in visual 
performance.  
 
IV. Hypotheses 
Previous studies have examined the relationship between foveal MPOD 
measurements with central visual function thus ignoring the spatial distribution.  
The previously identified relationship between MPOD and the 3 components of 
the Optical Hypothesis in the foveal region supports the investigation of 
parafoveal relationships with MPOD.  My hypotheses include: 
1) MPOD has an inverse relationship with glare disability and contrast 
sensitivity at foveal and parafoveal retinal loci.  
2) Integrated measures of MPOD across the diameter of the stimulus will 
better predict visual performance compared to discrete point 
measurements 
3) Integrated MPOD is inversely related to intraocular scatter 
 
V.  Methods 
The current study included a total of 33 subjects. The n-value was derived from 
an a priori power analysis using an 80% power estimate and a Cohen’s effect 
size of 0.5 expressed by the equation: N = (2.8/0.5)2 + 1 (Howell, 2007). The total 
subject sample number was divided into three equal cohorts of 11 subjects. Each 
cohort performed all testing over a 12 week period to ensure each subject was 
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able to complete all testing within a single academic semester and that all 
subjects progressed through the testing at the same rate.  
 
Study inclusion criteria required no evidence of ocular pathology and best 
corrected visual acuity of 20/25 in the right eye and age less than 35 in order to 
avoid any presbyopic effects.  Volunteer subjects were recruited from current 
optometry students enrolled at UMSL College of Optometry.  All subjects were 
current optometry students familiar with the devices and techniques presented 
during testing. The study sample included 11 males and 22 females with a mean 
age of 24.2 years ( = 2.7).  All procedures were approved by the UMSL 
Institutional Review Board.   
 
MPOD Spatial Distribution Measurements 
The study utilized a novel device based on Wooten et al. (1999) (Figure xx) that 
used customized heterochromatic flicker photometry (cHFP) to measure the 
nasal, temporal, superior, and inferior MPOD at 0o, 2o, 4o, 6o and 80 eccentricity. 
This radial pattern was used to generate a spatial profile of an individual subject’s 
MPOD that was then compared to a spatial distribution of contrast sensitivity and 
glare sensitivity at the corresponding degrees of eccentricity. 
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Figure 2 
A diagram of the free-view optical system used to measure MPOD.  (A1 and A2) Apertures 1 and 2; (BS) beam splitter; 
(L1 and L2) convex achromatic lenses; (PC) photocell; (S1 and S2) LED sources; (D1 and D2) optical diffusers (Wooten 
et al., 1999)   
 
The cHFP device is a free-view device requiring no head stabilization (Fig xx) 
with a fixed 40cm distance consisting of a 10o background field generated by a 
LED (472nm peak) and a holographic diffuser (85% transmission with 20o 
viewing angle) measuring 2.75 cd/m2. A 1o stimulus is superimposed on the 
background field using a beamsplitter and a triad LED arrangement consisting of 
two 460nm and one 564nm LED (half-bandwidth of 10nm). The measured peak 
output of the superimposed stimulus was 5.20cd/m2 for the 564nm LED and 
21.2cd/m2 for the 460nm LEDs. The LED triad utilized a pulse-width modulation 
(PWM) frequency control. PWM was chosen to regulate frequency which allows 
use of contact current control of the LED input. Constant current LED input 
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allowed strict control of spectral output. The triad array created a peak 
wavelength of 460nm and 564nm LEDs to flicker in counterphase to one another 
and an inverse yoked luminance control set at 0.10 cd/m2 for each detent of the 
subject control knob. A 5 arcmin fixation dot was printed on a transparent thin 
film and controlled by a step-motor which allowed precise positioning at 
eccentricities relative to the center of the 1o stimulus target. 
 
Figure 3 
The cHFP device designed and built for use during this project used to measure MPOD along 8 meridians at 0
o
, 2
o
, 4
o
 and 
6
o
 eccentricities. 
 
Each MPOD assessment session lasted for approximately 45-50 minutes but 
never exceeded 1 hour to control for fatigue and compliance.  Three sessions 
were scheduled for each subject and a fourth was optional if the subject required 
additional familiarization with the technique to reach repeatability during the initial 
training.  Each session used 5 repeated measures of their individual critical 
flicker fusion (CFF) threshold before any assessment of their MPOD was 
performed.   
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In order to optimize the accuracy of the MPOD measurements, each subject was 
required to identify their central CFF that determined all stimulus flicker rates at 
each retinal location. To begin each trial, the subject was adapted in a dark room 
for 5 minutes prior to beginning the testing. The subject then placed an eye patch 
over their left eye and chin in the fixed chin rest. A 40cm distance check was 
performed to ensure proper alignment and distance. Subjects were instructed to 
maintain stable head posture during testing and to close and cover their patched 
left eye. Once the device and subject were comfortably aligned, the subject 
would then grasp the adjustment knob prior to flicker threshold testing. The CFF 
was determined by isolating the 564nm LED as the flickering stimulus 
superimposed on the 472nm background. The stimulus frequency was set at 
values well below expected CFF thresholds and the subject was asked about the 
perception of flicker. If no flicker was perceived, the frequency of the 564nm 
stimulus was decreased until a prominent flicker was achieved. If prominent 
flicker was recognized by the subject, they were then instructed to turn the 
adjustment dial to the right 1 click at a time at a rate approximate to 1-2 seconds 
per click. The subject was asked to maintain strict fixation on the black dot in the 
center of the stimulus and assess the entire stimulus for flicker. The subjects 
were instructed to blink enough to allow for comfort but to assess for presence of 
flicker only when holding eye open without blinking. When the subject reached a 
point that a null flicker was reported, they were asked to stop, blink several times, 
and refixate the stimulus center. If null flicker was still reported, the frequency 
value was recorded and the examiner reset the flicker frequency to a value well 
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below threshold. If minimal flicker was still perceived by the subject, they were 
instructed to add only 1 additional click to the right to eliminate the flicker. If null 
flicker was achieved, this flicker frequency was recorded. If minimal flicker was 
still reported, the flicker value was reset and the CFF procedure was performed 
from the beginning. Five consecutive measures were taken and all values were 
within 1 Hz of one another or the testing was stopped, the subject was allowed to 
rest, and the CFF procedure was started from the beginning. A mean value of the 
5 repeated CFF measures were used to calculate the customized central flicker 
rate for each subject. Consistent with Snodderly et al. (2004) and Hammond et 
al. (2005) and Stringham et al. (2008), the subject’s central CFF was applied to 
an algorithm lookup table within the device programming to determine the fixed 
stimulus flicker rate at foveal, 2o, 4o, 60 and 8o eccentricities.   
 
Once the repeated measure CFF had been determined, the device was set to 
“LOCK” which then allowed the stimulus target to display the counter-phased 
460nm/564nm stimulus.  Foveal measurements of MPOD was assessed by 
maintaining the black fixation dot at the stimulus center and the examiner set the 
displayed relative units of the 460nm LED to values well-below equiluminance 
thresholds.  The subject was then asked to assess the entire 1o stimulus for 
flicker.  If flicker was perceived, the 460nm luminance was decreased by the 
examiner and the subject was reassessed.  If flicker was still perceptible by the 
subject, the CFF testing was repeated to maximize subject familiarity with flicker 
perception and improve the accuracy of the subject’s central CFF.  If null flicker 
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was perceived, the subject was instructed to turn the adjustment dial to the right 
1 click at a time at a rate approximate to 1-2 seconds per click. The subject was 
asked to maintain strict fixation on the black dot in the center of the stimulus and 
assess the entire stimulus for flicker. The subjects were instructed to blink 
enough to allow for comfort but to assess for presence of flicker only when 
holding eye open without blinking and follow a method of limits paradigm 
identical to the described CFF threshold measurement. 
 
Each session included five 0o and 80 eccentricity measurement values. The first 
session assessed the 2o eccentricity, the second session assessed the 4o 
eccentricity, and the third session included the 6o eccentricity. These 
eccentricities were assessed using the same procedure as the foveal 
measurement with the exception of the point of fixation. The examiner set the 
fixation dot to the corresponding eccentricity relative to the stimulus center. Each 
subject began with a different meridian to control for order effects. For example, 
Subject 1 began with temporal measurements, Subject 2 began with superior 
measurements, Subject 3 began with nasal measurements, and Subject 4 began 
with inferior measurements. This pattern was followed for all subjects in the same 
eccentricity. During the second session for all subjects, each began with a 
different meridian than assigned during their first session (i.e. Subject 1: begins 
with Session #1 at temporal location, Session #2 at superior location, and 
Session #3 at nasal location). Subjects were instructed to occasionally move 
their eyes to the midpoint of black fixation dot and stimulus and then immediately 
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back to fixation to overcome stimulus fading effects. The subjects were also 
instructed to blink several times and refixate the black dot before assess 
presence of stimulus target flicker. When parafoveal stimulus flicker was first 
perceived, the subjects followed the same protocol for determining foveal flicker:  
When the subject reached a point that a first, perceptible flicker was reported, 
they were asked to stop, blink several times, and refixate the stimulus center. If 
no perceptible flicker was reported after the refixation, the subject was instructed 
to continue with the testing. If perceptible flicker was still reported after refixation, 
the subject was asked to add only 1 additional click to the right. If the subject 
reported more pronounced flicker, the examiner would record the 460nm 
radiance value was recorded. If no additional flicker prominence was still 
perceived by the subject, they were instructed to remove the extra click by 
turning the adjustment dial to the left. This technique was performed for 5 
repeated measurements and a mean value was recorded for the foveal 460nm 
radiance value.   
 
The cHFP device was used to create the spatial map of MPOD for each subject 
by assessing optical density of the macular pigment using a 1o stimulus at 2o, 4o, 
6o eccentricity along four principle meridians: horizontal (0o / 180o) and vertical 
(90o / 270o) resulting in 13 discrete values (Figure 4). These values were 
recorded to produce a spatial map of MPOD.    
P a g e  | 85 
 
 
Figure 4 
Example of a radial pattern depicting the 8 principle meridians. MPOD was measured at 0°, 2°, 4°, and 6° locations along 
the inferior, nasal and temporal meridians.  Contrast sensitivity was determined at 3, 6, and 9cpd at the corresponding 
retinal locations. 
 
Two methods of calculating the MPOD spatial distribution across the macula for 
each subject were employed. The first method calculated the kurtosis values for 
each spatial distribution. Kurtosis an indicator of normality and measures the 
peak of the distribution. The greater the kurtosis value the more peaked the 
distribution relative to a normal distribution and is typically referred to as 
leptokurtic. The lesser the kurtosis value the flatter the distribution relative to a 
normal distribution and is typically referred to as platykutic. The second method 
calculated the area under the curve (AUC) value. MPOD values from each 
measured loci were plotted using Cartesian coordinates on an x,y graph. 
OriginPro9 software (OriginPro Corp, Northampton, MA) was utilized to best-fit 
the spatial distribution across the entire 16o macula and calculate integrated 
values for the 1o stimulus diameter at each loci and the 16o distribution. 
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Contrast Sensitivity and Glare Disability Measurements 
Stimuli for the CS and GD stimuli were generated with the Psykinematics 
program (Kybervision, Montreal, Canada) to create a vertical sinusoidal spatial 
grating pattern with a Gaussian envelope as a stimulus. These stimuli were 
presented on a 19”-CRT monitor using gamma correction of existing non-
linearity. Display calibration of the CRT monitor was assessed using a Spyder 3 
(Datacolor, Lawrenceville, NJ) device recognized and incorporated into the 
Psykinematics program.  Non-linearity was measured regularly throughout the 
project. The range of gamma reported by the Spyder3 device was 1.91 to 
1.98.The stimuli were presented on a background with a luminance controlled at 
20cd/m2. The psychophysical technique method of limits with an adaptive 
staircase (described below) was utilized to determine sensitivity threshold values. 
A mean value calculated from 6 reversals was recorded as a contrast sensitivity 
threshold estimation. The vertical sinusoidal spatial grating pattern was displayed 
with a 200 millisecond duration in order to control for fixation loss during stimulus 
presentation. 
 
The Michelson contrast value for each retinal location began at suprathreshold 
levels (as determined from 10 subject pilot study) and decreased in a relative 
step size at 15% before 1st reversal and increase in a relative step size at 15% 
until second reversal.  This relative change in contrast continued until 6 reversals 
were recorded and the mean of the 6 reversals was recorded as the threshold 
contrast sensitivity threshold.  
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Contrast sensitivity functions utilized luminance modulated sinusoidal gratings 
with a vertical orientation.  The stimulus subtended a visual angle of 1o with a 
spatial Gaussian envelope.  Measurements were taken under mesopic (3cd/m2) 
conditions using a method of limits described above with respect to a central 
fixation cross.  Values were recorded for 3 spatial frequencies (3 / 6 / 9cpd) at 
each eccentric point along the above listed meridians.   
 
GD was determined as the difference in contrast sensitivity between glare 
conditions and no glare conditions (CSNo Glare – CSGlare) at each retinal loci.  Glare 
condition measurements were also taken at 2o, 4o, 6o of eccentricity along each 
of the above listed principle meridians.  The glare apparatus utilized two 5o glare 
sources produced by two achromatic LEDs (Luxeon model LXHL LW6C, Luxeon 
Corp., Randoph, VT) located in 1” diameter optical tubes.  Each LED is attached 
to the base of a 6” tube in conjunction with 3 other optical system elements: 1) a 
10o holographic diffuser (used to make the glare image uniform, 2) an adjustable 
circular iris (used to define the glare circle size of 5o), and 3) a convex lens (used 
to focus the glare source at the distance of the CRT monitor).  The two tubes 
were positioned below the subject’s line of sight, directed vertically and reflected 
from a beam splitter oriented at 45o into the subject’s line of sight.  Based on the 
optical system, each glare source created a luminance of 1500 cd/m2 with a 
color temperature of 6500K.  Measurement of the glare sources was taken with a 
spectrophotometer (model 650; Photo Research Inc., Chatsworth, CA).  Strict 
control of the luminance output was achieved using software-controlled PWM 
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and luminance output was well within accepted safety values not to produce 
visible light-induced ocular damage. 
 
Figure 5 
The novel glare device designed and built for use during this project used to produce flanking glare sources to surround 
the 1
o
 grating stimulus at each retinal loci along the four cardinal meridians at 0
o
, 2
o
, 4
o
 and 6
o
 eccentricities. 
 
The two glare sources were aligned horizontally and each was centered 5o from 
the midpoint of the 1o sinusoidal grating pattern.  The inner boundaries of the 
glare source and the center of the grating pattern are separated by 3o of visual 
angle.  The subject’s view of the glare source is two circles of light spaced 
laterally (inner edge to inner edge) by 5o of visual angle.  Infra-red camera focus 
and subject feedback were employed through a precise alignment protocol 
ensuring that the glare circles were accurately positioned the correct distance 
from the midpoint of the grating pattern.  Subjects were presented the same 
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stimuli as used during the contrast sensitivity function testing described above.  
Subjects viewed the grating targets through a beam splitter that reflected the 
superimposed glare sources on the CRT background. 
 
Subjects were adapted at mesopic (<3cd/m2) conditions for 5 minutes preceding 
each session.  Five (5) measurements were conducted in total in order to 
maximize validity and repeatability.  Sequential presentation of the stimuli for 
each subject was uniquely determined by a random sequence generator to 
control for order effects.  Single sessions included: 1) foveal threshold 
determinations for all 3 spatial frequencies and 2) All eccentricity measurements 
at each meridian (0o, 90o, 180o, 270o) for each spatial frequency.  Each session 
was performed under no glare and glare conditions.  This resulted in a total of 8 
contrast sensitivity threshold sessions for each subject.  Initial starting spatial 
frequency was randomized to control for order effects.  CS threshold under no 
glare conditions was always performed first to allow familiarization of the task 
and, when possible, no more than 1 day would elapse between no glare and 
glare conditions.     
 
An infrared camera was used to monitor the eye during stimulus presentation to 
ensure proper fixation within 0.5o or less.  A transparency overlay with concentric 
rings corresponding to 0.5o of visual angle was applied to the video monitor.  
Subjects were encouraged throughout to blink frequently to minimize the Troxler 
effect and to regain fixation on central cross before button response to ensure 
P a g e  | 90 
 
proper alignment of eye prior to stimulus presentation.  Optional breaks were 
given at subjects request and mandatory breaks of 5 minutes were given at the 
completion of each eccentricity.  Typical duration of contrast sensitivity testing 
was approximately 45 to 50 minutes per session. 
 
MPOD was measured at four eccentricities (0o, 2o, 4o and 6o) and resulting 
values at each retinal eccentricity are a mean of five consecutive trials.  With the 
exception of the foveal measurements, the MPOD at the remaining three retinal 
eccentricities were calculated as a mean of five consecutive superior inferior, 
nasal and temporal measurements at that eccentricity for a total of 20 
measurements per mean eccentricity value.  
 
MPOD mean values for each retinal loci (0o, 2o, 4o and 6o) were fit to a 
Lorentzian distribution for both stimulus center and stimulus point of highest 
retinal sensitivity using OriginPro9 software (Figure 6). For the resulting two 
distributions, MPOD values at each retinal loci were determined by three 
separate methods: 1) Stimulus discrete value, 2) stimulus integrated across 1o and 
3) area under the curve (AUC) calculations integrated across 16o. Each 
distribution would have 4 discrete MPOD values and 5 integrated MPOD values 
from -0.5o to 0.5o, 1.5o to 2.5o, 3.5o to 4.5o, 5.5o to 6.5o and -8o to 8o. Peak foveal 
measures of MPOD will have only a single discrete measure due to the shared 
retinal point of stimulus center and stimulus point of highest retinal sensitivity. 
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Figure 6 
Hypothetical spatial distribution of MPOD fit to a Lorentzian function. The grey shaded area represents a 1
0
 area from -
0.5
0
 to 0.5
0
.  Origin Pro9 software was used to calculate integration values of a 1
0
 area at all measured eccentricities 
including the area under the curve from -8
0
 to 8
0
. 
 
Contrast Sensitivity, Glare Disability and Relative Glare Disability Correlations 
with MPOD 
CS differences between horizontal and vertical meridians were expected and 
well-documented (Westheimer, 1982 and Pointer et al., 1989). Therefore, 
correlations between CS and calculated MPOD for 0o, 2o, 4o and 6o eccentricities 
were evaluated as separate analyses: a horizontal meridian mean CS, a vertical 
meridian mean CS and a mean CS including all four meridians. Glare disability 
(GD) was measured as a difference in CS between no glare conditions and glare 
conditions of the same visual stimuli.  Resulting GD values were determined as 
absolute GD and relative GD.  Absolute GD was calculated as: CSNo Glare – 
CSGlare and is referred to as GD.  Relative GD was calculated as : (CSNo Glare –
CSGlare) / CSNo Glare and is referred to as RGD.    
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Correlations of discrete MPOD values along with the two integrated values 
across the 1o stimulus for each Lorentzian distribution with CS, GD and RGD of 
the 1o grating target corresponding to the same retinal loci at 3 separate spatial 
frequencies: 3cpd, 6cpd and 9cpd were calculated. At all 3 spatial frequencies, 
MPOD correlations with GD and RGD were evaluated in two ways. First, existing 
literature exploring MPOD and potential effects on CS and GD have utilized 
foveal MPOD measurement in their analysis (Hammond et al., 2013 and 
Stringham et al., 2011). In an effort to build upon existing research, foveal 
measurements of MPOD were correlated with GD and RGD at each eccentricity 
(0o, 2o, 4o, and 6o). Second, previous studies exploring MPOD and potential 
effects on CS and GD have not evaluated the relationship of parafoveal MPOD 
values with parafoveal visual performance. In an effort to expand existing 
research, correlations of corresponding eccentricities of MPOD and GD and RGD 
were also performed (i.e. 20 MPOD with 20 GD and RGD, 40 MPOD with 4o GD 
and RGD and 60 MPOD with 6o GD and RGD). The sample n-value was derived 
from an a priori estimate using 80% power and a Cohen’s effect size of 0.5 and 
all correlational analyses were designed prior to data collection. Due to the a 
prior nature of the experimental design, Bonferroni corrections were not utilized 
in an effort to reduce the risk of false negatives and the consequent decrease in 
statistical power.  
 
Independent sample t-tests were incorporated to evaluate differences in GD and 
RGD between the highest and lowest quartiles of foveal MPOD. A Levene’s 
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Tests for Equality of Variances was also performed for each independent sample 
t-test. If a significant Levene’s test was identified, the highest and lowest quartiles 
of foveal MPOD are assumed to have unequal variances. In such cases, a non-
parametric Mann-Whitney test for significance was performed. Effect sizes for 
independent t-test results were also calculated. 
 
Scatterplots were also performed across all 3 spatial frequencies and were 
evaluated using GD and RGD. First, foveal measurements of MPOD were 
correlated with GD  at each eccentricity (0o, 2o, 4o, and 6o) as three different 
calculations (i.e. 1) foveal discrete value vs. 0o eccentricity, 2) foveal MPOD 
integrated across 1o assuming stimulus center vs. 0o eccentricity and 3) foveal 
MPOD integrated across 1o assuming stimulus point at highest retinal sensitivity 
vs. 0o eccentricity). Second, the same three foveal measurements of MPOD were 
plotted against RGD at each eccentricity. Covariance values and regression 
relationships between foveal MPOD and GD and RGD for each scatterplot were 
evaluated. 
 
Intraocular Scatter Correlations with MPOD 
Intraocular forward scatter was assessed through a direct compensation 
comparison method using the C-Quant device (Oculus, USA). The C-Quant 
device is a commercially-available clinical device able to measure forward 
scattered intraocular light through a direct comparison method.  The device uses 
hemifield comparison of flicker, similar to the flicker perception utilized for the 
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cHFP device. The flicker compensation comparison is calculated using a 3.3o 
diameter target along with a glare source annulus with an inner diameter of 10o 
and an outer diameter of 20o with a background luminance of 25cd/m2. A 2AFC 
method is employed using a fixed temporal rate of 8Hz randomly given to one 
side of the hemifield. The subject was instructed to indicate the lateral side of the 
target in which flicker is perceived. A complete description of the psychophysical 
technique is provided by van den Berg et al. (2011).  The validity and reliability 
algorithms are incorporated within the C-Quant device and all assessments of 
intraocular scatter will follow the established guidelines of the commercial device. 
A mean intraocular scatter value was determined using the first 5 valid, 
repeatable measures as determined by the commercial device and represented 
as ESD (estimated standard deviation) and Q (reliability) parameters.   
 
MPOD influences on intraocular scatter were evaluated by four different values: 
foveal stimulus discrete value, foveal stimulus integrated across 1o, AUC 
calculations integrated across 16o assuming stimulus center and AUC integrated 
across 16o assuming stimulus point of highest sensitivity were evaluated as 
Pearson correlation coefficients with measures of intraocular scatter.  
 
Scatterplots were also performed and evaluated in four ways: foveal stimulus 
discrete value, foveal stimulus integrated across 1o and AUC calculations 
integrated across 16o for each distribution were plotted against the mean 
intraocular scatter value for each subject.  
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VI. Results 
A. Macular Pigment Spatial Distribution 
The MPOD spatial distribution results for the 33 subject sample was fit to a 1st-
order exponential decay curve to assess the variability in the data described by 
the r2 value in two different methods: 
1) Center point of 1o stimulus at each foveal eccentricity 
2) Point of highest sensitivity within the 1o stimulus at each foveal eccentricity 
The resulting MPOD values at each foveal eccentricity are a mean of the 
superior inferior, nasal and temporal measurements from all 33 subjects. 
Resulting MPOD spatial distribution profiles were also fit to a Lorentzian curve 
and integrated values across the1o stimulus at each retinal loci and across the 
16o of central retina were calculated from both measurements. Individual 
Lorentzian distribution curves were also fit for each of the 33 subjects. The cHFP 
device identified reliable MPOD spatial distribution maps and showed a 1st order 
exponential decay function with eccentricity across the 33 subject study sample. 
Standard error of the mean measured for 0o eccentricity was less than 0.01 log 
unit, 2o eccentricity was 0.01, 4o eccentricity was 0.01 and 60 eccentricity was 
0.02 log unit. 
 
Correlations of MPOD at each eccentricity were performed among the superior, 
inferior, temporal, and nasal locations. Correlation values among the four 
measured meridians at 2o eccentricity range between 0.955 and 0.968 providing 
support of a high level of symmetry among measured meridians when MPOD is 
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fit to a 1st order exponential function at each of the measured meridians (Table 
1). Correlations among the four measured meridians at 4o eccentricity range 
between 0.928 and 0.947 providing additional support of MPOD symmetry 
among the measured meridians when the spatial distribution is measured as a 1st 
order exponential function at each of the meridians (Table 2). Correlations 
among the four measured meridians at 6o eccentricity range between 0.875 and 
0.929 supporting the symmetry of MPOD spatial distribution among the four 
measured meridians along with increased variability in MPOD assessment with 
increasing eccentricity (Table 3).  MPOD spatial distribution of the subject sample 
fit to stimulus center showed an r2 = 0.885 with a y-intercept of 0.426 
corresponding to peak foveal density (Figure 7). The same MPOD values fit to 
the stimulus point at highest retinal sensitivity showed an r2 = 0.907 with a y-
intercept of 0.387 corresponding to peak foveal density (Figure 8).    
 
Figure 7 
Graphical depiction of 1
st
-order exponential decay function demonstrated by MPOD spatial distribution in the 33 subject 
sample assuming a stimulus center measurement. 
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Figure 8 
Graphical depiction of 1
st
-order exponential decay function demonstrated by MPOD spatial distribution in the 33 subject 
sample assuming a highest retinal sensitivity stimuli measurement. 
 
 
The cHFP device used to assess MPOD was designed with 1o stimuli set to 
equal center-to-center stimuli spacing of 2o across the macula.  When MPOD 
spatial distribution is fit to the center of the stimulus, the 2o stimulus spacing 
remains constant.  When the spatial distribution is fit to the inner edge, the foveal 
measurement edge lies at 0.5o and the stimulus inner edge at 2o lies at 1.5o of 
foveal eccentricity.  MPOD spatial distribution was also fit to a 1st order 
exponential curve excluding the central measurement value.  This approach 
allowed a fixed 2o separation for the center of the stimulus fit (e.g. 2o, 4o, 6o) and 
the inner edge of the stimulus fit (e.g. 1.5o, 3.5o, 5.5o).  The stimuli center fit 
(Figure 9) and the stimuli point at highest retinal sensitivity fit (Figure 10) 
revealed similar covariance measures of r2 = 0.877 and r2 = 0.876, respectively. 
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Figure 9 
Graphical depiction of 1
st
-order exponential decay function demonstrated by MPOD spatial distribution in the subject 
sample assuming a stimuli center measurement excluding foveal measurement. 
 
 
 
 
Figure 10 
Graphical depiction of 1
st
-order exponential decay function demonstrated by MPOD spatial distribution in the subject 
sample assuming stimulus point at highest retinal sensitivity measurement excluding foveal measurement. 
 
The center stimuli fit exhibited a y-intercept of 0.629 while the inner edge of the 
stimuli, analogous to the point of highest retinal sensitivity, fit exhibited a y-
intercept of 0.474.  The inner stimuli edge fit agrees more closely with the peak 
foveal density of both the central (y-intercept = 0.426) and point of highest retinal 
sensitivity (y-intercept = 0.387) stimuli fit when the foveal measurement value is 
included in the 1st order exponential fit.   
 
Results from the kurtosis calculations for the 33 subject sample revealed a mean 
value of 2.78 (=1.81).  The positive mean value with a relatively large variance 
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indicate a leptokurtic distribution that shows a sharp, central peak compared to a 
Gaussian distribution and substantial variability in spatial distribution across the 
sample. Examples of the variability in kurtosis values are displayed as Lorentzian 
curves fit for the subject with the highest kurtosis value (Figure 11) and the 
subject with the lowest kurtosis value (Figure 12). The Lorentzian curves for each 
subject are fit assuming stimulus center and assuming stimulus point at highest 
retinal sensitivity. 
 
 
Figure 11 
Lorentzian fit to stimulus center (left) and stimulus point of highest retinal sensitivity (right) for subject with highest kurtosis 
value. 
 
 
 
Figure 12 
Lorentzian fit to stimulus center (left) and stimulus point of highest retinal sensitivity (right) for subject with highest kurtosis 
value. 
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AUC calculations showed differences in mean integrated values when spatial 
distributions were fit to the center of the stimuli [mean of 1.778 (0.393)] versus 
the stimuli position at highest retinal sensitivity [mean of 1.489 (0.331)] (Table 4). 
The AUC calculations were highly correlated with one another (r = 0.997, 
p<0.001) and showed a non-significant relationship with kurtosis values (AUC 
center stimuli r = -0.004, p=0.984 and AUC highest sensitivity stimuli position r = 
-0.062, p=0.733). 
 
B. Contrast Sensitivity and Glare Disability across the Macula 
Across all three spatial frequency stimuli, a decrease in CS was displayed with 
increasing retinal eccentricity.  Targets with the lowest spatial frequency (3cpd) 
resulted in the highest mean CS at all retinal loci measured and targets with the 
highest spatial frequency (9cpd) resulted in the lowest mean CS. Variability 
within the 33 subject sample also showed a consistent trend: targets with a 
lowest spatial frequency (3cpd) demonstrated the lowest variability and targets 
with the highest spatial frequency (9cpd) demonstrated the highest variability.  
Variability also increases as a function of retinal eccentricity with the highest 
variability at the greatest eccentricity. This relationship was consistent across all 
subjects.   
 
CS showed differences along the horizontal meridians as compared to the 
vertical meridians.  The vertical meridians demonstrated a greater decrease in 
CS as a function of eccentricity than the horizontal meridians.  The differences in 
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CS along the horizontal versus vertical meridians also demonstrated a 
dependence on spatial frequency.  All three spatial frequencies (3,6,9cpd) 
demonstrated a significant difference in measured CS between horizontal and 
vertical meridians at 2o, 4o and 6o of eccentricity (Table 4, Table 5 and Table 6).  
 
Independent Samples t-test 
2
o
 Eccentricity   
 t-value Sig. 
3cpd stimuli CS 4.761** <0.001 
6cpd stimuli CS 2.617** 0.01 
9cpd stimuli CS
 
2.374* 0.019 
Table 5 
Independent samples t-test for horizontal versus vertical meridians at 2
o
 for 3, 6 and 9cpd grating targets Levene’s Test 
for Equal Variances was non-significant so equal variances were assumed (* p ≤ 0.05 and**p ≤ 0.01) 
 
 
 
 
Independent Samples t-test 
4
o
 Eccentricity   
 t-value Sig. 
3cpd stimuli CS 5.268** <0.001 
6cpd stimuli CS 3.638** <0.001 
9cpd stimuli CS
 
3.162** 0.002 
Table 6 
Independent samples t-test for horizontal versus vertical meridians at 4
o
 for 3, 6 and 9cpd grating targets Levene’s Test 
for Equal Variances was non-significant so equal variances were assumed (* p ≤ 0.05 and**p ≤ 0.01) 
 
 
 
 
Independent Samples t-test 
6
o
 Eccentricity   
 t-value Sig. 
3cpd stimuli CS 4.242** <0.001 
6cpd stimuli CS 4.881** <0.001 
9cpd stimuli CS
 
8.002** <0.001 
Table 7 
Independent samples t-test for horizontal versus vertical meridians at 6
o
 for 3, 6 and 9cpd grating targets Levene’s Test 
for Equal Variances was significant so equal variances were not assumed (* p ≤ 0.05 and**p ≤ 0.01) 
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The highest spatial frequencies (3cpd) showed the least differences in CS 
between the horizontal and vertical meridians (Figure 15 and Figure 16) when 
compared to the 6cpd targets (Figure 17 and Figure 18) and the 9cpd targets 
(Figure 19 and Figure 20). A complete picture of mean CS under no glare 
conditions and glare conditions at 0o, 2o, 4o and 6o as a function of eccentricity for 
3, 6 and 9cpd stimuli is included in Appendix 2 (Figure 21). The plotted mean 
values show a substantial loss of CS with increasing eccentricity using 9cpd 
stimuli relative to 3cpd stimuli with greater loss of CS under glare conditions for 
9cpd stimuli relative to 3cpd stimuli. Error bars indicate a 95% confidence 
interval. 
 
At 3cpd, 21 of 33 subjects showed increased GD with increased foveal 
eccentricity. However, 24 of 33 subjects showed increased RGD with increasing 
foveal eccentricity. Overall, both GD and RGD were slightly higher at the fovea 
where peak MPOD is located relative to GD at 20 where MPOD is measured 
lower. 
 
At 6cpd, 24 of 33 subjects showed increased GD with increased foveal 
eccentricity. However, 26 of 33 subjects showed increased RGD with increased 
foveal eccentricity. Overall, GD was slightly higher at the fovea where peak 
MPOD is located relative to GD at 20 where MPOD is measured lower while RGD 
tended to be lower at the fovea where peak MPOD is relatively higher. 
 
P a g e  | 103 
 
At 9cpd, 25 of 33 subjects showed increased GD with increased foveal 
eccentricity. However, 28 of 33 subjects showed increased RGD with increased 
foveal eccentricity. Overall, GD was slightly higher at the fovea where peak 
MPOD is located relative to GD at 20 where MPOD is measured lower while RGD 
tended to be lower at the fovea where peak MPOD is relatively higher. 
 
Across all three spatial frequency stimuli, a general trend of increased GD and 
RGD with increasing retinal eccentricity was seen, although a number of subjects 
showed violations of this trend.  More direct relationships between RGD and 
eccentricity (i.e. increased RGD with increased eccentricity) were identified than 
between GD and eccentricity.  Both GD and RGD exhibited a spatial frequency 
influence: Higher spatial frequencies showed less inverse relationships.  
Increasing retinal eccentricity resulting in increased GD and RGD was identified 
more often for 9cpd targets than for 3cpd targets. 
 
GD and RGD also showed less differences along the horizontal meridians versus 
the vertical meridians as compared CS.  The measured GD and RGD between 
the horizontal and vertical meridians showed similar values supporting a 
comparable function of MP along all meridians.  The effects of MP GD radiate 
outward from the fovea where MPOD is the highest to the 60 eccentricity where 
MPOD greatly reduced. 
 
P a g e  | 104 
 
C. Relationship between MPOD, Contrast Sensitivity, Glare Disability, 
Relative Glare Disability and Intraocular Scatter 
MPOD results at each eccentricity were fit to a Lorentzian distribution for both 
stimulus center and stimulus point of highest sensitivity. For the resulting two 
distributions, MPOD values were determined by three separate methods: 1) 
Stimulus discrete value, 2) Stimulus integrated across 1o and 3) AUC calculations 
integrated across 16o. Each eccentricity (0o, 2o, 4o, 6o) had three resulting 
measures correlated with corresponding eccentricities of CS, GD and RGD. 
Foveal MPOD measures were correlated with all measured eccentricities (0o, 2o, 
4o, 6o) of CS, GD and RGD. Foveal discrete values, foveal stimulus center 
integrated across 10, AUC calculations integrated across 16o assuming stimulus 
center and AUC integrated across 16o assuming stimulus point of highest 
sensitivity were evaluated as Pearson correlation coefficients with measures of 
intraocular scatter.  
 
Independent sample t-testing of differences in CS between the highest and 
lowest quartiles of foveal MPOD required ranking of foveal MPOD values. In all 
cases, the top and bottom quartiles followed the same ordering when ranked as 
foveal MPOD measured as a discrete point, foveal MPOD measured as a 10 
integrated area assuming stimulus center measure or foveal MPOD measured as 
a 10 integrated area assuming a stimulus point at highest retinal sensitivity. 
Therefore, independent samples t-testing will refer to MPOD quartiles as ‘foveal 
MPOD’. In general, correlation coefficients of foveal MPOD measured as a 10 
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integrated area assuming a stimulus point at highest retinal sensitivity and RGD 
tended to show the highest values. Therefore, scatterplot analysis will refer to 
foveal MPOD measured as a 10 integrated area assuming a stimulus point at 
highest retinal sensitivity as the abscissa value ‘MPOD’ and RGD as the ordinate 
value for all figures. 
 
Contrast Sensitivity correlations with MPOD 
Overall, no significant correlation between CS and MPOD was demonstrated 
within the 33 subject sample.  At all 3 spatial frequencies, MPOD associations 
with CS were evaluated in 2 ways.  First, foveal measurements of MPOD were 
correlated with both horizontal meridian CS and vertical meridian CS separately 
then as a mean CS incorporating all four meridians at all eccentricities (i.e. 
Foveal MPOD vs. foveal CS, foveal MPOD vs. 2o CS, foveal MPOD vs. 4o CS 
and foveal MPOD vs. 6o CS). Second, correlations of corresponding 
eccentricities of MPOD and both horizontal meridian CS and vertical meridian CS 
then as a mean CS incorporating all four meridians were performed (i.e. 2o 
MPOD vs. 2o CS, 4o MPOD vs. 4o CS and 6o MPOD vs. 6o CS). 
 
3cpd CS correlations with MPOD 
At 3cpd, horizontal meridian CS, vertical meridian CS and mean CS correlations 
at all eccentricities (0o, 2o, 4o and 6o) with foveal MPOD measured as a discrete 
point, foveal MPOD measured as a 1o integrated area assuming stimulus center 
measure and foveal MPOD measured as a 1o integrated area assuming a 
P a g e  | 106 
 
stimulus point at highest retinal sensitivity were non-significant (Table 8, Table 9, 
Table 10).  
 
At 3cpd, 2o horizontal meridian CS, 2o vertical meridian CS and mean 2o CS 
correlations with 20 MPOD measured as a discrete point, 2o MPOD measured as 
a 10 integrated area assuming stimulus center point measure and 2o MPOD 
measured as a 1o integrated area assuming a stimulus point at highest retinal 
sensitivity were non-significant (Table 11, Table 12, Table 13). Horizontal 
meridian 4o CS, vertical meridian 4o CS and mean 4o CS correlations with all 
three measures of MPOD at 4o eccentricity were non-significant (Table 14, Table 
15, Table 16). Horizontal meridian 6o CS, vertical meridian 6o CS and mean 6o 
CS correlations with all three measures of MPOD at 6o eccentricity were also 
non-significant (Table 17, Table 18, Table 19). 
 
 
 
An independent sample t-test of CS differences at 0o, 2o, 4o and 6o eccentricities 
between the highest and lowest quartiles of foveal MPOD as a 1o integrated area 
assuming a stimulus point at highest retinal sensitivity was also performed using 
an independent sample t-test.  Results for Levene’s Test for Equal Variances 
were non-significant so equal variances were assumed. At 3cpd, no significant 
differences in CS between top and bottom quartiles of foveal MPOD were 
identified (Table 20).  
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6cpd CS correlations with MPOD 
At 6cpd, horizontal meridian CS, vertical meridian CS and mean CS correlations 
at all eccentricities (0o, 2o, 4o and 6o) with foveal MPOD measured as a discrete 
point, foveal MPOD measured as a 1o integrated area assuming stimulus center 
measure and foveal MPOD measured as a 1o integrated area assuming a 
stimulus point at highest retinal sensitivity were non-significant (Table 21, Table 
22, Table 23).  
 
At 6cpd, 2o horizontal meridian CS, 2o vertical meridian CS and mean 2o CS 
correlations with 20 MPOD measured as a discrete point, 2o MPOD measured as 
a 10 integrated area assuming stimulus center point measure and 2o MPOD 
measured as a 10 integrated area assuming a stimulus point at highest retinal 
sensitivity were non-significant (Table 24, Table 25, Table 26). Horizontal 
meridian 4o CS, vertical meridian 4o CS and mean 4o CS correlations with all 
three measures of MPOD at 4o eccentricity were non-significant (Table 27, Table 
28, Table 29). Horizontal meridian 6o CS, vertical meridian 6o CS and mean 6o 
CS correlations with all three measures of MPOD at 6o eccentricity were also 
non-significant (Table 30, Table 31, Table 32). 
 
An independent sample t-test of CS differences at 0o, 2o, 4o and 6o eccentricities 
between the highest and lowest quartiles of foveal MPOD as a 1o integrated area 
assuming a stimulus point at highest retinal sensitivity was also performed using 
an independent sample t-test. Results for Levene’s Test for Equal Variances were 
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non-significant so equal variances were assumed.  At 6cpd, no significant 
differences in CS between top and bottom quartiles of foveal MPOD were 
identified (Table 33).  
 
9cpd CS correlations with MPOD 
At 6cpd, horizontal meridian CS, vertical meridian CS and mean CS correlations 
at all eccentricities (0o, 2o, 4o and 6o) with foveal MPOD measured as a discrete 
point, foveal MPOD measured as a 1o integrated area assuming stimulus center 
measure and foveal MPOD measured as a 1o integrated area assuming a 
stimulus point at highest retinal sensitivity were non-significant (Table 34, Table 
35, Table 36).  
 
At 9cpd, 2o horizontal meridian CS, 2o vertical meridian CS and mean 2o CS 
correlations with 2o MPOD measured as a discrete point, 2o MPOD measured as 
a 1o integrated area assuming stimulus center point measure and 2o MPOD 
measured as a 1o integrated area assuming a stimulus point at highest retinal 
sensitivity were non-significant (Table 37, Table 38, Table 39). Horizontal 
meridian 4o CS, vertical meridian 4o CS and mean 4o CS correlations with all 
three measures of MPOD at 4o eccentricity were non-significant (Table 40, Table 
41, Table 42). Horizontal meridian 6o CS, vertical meridian 6o CS and mean 6o 
CS correlations with all three measures of MPOD at 6o eccentricity were also 
non-significant (Table 43, Table 44, Table 45). 
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An independent sample t-test of CS differences at 0o, 2o, 4o and 6o eccentricities 
between the highest and lowest quartiles of foveal MPOD as a 1o integrated area 
assuming a stimulus point at highest retinal sensitivity was also performed using 
an independent sample t-test. Results for Levene’s Test for Equal Variances were 
non-significant so equal variances were assumed. At 9cpd, no significant 
differences in CS between top and bottom quartiles of foveal MPOD were 
identified (Table 46).  
 
Glare Disability and Relative Glare Disability correlations with MPOD 
Non-significant correlations between both horizontal and vertical meridian CS 
with MPOD allowed the use of a mean GD value and RGD value incorporating all 
four meridians. GD and RGD are measurements of the SW attenuation property 
exhibited by MP. This attenuation should be exhibited in the same symmetric 
pattern as MPOD spatial distribution indicated by the highly correlated MPOD 
values among the four meridians at each eccentricity. 
 
 At 3cpd, both foveal GD and RGD correlations with foveal MPOD measured as a 
discrete point, foveal MPOD as a 1o integrated area assuming stimulus center 
measure and foveal MPOD as a 1o integrated area assuming a stimulus point at 
highest retinal sensitivity were non-significant.  Two degree GD correlations with 
foveal MPOD measured as a discrete point (GD: r = -0.327, p = 0.063), foveal 
MPOD as a 1o integrated area assuming stimulus center measure (GD: r = -
0.333, p = 0.058) and foveal MPOD as a 1o integrated area assuming a stimulus 
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point at highest retinal sensitivity (GD: r = -0.331, p = 0.060) were near 
significant. Two degree RGD correlations with foveal MPOD measured as a 
discrete point (RGD: r = -0.335, p = 0.058), foveal MPOD as a 1o integrated area 
assuming stimulus center measure (RGD: r = -0.342, p = 0.056) and foveal 
MPOD as a 1o integrated area assuming a stimulus point at highest retinal 
sensitivity (RGD: r = -0.341, p = 0.055) were also near significant.  Four degree 
GD and RGD correlations with all three foveal MPOD measurements were non-
significant. Six degree GD and RGD correlations with all three foveal MPOD 
measurements were also non-significant (Table 47). 
 
At 3cpd, 2o GD and RGD correlations with 2o MPOD measured as a discrete 
point, 2o MPOD measured as a 1o integrated area assuming stimulus center 
measure and 2o MPOD measured as a 1o integrated area assuming a stimulus 
point at highest retinal sensitivity were non-significant (Table 48). Four degree 
GD and RGD correlations with all three measures of MPOD at 4oeccentricity 
were non-significant (Table 49). Six degree GD and RGD correlations with all 
three measures of MPOD at 6oeccentricity were also non-significant (Table 50).  
 
An independent sample t-test analysis of GD and RGD differences at 0o, 2o, 4o 
and 6o eccentricities between the highest and lowest quartiles of foveal MPOD as 
a 1o integrated area assuming a stimulus point at highest retinal sensitivity was 
also performed.  At 3cpd, GD differences at all retinal eccentricities were non-
significant between top and bottom quartiles of foveal MPOD. However, 
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significant RGD differences were identified at 2o, 4o and 6o eccentricity. An effect 
size correlation between t-test values and degrees of freedom for GD and RGD 
at each eccentricity was also calculated (Table 51).  
 
Independent Samples t-test 
3cpd    
 t-value Sig. 
Effect 
Size (r) 
GD_0
o 
-0.522 0.609 0.129 
RGD_0
o 
-1.040 0.314 0.252 
GD_2
o 
-1.798 0.102 0.410 
RGD_2
o 
-2.210* 0.048 0.484 
GD_4
o 
-1.741 0.116 0.399 
RGD_4
o 
-2.356* 0.043 0.580 
GD_6
o 
-1.216 0.246 0.291 
RGD_6
o 
-2.287* 0.045 0.496 
Table 51 
Independent samples t-test for glare disability and relative glare disability at 0
o
, 2
o
, 4
o
 and 6
o
 for 3cpd grating targets 
between the highest and lowest foveal MPOD as a 1
o
 integrated area assuming a stimulus point at highest retinal 
sensitivity quartiles. Effect size correlations were calculated using degrees of freedom = 16. Levene’s Test for Equal 
Variances was significant so equal variances were not assumed (* p ≤ 0.05 and**p ≤ 0.01) 
 
 
 
A Levene’s Test for Equality of Variances between the highest and lowest 
quartile were significant at 2o RGD, 4o RGD and 6o RGD. A non-parametric 
Mann-Whitney U test between the highest and lowest foveal MPOD quartiles for 
RGD at 4
o
 and 6
o
 resulted in a significant difference at 4o and a non-significant 
difference at 6o (Table 52). 
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Mann-Whitney U Test 
Null Hypothesis of Equal Means 
Between Quartiles: 
Significance Decision 
GD_0
o 
0.489 Retain Null Hypothesis 
RGD_0
o 
0.436 Retain Null Hypothesis 
GD_2
o 
0.113 Retain Null Hypothesis 
RGD_2
o 
0.040* Reject Null Hypothesis 
GD_4
o 
0.136 Retain Null Hypothesis 
RGD_4
o 
0.024* Reject Null Hypothesis 
GD_6
o 
0.387 Retain Null Hypothesis 
RGD_6
o 
0.094 Retain Null Hypothesis 
Table 52 
A non-parametric independent samples Mann-Whitney U test for glare disability and relative glare disability at 0
o
, 2
o
, 4
o
 
and 6
o
 for 3cpd grating targets between the highest and lowest foveal MPOD as a 1
o
 integrated area assuming a stimulus 
point at highest retinal sensitivity quartiles (* p ≤ 0.05 and **p ≤ 0.01) 
 
The range of calculated values for RGD using 3cpd stimuli at each eccentricity 
was 0.37 at 0o, 0.36 at 2o, 0.35 at 4o and 0.36 at 6o. The similar range at each 
retinal eccentricity indicates no trend of increasing GD with increasing 
eccentricity and concurrent decreasing MPOD. Scatterplots of all 3 foveal 
measures of MPOD against RGD revealed that in all cases, a positive 
relationship was seen at all eccentricities. Scatterplots using RGD and foveal 
MPOD measured as a 1o integrated area assuming a stimulus point at highest 
retinal sensitivity explained low amounts of variance at all eccentricities (0o r2 = 
0.052 [Figure 20], 2o r2 = 0.116 [Figure 21], 4o r2 = 0.069 [Figure 22] and 6o r2 = 
0.062 [Figure 23]). Significance for the regression scatterplots was calculated for 
foveal MPOD as a 1o integrated area assuming a stimulus point at highest retinal 
sensitivity and RGD at 0o, 2o, 4o and 6o for 3cpd stimuli.  Non-significant F scores 
were found between integrated foveal MPOD and RGD at all eccentricities for 
3cpd stimuli (Table 53). A multiple regression using foveal MPOD as a 1o 
integrated area assuming a stimulus point at highest retinal sensitivity and 
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corresponding kurtosis value as predictors for resulting RGD at all eccentricities 
was also performed. Non-significant F scores were identified at all eccentricities 
(0o, 2o, 4o and 6o) (Table 54). 
 
 
Figure 20 
Scatterplot of integrated foveal MPOD at highest retinal sensitivity across 1
0
 stimuli versus RGD at 0
0
 eccentricity at 3cpd.  
 
 
 
 
 
 
 
Figure 21 
Scatterplot of integrated foveal MPOD at highest retinal sensitivity across 1
0
 stimuli versus RGD at 2
0
 eccentricity at 3cpd.  
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Figure 22 
Scatterplot of integrated foveal MPOD at highest retinal sensitivity across 1
o
 stimuli versus RGD at 4
0
 eccentricity at 3cpd.  
 
 
 
 
 
Figure 23 
Scatterplot of integrated foveal MPOD at highest retinal sensitivity across 1
o
 stimuli versus RGD at 6
0
 eccentricity at 3cpd.  
 
Although the independent sample t-test revealed significant differences in RGD 
between the highest and lowest quartiles of foveal MPOD at 2o and 4o 
eccentricity, scatterplot results demonstrated relatively low amount of variance 
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explained at 0o eccentricity (r2 = 0.052) and the 2o eccentricity (r2 = 0.116) and 
nearly equivalent covariance measures between 4o (r2 = 0.069) and 6o (r2 = 
0.062) eccentricity.  
 
6cpd Glare Disability and Relative Glare Disability correlations with MPOD 
At 6cpd, foveal GD correlations with foveal MPOD measured as a discrete point, 
foveal MPOD as a 1o integrated area assuming stimulus center measure and 
foveal MPOD as a 1o integrated area assuming stimulus point at highest retinal 
sensitivity were all non-significant. However, RGD correlations with foveal MPOD 
measured as a discrete point (RGD: r = -0.401, p = 0.023), foveal MPOD 
measured as a 1o integrated area assuming stimulus center (RGD: r = -0.412, p 
= 0.017) and foveal MPOD measured as a 1o integrated area assuming a 
stimulus point at highest retinal sensitivity (RGD: r = -0.418, p = 0.015) were 
significant (Table 55).   
6cpd 
 GD_0
o
 RGD_0
o
 GD_2
o
 RGD_2
o
 GD_4
o
 RGD_4
o
 GD_6
o
 RGD_6
o
 
Foveal MPOD 
Discrete Point 
Pearson 
Correlation 
-0.240 -0.401* -0.294 -0.355* -0.164 -0.255 -0.044 -0.189 
 
Sig. (2-
tailed) 
0.178 0.023 0.097 0.041 0.362 0.151 0.807 0.293 
Foveal MPOD 
Integrated 
Stimulus Center 
Pearson 
Correlation 
-0.255 -0.412* -0.291 -0.352* -0.159 -0.252 -0.034 -0.180 
 
Sig. (2-
tailed) 
0.152 0.017 0.100 0.044 0.378 0.158 0.850 0.317 
Foveal MPOD 
Integrated 
Stimulus Highest 
Sensitivity 
Pearson 
Correlation 
-0.265 -0.418* -0.292 -0.354* -0.155 -0.248 -0.030 -0.173 
 
Sig. (2-
tailed) 
0.137 0.015 0.099 0.043 .390 0.163 0.870 0.335 
Table 55 
Correlation coefficients for MPOD at 0
o
 and glare disability and relative glare disability at 0
o
, 2
o
, 4
o
 and 6
o
 for 6cpd grating 
targets. (* p ≤ 0.05 and **p ≤ 0.01) 
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Two degree GD correlations with foveal MPOD measured as a discrete point, 
foveal MPOD measured as a 1o integrated area assuming stimulus center 
measure and foveal MPOD measured as a 1o integrated area assuming a 
stimulus point at highest retinal sensitivity were non-significant. Two degree RGD 
correlations with foveal MPOD measured as a discrete point (RGD: r = -0.355, p= 
0.041), foveal MPOD measured as a 1o integrated area assuming stimulus center 
measure (RGD: r = -0.352, p = 0.044) and foveal MPOD as a 1o integrated area 
assuming a stimulus point at highest retinal sensitivity (RGD: r = -0.354, p = 
0.043) were significant. Four degree GD and RGD correlations with all three 
foveal MPOD measurements were non-significant. Six degree GD and RGD 
correlations with all three foveal MPOD measurements were non-significant 
(Table 55). 
 
At 6cpd, 2o GD and RGD correlations with 2o MPOD measured as a discrete 
point, 2o MPOD measured as a 1o integrated area assuming stimulus center 
measure and 2o MPOD measured as a 1o integrated area assuming a stimulus 
point at highest retinal sensitivity were non-significant (Table 56). Four degree 
GD and RGD correlations with all three measures of MPOD at 4oeccentricity 
were non-significant (Table 57). Six degree GD and RGD correlations with all 
three measures of MPOD at 6oeccentricity were also non-significant (Table 58). 
 
An independent sample t-test analysis of GD and RGD differences at 0o, 2o, 4o 
and 6o eccentricities between the highest and lowest quartiles of foveal MPOD 
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was performed. At 6cpd, non- significant GD differences were identified at 0o, 2o, 
4o, and 6o eccentricities between top and bottom quartiles of foveal MPOD. 
However, significant RGD differences were identified at 0o, 2o and 4o eccentricity 
between top and bottom quartiles of foveal MPOD. An effect size correlation 
between t-test values and degrees of freedom for GD and RGD at each 
eccentricity was also calculated (Table 59). A Levene’s Test for Equality of 
Variances between the highest and lowest quartile was significant at 6o RGD, 
however the non-significant t-value required no additional non-parametric testing. 
Independent Samples t-test 
6cpd    
 t-value Sig. 
Effect 
Size (r) 
GD_0
o 
-1.203 0.246 0.288 
RGD_0
o 
-2.118* 0.049 0.468 
GD_2
0 
-1.919 0.073 0.433 
RGD_2
0 
-2.443* 0.027 0.521 
GD_4
0 
-1.143 0.207 0.274 
RGD_4
0 
-2.158* 0.046 0.475 
GD_6
0 
-0.205 0.840 0.051 
RGD_6
0 
-1.007 0.329 0.244 
Table 59 
Independent samples t-test for glare disability and relative glare disability at 0
o
, 2
o
, 4
o
 and 6
o
 eccentricity for 6cpd grating 
targets between the highest and lowest foveal MPOD as a 1
o
 integrated area assuming a stimulus point at highest retinal 
sensitivity quartiles. Effect size correlations were calculated using degrees of freedom = 16. Levene’s Test for Equal 
Variances was non-significant so equal variances were assumed. (* p ≤ 0.05 and **p ≤ 0.01) 
 
The range of calculated values for RGD using 6cpd stimuli at each eccentricity 
was 0.21 at 0o, 0.34 at 2o, 0.45 at 4o and 0.59 at 6o. The trend of increasing GD 
was seen with increasing eccentricity and concurrent decreasing MPOD. 
Scatterplots of all three foveal measures of MPOD against RGD revealed that in 
all cases, a positive relationship was seen at all eccentricities. Scatterplots using 
RGD and foveal MPOD measured as a 1o integrated area assuming a stimulus 
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point at highest retinal sensitivity explained the greatest amount of variance at all 
eccentricities (0o r2 = 0.175 [Figure 24], 2o r2 = 0.126 [Figure 25], 4o r2 = 0.062 
[Figure 26] and 6o r2 = 0.030 [Figure 27]).  
 
Significance for the scatterplots was calculated for foveal MPOD as a 10 
integrated area assuming a stimulus point at highest retinal sensitivity and RGD 
at 0o, 2o, 4o and 6o for 6cpd stimuli.  A significant F value was found between 
foveal MPOD as a 1o integrated area assuming stimulus point at highest retinal 
sensitivity and 0o and non-significant F values were at 2o, 4o and 6o eccentricities 
for 6cpd stimuli (Table 60). A multiple regression using foveal MPOD as a 1o 
integrated area assuming a stimulus point at highest retinal sensitivity and 
corresponding kurtosis value as predictors for resulting RGD at all eccentricities 
was also performed. Non-significant F scores were identified at all eccentricities 
(0o, 2o, 4o and 6o) (Table 61). 
 
Figure 24 
Scatterplot of integrated foveal MPOD at highest retinal sensitivity across 1
o
 stimuli versus RGD at 0
o
 eccentricity at 6cpd.  
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Figure 25 
Scatterplot of integrated foveal MPOD at highest retinal sensitivity across 1
o
 stimuli versus RGD at 2
o
 eccentricity at 6cpd.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26 
Scatterplot of integrated foveal MPOD at highest retinal sensitivity across 1
o
 stimuli versus RGD at 4
o
 eccentricity at 6cpd.  
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Figure 27 
Scatterplot of integrated foveal MPOD at highest retinal sensitivity across 1
o
 stimuli versus RGD at 6
o
 eccentricity at 6cpd.  
 
 
 
 
 
Regression Fit for 6cpd Stimuli 
Integrated Foveal MPOD F Significance 
RGD_0
o
 6.575* 0.015 
RGD_2
o 
4.449* 0.043 
RGD_4
o 
2.039 0.163 
RGD_6
o
 0.958 0.335 
Table 60 
Regression fit significance table for foveal MPOD as a 1
o
 integrated area assuming stimulus point at highest retinal 
sensitivity and relative glare disability at 0
o
, 2
o
, 4
o
 and 6
o
 using 6cpd grating targets. (* p ≤ 0.05 and **p ≤ 0.01) 
 
As the independent sample t-test revealed significant differences in RGD at 0o, 2o 
and 4o of eccentricity between the highest and lowest quartiles of foveal MPOD 
as a 1o integrated area assuming stimulus point at highest retinal sensitivity, 
scatterplot results demonstrated the greatest amount of variance explained at the 
0o (r2 = 0.175) followed by the 2o eccentricity (r2 = 0.1255) and 4o eccentricity (r2 
= 0.069) and the least amount of variance explained at the 6o eccentricity (r2 = 
0.030).  
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9cpd Glare Disability and Relative Glare Disability correlations with MPOD 
At 9cpd, both foveal GD and RGD with foveal MPOD measured as a discrete 
point (GD: r = -0.395, p= 0.023 and RGD: r = -0.491, p = 0.004), foveal MPOD 
measured as a 1o integrated area assuming stimulus center measure (GD: r = -
0.406, p = 0.019 and RGD: r = -0.501, p = 0.003) and foveal MPOD measured as 
a 10 integrated area assuming a stimulus point at highest retinal sensitivity (GD: r 
= -0.413, p = 0.017 and RGD: r = -0.505, p = 0.003) were significant. Two degree 
GD and RGD correlations with foveal MPOD measured as a discrete point (GD: r 
= -0.358, p = 0.043 and RGD: r = -0.401, p = 0.017), foveal MPOD measured as 
a 1o integrated area assuming stimulus center measure (GD: r = -0.359, p = 
0.043 and RGD: r = -0.407, p = 0.016) and foveal MPOD measured as a 1o 
integrated area assuming a stimulus point at highest retinal sensitivity (GD: r = -
0.377, p = 0.032 and RGD: r = -0.421, p = 0.015) were significant (Table 62).  
 
Four degree GD correlations with all three foveal MPOD measurements were 
non-significant. However, four degree RGD correlations with foveal MPOD 
measured as a discrete point (RGD: r = -0.372, p = 0.033), foveal MPOD 
measured as a 1o integrated area assuming stimulus center measure (RGD: r = -
0.368, p = 0.035) and foveal MPOD measured as a 1o integrated area assuming 
a stimulus point at highest retinal sensitivity (RGD: r = -0.373, p = 0.033) were 
significant. Six degree GD and RGD correlations with all three measures of 
foveal MPOD were non-significant (Table 62). 
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9cpd 
 GD_0
o
 RGD_0
o
 GD_2
o
 RGD_2
o
 GD_4
o
 RGD_4
o
 GD_6
o
 RGD_6
o
 
Foveal MPOD 
Discrete Point 
Pearson 
Correlation 
-0.395* -0.491** -0.358* -0.401* -0.282 -0.372* -0.051 -0.168 
 
Sig. (2-
tailed) 
0.023 0.004 0.043 0.017 0.112 0.033 0.777 0.351 
Foveal MPOD 
Integrated 
Stimulus Center 
Pearson 
Correlation 
-0.406* -0.501** -0.359* -0.407* -0.270 -0.368* -0.044 -0.162 
 
Sig. (2-
tailed) 
0.019 0.003 0.043 0.016 0.128 0.035 0.808 0.368 
Foveal MPOD 
Integrated 
Stimulus 
Highest 
Sensitivity 
Pearson 
Correlation 
-0.413* -0.505** -0.377* -0.421** -0.274 -0.373* -0.043 -0.162 
 
Sig. (2-
tailed) 
0.017 0.003 0.032 0.015 0.123 0.033 0.814 0.367 
Table 62 
Correlation coefficients for foveal MPOD as a 1
o
 integrated area assuming stimulus point at highest retinal sensitivity at 0
o
 
and glare disability and relative glare disability at 0
o
 , 2
o
, 4
o
 and 6
o
 for 9cpd grating targets. (* p ≤ 0.05 and **p ≤ 0.01) 
 
At 9cpd, 2o GD and RGD correlations with 2o MPOD measured as a discrete 
point (GD: r = -0.421, p = 0.015 and RGD: r = -0.445, p = 0.009), 2o MPOD 
measured as a 10 integrated area assuming stimulus center measure (GD: r = -
0.434, p = 0.011 and RGD: r = -0.457, p = 0.008) and 2o MPOD measured as a 
1o integrated area assuming a stimulus point at highest retinal sensitivity (GD: r = 
-0.399, p = 0.021 and RGD: r = -0.411, p = 0.018) were significant (Table 63). 
9cpd   GD_2
o
 RGD_2
o
 
2
o
 MPOD Discrete 
Point
 
Pearson 
Correlation 
-0.421* -0.445** 
  Sig. (2-tailed) 0.015 0.009 
2
o
 MPOD 
Integrated 
Stimulus Center
 
Pearson 
Correlation 
-0.434** -0.457** 
 Sig. (2-tailed) 0.011 0.008 
2
o
 MPOD 
Integrated 
Stimulus Highest 
Sensitivity
 
Pearson 
Correlation 
-0.399* -0.411* 
 Sig. (2-tailed) 0.021 0.018 
Table 63 
Correlation coefficients for MPOD at 2
o
 and glare disability and relative glare disability at 2
o
 for 9cpd grating targets. (* p ≤ 
0.05 and **p ≤ 0.01) 
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Four degree GD correlations with 4o MPOD measured as a 1o integrated area 
assuming stimulus center measure (GD: r = -0.353, p = 0.044) was significant. 
Four degree RGD correlations with 4o MPOD measured as a 1o integrated area 
assuming stimulus center measure (RGD: r= -0.381, p = 0.029) and MPOD 
measured as a 1o integrated area assuming a stimulus point at highest retinal 
sensitivity (RGD: r = -0.359, p = 0.040) were significant (Table 64). Six degree 
GD and RGD correlations with all three measures of MPOD at 6o eccentricity 
were non-significant (Table 65). 
9cpd   GD_4
o
 RGD_4
o
 
4
o
 MPOD Discrete 
Point
 
Pearson 
Correlation 
-0.332 -0.341 
  Sig. (2-tailed) 0.059 0.052 
4
o
 MPOD 
Integrated 
Stimulus Center
 
Pearson 
Correlation 
-0.353* -0.381* 
 Sig. (2-tailed) 0.044 0.029 
4
o
 MPOD 
Integrated 
Stimulus Highest 
Sensitivity
 
Pearson 
Correlation 
-0.339 -0.359* 
 Sig. (2-tailed) 0.054 0.040 
Table 64 
Correlation coefficients for MPOD at 4
o
 and glare disability and relative glare disability at 4
o
 for 9cpd grating targets. (*p ≤ 
0.05 and **p ≤ 0.01) 
 
 
An independent sample t-test analysis of GD and RGD differences at 0o, 2o, 4o 
and 6o eccentricities between the highest and lowest quartiles of foveal MPOD as 
a 1o integrated area assuming stimulus point at highest retinal sensitivity was 
also performed.  At 9cpd, significant GD and RGD differences were 
demonstrated at 0o and 2o with non-significant differences at 4o and 6oeccentricity 
between top and bottom quartiles of foveal MPOD (Table 66).  
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Independent Samples t-test 
9cpd    
 t-value Sig. 
Effect 
Size (r) 
GD_0
o 
-2.184* 0.049 0.479 
RGD_0
o 
-2.867* 0.015 0.583 
GD_2
o 
-2.527* 0.022 0.534 
RGD_2
o 
-2.811* 0.016 0.575 
GD_4
o 
-2.215* 0.042 0.484 
RGD_4
o 
-2.452* 0.026 0.523 
GD_6
o 
-0.055 0.957 0.014 
RGD_6
o 
-0.808 0.431 0.198 
Table 66 
Independent samples t-test for glare disability and relative glare disability at 0
o
, 2
o
, 4
o
 and 6
o
 for 9cpd grating targets 
between the highest and lowest foveal MPOD as a 1
o
 integrated area assuming stimulus point at highest retinal sensitivity 
quartiles. Effect size correlations were calculated using degrees of freedom = 16. Levene’s Test for Equal Variances was 
significant so equal variances were not assumed. (* p ≤ 0.05 and **p ≤ 0.01) 
 
 
Levene’s Test for Equality of Variances between the highest and lowest quartiles 
of foveal MPOD as a 1o integrated area assuming stimulus point at highest 
retinal sensitivity was significant at 0o RGD, 2o RGD and 4o GD indicating a non-
normal distribution. A non-parametric Mann-Whitney U test between the highest 
and lowest foveal MPOD quartiles resulted in a significant difference at both 0o 
and 2o RGD and non-significance at 4o GD (Table 67). 
Mann-Whitney U test 
Null Hypothesis of Equal Means 
Between Quartiles: 
Significance Decision 
GD_0
o
 0.031* Reject Null Hypothesis 
RGD_0
o
 0.024* Reject Null Hypothesis 
GD_2
o 
0.019* Reject Null Hypothesis 
RGD_2
o 
0.031* Reject Null Hypothesis 
GD_4
o 
0.063 Retain Null Hypothesis 
RGD_4
o 
0.016* Reject Null Hypothesis 
GD_6
o 
0.605 Retain Null Hypothesis 
RGD_6
o 
0.387 Retain Null Hypothesis 
Table 67 
A non-parametric independent samples Mann-Whitney U test for glare disability and relative glare disability at 0
o
, 2
o
, 4
o
 
and 6
o
 for 9cpd grating targets between the highest and lowest quartiles of foveal MPOD as a 1
o
 integrated area 
assuming stimulus point at highest retinal sensitivity (*p ≤ 0.05 and **p ≤ 0.01) 
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The range of calculated values for RGD using 9cpd stimuli at each eccentricity 
was 0.27 at 0o, 0.35 at 2o, 0.43 at 4o and 0.46 at 6o. The trend of increasing GD 
was seen with increasing eccentricity and concurrent decreasing MPOD. 
Scatterplots of all three foveal measures of MPOD with RGD revealed that in all 
cases, a positive regression relationship was seen at all eccentricities. 
Scatterplots using RGD explained a moderate to high amount of variance in the 
data at 0o, 2o and 4o eccentricities (0o r2 = 0.255 [Figure 28], 2o r2 = 0.177 [Figure 
29], 4o r2 = 0.139 [Figure 30]) and a low amount of variance at 6o (r2 = 0.026) 
[Figure 31].  
 
Significance for the scatterplots was calculated for foveal MPOD as a 1o 
integrated area assuming a stimulus point at highest retinal sensitivity and RGD 
at 0o, 2o, 4o and 6o for 6cpd stimuli.  A significant F value was found between 
foveal MPOD as a 1o integrated area assuming stimulus point at highest retinal 
sensitivity and  RGD at 0o, 2o and 4o and non-significance at 6o (Table 68). A 
multiple regression using foveal MPOD as a 1o integrated area assuming a 
stimulus point at highest retinal sensitivity and corresponding kurtosis value as 
predictors for resulting RGD at all eccentricities was also performed. Significant F 
scores were identified at 0o, 2o and 4o eccentricities with non-significance at 6o 
(Table 69). 
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Figure 28 
Scatterplot of integrated foveal MPOD at highest retinal sensitivity across 1
o
 stimuli versus RGD at 0
o
 eccentricity at 9cpd.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 29 
Scatterplot of integrated foveal MPOD at highest retinal sensitivity across 1
o
 stimuli versus RGD at 2
o
 eccentricity at 9cpd.  
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Figure 30 
Scatterplot of integrated foveal MPOD at highest retinal sensitivity across 1
o
 stimuli versus RGD at 4
o
 eccentricity at 9cpd.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 31 
Scatterplot of integrated foveal MPOD at highest retinal sensitivity across 1
o
 stimuli versus RGD at 6
o
 eccentricity at 9cpd. 
 
 
P a g e  | 128 
 
Regression Fit for 9cpd Stimuli 
Integrated Foveal MPOD F Significance 
RGD_0
o 
10.614 ** 0.003 
RGD_2
o 
6.681 * 0.015 
RGD_4
o 
5.007 * 0.033 
RGD_6
o
 0.834 0.369 
Table 68 
Regression fit significance table for foveal MPOD integrated across 1
0
 assuming stimulus point at highest retinal 
sensitivity and relative glare disability at 0
o
, 2
p
, 4
o
 and 6
o
 using 9cpd grating targets. (*p ≤ 0.05 and **p ≤ 0.01) 
 
 
 
Multiple Regression Fit for 9cpd Stimuli 
Integrated Foveal MPOD and 
Kurtosis as Predictors 
F Significance 
RGD_0
o
 5.174* 0.012 
RGD_2
o 
3.610* 0.039 
RGD_4
o 
3.397* 0.047 
RGD_6
o
 0.414 0.665 
Table 69 
Multiple regression fit significance table for foveal MPOD integrated across 1
o
 assuming stimulus point at highest retinal 
sensitivity and kurtosis values as predictors for relative glare disability at 0
o
, 2
o
, 4
o
 and 6
o
 using 9cpd grating targets. (*p ≤ 
0.05 and **p ≤ 0.01) 
 
 
As the independent sample t-test revealed significant differences between RGD 
at 0o, 2o and 4o of eccentricity, scatterplot results demonstrated the greatest 
amount of variance explained at the 0o (r2 = 0.255) followed by the 2o eccentricity 
(r2 = 0.177) then 4o eccentricity (r2 = 0.139) and the least amount of variance 
explained at the 6o eccentricity (r2 = 0.026).  
Below shows a radial summary plot of correlation values between MPOD 
calculated as a discrete value with GD and RGD (Figure 32). The plots show the 
differences in correlation results among meridians as well as decreasing 
correlation between MPOD and glare attenuation with increasing eccentricity.  A 
similar radial summary plot of correlation values between MPOD calculated as a 
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1o integrated area assuming stimulus point at highest retinal sensitivity with GD 
and RGD. Similar differences in correlation results among meridians as well as 
decreasing correlation between MPOD and glare attenuation with increasing 
eccentricity are seen (Figure 33). 
 
Figure 32 
Summary plots indicating correlation and significance values for corresponding locations of MPOD measured as a 
discrete value and both GD (left) and RGD (right) using 9cpd stimuli . (*p ≤ 0.05 and **p ≤ 0.01) 
 
Figure 33 
Summary plots indicating correlation and significance values for corresponding locations of MPOD as a 1
o
 integrated area 
assuming stimulus point at highest retinal sensitivity and GD (left) and RGD (right) using 9cpd stimuli. (*p ≤ 0.05 and **p ≤ 
0.01) 
 
-0.331 -0.217 -0.101 
-0.319* 
-0.342 
-0.158 
-0.172 -0.307 -0.407* 
-0.415* 
-0.338 
-0.051 
-0.395* 
-0.341 -0.286 -0.114 
-0.399* 
-0.321 
-0.180 
-0.201 -0.318 -0.415* 
-0.391* 
-0.351* 
-0.066 
-0.413* 
-0.335 -0.245 -0.127 
-0.405* 
-
0.362* 
-0.143 
-0.158 -0.323 -0.398* 
-0.340* 
-0.352* 
-0.081 
-0.491* 
-0.337 -0.399* -0.127 
-0.421* 
-0.302 
-0.193 
-0.201 -0.352* -0.401* 
-0.347* 
-0.340 
-0.099 
-0.505* 
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Intraocular Scatter Correlations with MPOD 
Intraocular scatter was evaluated as four separate correlation coefficients: 1) 
foveal MPOD discrete value, 2) foveal MPOD integrated across 1o, 3) AUC 
integrated across 16o assuming stimulus center and 4) AUC integrated across 16o 
assuming stimulus point of highest sensitivity 
 
Intraocular scatter correlations with foveal MPOD discrete value (r = -0.348, p = 
0.078), foveal MPOD integrated across 1o (r = -0.346, p = 0.080), AUC integrated 
across 16o assuming stimulus center (r = -0.261, p = 0.142) and AUC integrated 
across 16o assuming stimulus point of highest sensitivity (r = -0.253, p = 0.156) 
were non-significant (Table 70). 
  
Foveal 
MPOD 
Discrete 
Point 
Foveal 
MPOD 
Integrated 
Stimulus 
Highest 
Sensitivity 
Integrated 
AUC MPOD 
across 16
o
 
Stimulus 
Center 
Integrated 
AUC MPOD 
across 16
o
 
Stimulus 
Highest 
Sensitivity 
Intraocular 
Scatter
 
Pearson 
Correlation 
-0.348 -0.346 -0.261 -0.253 
 
Sig. (2-tailed) 0.078 0.080 0.142 0.156 
Table 70 
Correlation coefficients for intraocular scatter thresholds and MPOD measured at 0
o
 integrated across the 1
o
 stimulus and 
integrated across the 16
o
 macula. 
 
An independent sample t-test analysis of intraocular scatter differences between 
the highest and lowest quartiles of foveal MPOD revealed significant differences 
(Table 71).  
Independent Samples t-test 
 t-value Sig. 
Intraocular Scatter -2.715* 0.015 
Table 71 
Independent samples t-test for intraocular scatter between the highest and lowest foveal MPOD quartiles. Levene’s Test 
for Equal Variances was non-significant so equal variances were assumed. (* p ≤ 0.05 and **p ≤ 0.01) 
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A scatterplot of foveal MPOD integrated across 1o with intraocular scatter values 
was performed resulting in a r2 = 0.117. An inverse relationship was seen 
supporting the hypothesis that higher foveal MPOD levels are associated with 
decreased levels of intraocular scatter (Figure 34). Significance for the scatterplot 
was calculated for foveal MPOD as a 1o integrated area assuming a stimulus 
point at highest retinal sensitivity and intraocular scatter.  A non- significant F 
value was found between foveal MPOD and intraocular scatter (Table 72). 
Figure 34 
Scatterplot of integrated foveal MPOD at highest retinal sensitivity across 1
o
 stimuli versus intraocular scatter. 
 
 
Regression Fit for Intraocular Scatter 
Integrated Foveal MPOD F Significance 
Intraocular Scatter 3.179 0.084 
Table 72 
Regression fit significance table for foveal MPOD integrated across 1
0
 and intraocular scatter values 
 
Three summary tables of correlations between foveal MPOD measured as a 
discrete point (Table 73), foveal MPOD measured as a 1o integrated area 
assuming stimulus center measure (Table 74) and foveal MPOD measured as a 
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1o integrated area assuming a stimulus point at highest retinal sensitivity (Table 
75) with CS, GD and RGD at all measured retinal eccentricities (0o, 2o, 4o and 6o) 
at all measured spatial frequencies (3, 6, 9cpd) are provided below. 
 
Foveal MPOD Measured as a Discrete Point 
 Contrast Sensitivity Glare Disability Relative Glare Disability 
 
3cpd 6cpd 9cpd 3cpd 6cpd 9cpd 3cpd 6cpd 9cpd 
0
o 
NS NS NS NS NS -0.392* NS -0.401* -0.491** 
2
o 
NS NS NS NS NS -0.358* NS -0.316* -0.469** 
4
o
 NS NS NS NS NS NS NS NS -0.372** 
6
o
 NS NS NS NS NS NS NS NS NS 
Table 73 
Correlation coefficients for foveal MPOD as a discrete point measure and contrast sensitivity, glare disability and relative 
glare disability at 0
o
, 2
o
, 4
o
 and 6
o
 of eccentricity for 3, 6 and 9cpd grating targets. (* p ≤ 0.05 and **p ≤ 0.01) 
 
 
 
 
 
Foveal MPOD as 1
o
 Integrated Area Assuming Stimulus Center  
 Contrast Sensitivity Glare Disability Relative Glare Disability 
 
3cpd 6cpd 9cpd 3cpd 6cpd 9cpd 3cpd 6cpd 9cpd 
0
o 
NS NS NS NS NS -0.406* NS -0.412* -0.501** 
2
o 
NS NS NS NS NS -0.359* NS -0.316* -0.475** 
4
o
 NS NS NS NS NS NS NS NS -0.368** 
6
o
 NS NS NS NS NS NS NS NS NS 
Table 74 
Correlation coefficients for foveal MPOD measured as a 1
o
 integrated area assuming stimulus center measure and 
contrast sensitivity, glare disability and relative glare disability at 0
o
, 2
o
, 4
o
 and 6
o
 of eccentricity for 3, 6 and 9cpd grating 
targets. (* p ≤ 0.05 and **p ≤ 0.01) 
 
 
 
 
 
Foveal MPOD as 1
o
Integrated Area Assuming Stimulus Point of Highest Retinal Sensitivity  
 Contrast Sensitivity Glare Disability Relative Glare Disability 
 
3cpd 6cpd 9cpd 3cpd 6cpd 9cpd 3cpd 6cpd 9cpd 
0
o 
NS NS NS NS NS -0.413* NS -0.418* -0.505** 
2
o 
NS NS NS NS NS -0.377* NS -0.315* -0.489** 
4
o
 NS NS NS NS NS NS NS NS -0.373** 
6
o
 NS NS NS NS NS NS NS NS NS 
Table 75 
Correlation coefficients for foveal MPOD measured as a 1
o
 integrated area assuming a stimulus point at highest retinal 
sensitivity and contrast sensitivity, glare disability and relative glare disability at 0
o
, 2
o
, 4
o
 and 6
o
 of eccentricity for 3, 6 and 
9cpd grating targets. (* p ≤ 0.05 and **p ≤ 0.01) 
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VII. Discussion 
A. Macular Pigment Spatial Distribution 
The spatial distribution of MP in this sample as measured by cHFP was well-
described by a first-order exponential function originating at the foveal center in 
agreement with ex vivo HPLC studies (Handelman et al., 1988) and a Lorentzian 
function across the macula (Stringham et al., 2003 and Wenzel et al., 2006). 
Spatial distribution results from this experiment show similar covariance values 
when MPOD measures at eccentricities across the macula assuming stimulus 
point at highest retinal sensitivity (r2 = 0.907) versus stimulus center (r2 = 0.885) 
are fit to a Lorentzian function. The similar covariance values support an 
adequate description of MPOD spatial distribution by assuming either stimulus 
center measurement or stimulus point at highest retinal sensitivity. Although the 
study sample distribution is best fit by a Lorentzian function across the macula, 
large individual differences in distribution shape are seen. 
 
The study sample demonstrates a mean positive kurtosis (i.e. leptokurtic) value. 
This offers support of the Lorentzian fit to MPOD spatial distribution over a 
Gaussian fit due to the higher central peak of the Lorentzian function. The 
relatively large variance in the kurtosis values also supports the large variability 
in individual MPOD spatial distributions when fit to a Lorentzian function. The 
close agreement between the separate AUC measurements suggest that when 
considering the spatial distribution across the 16o macula, stimulus center and 
stimulus point at highest retinal sensitivity are comparable descriptors. Methods 
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of MPOD spatial distribution including kurtotic descriptions and integrated AUC 
calculations show substantial variability among individuals and within the 
substantial variability is where differences in visual performance measures may 
lie. 
 
In an effort to minimize receptive field interaction or underlying photoreceptor 
response differences, the MPOD spatial distribution was also fit to a 1st order 
exponential curve excluding the 0o measurement value. The relative agreement 
of the y-intercept of the highest retinal sensitivity when the 0o measurement is 
excluded (y-intercept = 0.477) versus stimulus center when 0o measurement is 
excluded (y-intercept = 0.629) with both the stimulus point of highest retinal 
sensitivity with 0o measurement (y-intercept = 0.387) and stimulus center with 0o 
measurement (y-intercept = 0.426) may offer support that the point of highest 
retinal sensitivity subtended by the stimuli is the measurement point of MPOD 
using HFP techniques. 
 
The overall distribution measure of MPOD shows an inverse association with 
retinal eccentricity. The trend of decreasing MPOD as a function of eccentricity 
has been documented by both ex vivo studies (Snodderly et al., 1984 and Bone 
et al., 1985) and in vivo studies (Hammond et al., 1997 and Wooten et al., 2005) 
of the MP spatial distribution.  The results of this experiment support and confirm 
the previously identified first order exponential decay curve exhibited by MP as a 
function of retinal eccentricity. Several studies have described a secondary peak 
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or ring-like structure of MPOD that is found between approximately 0.500 and 
0.850 eccentric to fovea in 10-20% of the general population (Berendschot et al., 
2006 and Dietzel et al., 2011). The cHFP device designed and built for this 
project focused on the overall spatial distribution from 0o to 8o eccentricity 
measured with a 1o stimulus at 2o intervals.  Due to this device design, 
measurement and verification of predicted ring-like MPOD findings is not within 
the scope of the current project but design modifications to the existing cHFP 
device would allow such a measurement.   
 
Anatomic structure has also been demonstrated to influence MPOD spatial 
profiles. Specifically, Nolan et al. (2008) found that foveal width was associated 
with non-typical MP spatial distribution. Increased foveal width was significantly 
related to MP spatial profiles due in part to increased length of the foveal cone 
axons. The slope of the foveal depression was also shown to influence the slope 
of the MPOD spatial distribution: Steep foveal depressions were significantly 
related to steep MPOD spatial distributions. 
 
Risk factors such as age and increased oxidative stress along with differences in 
foveal anatomic architecture have been shown to create non-exponential 
declines in MPOD spatial distribution with increasing eccentricity. Assessment of 
MPOD spatial distribution for these individuals would likely be better expressed 
as an integrated area under the curve. Results from the current experiment 
across 33 subjects ages 22-34 supported a monotonic exponential decay curve 
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consistent with Kirby et al. (2010) which found that younger subjects tended to 
exhibit a typical exponential decay function with increasing eccentricity when 
measured by HFP. Kirby et al. also hypothesized that changes in the typical 
exponential function of MPOD distribution with age may be in part to cumulative 
SW absorption. 
 
B. Contrast Sensitivity and Glare Disability Across the Macula 
The overall distribution measures of CS and GD show an inverse association 
with retinal eccentricity. The decreasing CS with increasing retinal eccentricity 
demonstrated in this experiment is also supported in previous studies (Pointer et 
al., 1989). The inverse association of CS and retinal eccentricity is a 
consequence of the simultaneous decreasing cone density and increasing 
receptive field size that occurs with increasing retinal eccentricity (Virsu and 
Rovamo, 1979).  The measure of GD was defined as a difference in CS under no 
glare and glare conditions. The subjects’ underlying CS affects both measures 
and absolute GD reflected greater variability in sensitivity measures than relative 
GD. In order to parse out existing differences in GD specific to glare effects 
among individuals, a normalization of the absolute GD measure was determined 
through calculation of the RGD defined as (CSNo Glare – CSGlare) / CSNo Glare.  
 
Theoretically, as the MPOD decreases with increasing retinal eccentricity, the 
resulting GD should increase and sensitivity measures will decrease. GD was 
measured as a difference in CS and followed similar inverse associations with 
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retinal eccentricity.  When GD was calculated, large variability at each retinal 
eccentricity within the sample was seen.  The transformation of absolute GD into 
RGD allowed differences in sensitivity specific to glare to be identified and 
created less variability within the measures at each eccentricity. A greater 
number of RGD than GD results followed an expected trend of decreasing 
sensitivity with decreasing retinal eccentricity. 
 
Stimuli were not scaled to account for receptive field changes with increasing 
sensitivity in order to compare equivalent integrated MPOD measures with 
grating targets areas. Increased parafoveal target sizes would require increased 
HFP stimuli to allow for equivalent integration comparisons. Due to the 
Lorentzian spatial distribution of MPOD across the macula, larger areas of 
integration would likely mask small differences between individual MPOD 
distributions. 
 
Vertical grating orientations were utilized for CS and GD stimuli to allow for direct 
comparisons of results to the existing studies that also used vertical grating 
orientations (Loughman et al., 2010 and Nolan et al., 2011). The experimental 
design of this project utilized the same vertical grating targets for both glare and 
no glare conditions. Identical stimuli for both conditions allowed target resolution 
threshold by each subject to be identified in the same manner for both conditions 
helping to control for edge detection resulting from microsaccadic activity during 
fixation. 
P a g e  | 138 
 
C. Relationship between MPOD, Contrast Sensitivity, Glare Disability and 
Intraocular Scatter 
Hypothesis #1 
MPOD has an inverse relationship with glare disability and contrast sensitivity at 
both foveal and parafoveal retinal loci. 
 
Results from this study did not identify an association between MPOD and CS at 
foveal or parafoveal loci. Due the non-significant relationship between MPOD 
and CS and the calculation of GD as CSNo Glare - CSGlare, no significant 
correlations between MPOD and GD were found. However, when underlying CS 
results were controlled for by calculating RGD as (CSNo Glare - CSGlare) / CSNo Glare, 
study results supported a significant inverse relationship between foveal MPOD 
and RGD out to 4o eccentricity using 9cpd targets. 
 
Hypothesis #2 
Integrated measures of MPOD across the diameter of the stimulus will better 
predict visual performance compared to discrete point measurements. 
 
MPOD was calculated as an integrated measure across the 1o stimulus 
assuming a central stimulus measure and across the 1o stimulus assuming a 
point of highest retinal sensitivity. Results from this study demonstrated similar 
significant correlations when MPOD measurements assumed either an integrated 
measure or a discrete measure. These similarities may be due to relatively small 
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differences in corresponding integrated and discrete MPOD measures within an 
individual subject. It is likely that both HFP and the adaptive staircase method of 
limits CS task involved the stimulus point which subtended the highest retinal 
sensitivity. 
 
Hypothesis #3 
Integrated MPOD is inversely related to intraocular scatter. 
 
Intraocular scatter was assessed using a psychophysical central flicker 
comparison technique. Similar to the HFP device, the perception of subtle flicker 
differences were likely identified by the point of highest retinal sensitivity. The 
corresponding regions of subtle flicker comparison difference measurement and 
MPOD measurement may explain the higher correlation values between foveal 
MPOD and intraocular scatter rather than integrated MPOD across the 16o 
macula. Although correlations between foveal MPOD and intraocular scatter 
were non-significant, an inverse trend between was demonstrated. 
 
Overall, results of this study demonstrated non-significant correlations between 
MPOD and CS at all retinal eccentricities at 3, 6 and 9cpd spatial frequencies. 
Only 1 previous non-supplementation study of MP has reported significant 
findings between MPOD and CS (Loughman et al., 2010).  These differences in 
results may be due to differences in experimental design including stimuli 
configuration and psychophysical methods. The Loughman et al. (2010) study 
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utilized vertical Gabor patches with a spatial Gaussian envelope generated by a 
Metropsis Visual Stimulus Generation device (Cambridge Research Systems 
Ltd., Cambridge, UK) presented on a 19” CRT monitor which subtended 4.20 of 
visual angle. A four alternative forced choice test was used and targets were 
randomly presented at a 20 spatial offset from a central fixation cross. An 
adaptive staircase method was used to determine contrast threshold.  The target 
visibility was started above expected subject threshold values (determined from 
previous pilot study) and decreased at 0.3 log unit steps until the first reversal 
then was presented at 0.15 log unit steps until 12 reversal were recorded.  
Threshold was identified at the midpoint of 12 reversal points for five different 
spatial frequencies: 1.0, 4.1, 7.5, 11.8 and 20.7cpd. 
 
The hypothesized role of MP influences on CS has been attributed to SW 
attenuation effects of chromatic aberration and intraocular scatter leading to 
retinal image resolution increases through reduced lateral inhibition and 
enhanced receptive field responses (Loughman et al., 2010). Lack of correlation 
significance between MPOD and CS may also have been due to the spectral 
composition and the predominance of LW light contained within the stimuli and 
background. Spectral analysis of the CRT display used in stimuli generation was 
performed using the same spectrophotometer (model 650; Photo Research Inc., 
Chatsworth, CA) used in calibration of the LED glare sources.  
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Spectrophotometer results for the CRT used showed a luminance output of 
20cd/m2 with a peak wavelength of 624nm. The well-documented SW 
attenuation property of MP underlies the Optical Hypothesis described earlier.  
The absorption bandwidth of MP extends from approximately 400nm to 520nm 
with a peak absorbance of 460nm. The peak spectral output of the stimuli and 
background of produced by the CRT display used in the experiment is far outside 
the absorption spectrum of MP providing a possible explanation for the non-
significant relationship between MPOD and CS. 
 
3cpd Stimuli GD and RGD 
Non-significant correlations of GD at 3cpd with both foveal and eccentric MPOD 
measures are likely due to the influence of the underlying CS variability among 
subjects. The method used to calculate GD was a difference in CS under no 
glare and glare conditions. CS at the fovea and across the macula showed high 
variability within the study sample and no significant relationship with MPOD 
measures. The lack of significant correlation between foveal and eccentric 
MPOD measures with CS likely influences the same lack of correlation between 
foveal and eccentric MPOD measures with GD. A function of calculating relative 
GD is a normalization of GD and an isolation of glare-dependent effects on CS 
measures. Non-significant correlations of RGD at 3cpd with both foveal and 
eccentric MPOD measures may be a result of the low spatial frequency stimuli 
used. Roumes et al. (2001) and Aguirre et al. (2007) found that the effect of glare 
is greatest within spatial frequencies with the highest CS and visual effects due 
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to glare conditions decreased CS primarily within the low spatial frequency 
range. 
 
Although correlations were non-significant, a significant difference in RGD 
between the highest and lowest quartiles of foveal MPOD was identified at 2o 
and 4o. Theses significant differences between quartiles exist at low foveal 
eccentricities where MPOD is relatively higher than 6o. Additionally, the 
calculated effect sizes at 2o and 4o eccentricity were r = 0.484 and r = 0.508, 
respectively. Using Cohen’s guidelines (Howell, 2007), correlational effect sizes 
greater than 0.4 are generally accepted as large providing that differences 
between the highest and lowest foveal MPOD quartiles are statistically significant 
and meaningful.  
 
No significant difference in RGD was found at 6o where MPOD is relatively lower. 
This dependence on foveal eccentricity and relative MPOD may support a 
minimum value of MPOD may be necessary to confer RGD benefits to a subject. 
The lack of a significant difference in RGD at 00 eccentricity between the highest 
and lowest MPOD quartiles was unexpected.  The non-significant difference may 
be a result of the high degree of variability within the RGD calculations at 00 
among the subject sample for 3cpd stimuli compared to 6cpd and 9cpd stimuli. 
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6cpd Stimuli GD and RGD 
Non-significant correlations between GD and foveal measures at 6cpd were 
identified. These non-significant correlations are likely a result of the underlying 
non-significant CS correlations with foveal MPOD or a lesser effect of MPOD 
glare attenuation on low to moderate spatial frequencies. Significant correlations 
of RGD with foveal MPOD measures were found at 00 and 20 and marginal 
significance of RGD with foveal MPOD measures at 40 foveal eccentricity.  The 
findings of correlational significance with 6cpd stimuli and non-significance with 
3cpd stimuli support a possible spatial frequency influence on RGD effects.  
 
Significant differences in RGD between the highest and lowest quartiles of foveal 
MPOD were identified at 0o, 2o and 4o of foveal eccentricity with non-significant 
differences in GD at the same foveal eccentricities. These differences between 
GD and RGD support the importance of normalizing the effects of CS in order to 
evaluate distinct glare attenuation effects. Additionally, the calculated effect sizes 
for RGD at 0o, 2o and 4o eccentricity were r = 0.468, r = 0.521 and r = 0.475, 
respectively. The combination of statistical significance with a robust effect size 
suggests that differences between the highest and lowest foveal MPOD quartiles 
are meaningful.  
 
The overall range of RGD for 6cpd stimuli at all eccentricities revealed a trend of 
increasing RGD with decreasing MPOD. Significant differences in RGD found at 
low foveal eccentricities with relatively greater MPOD in combination with non-
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significant differences in RGD at high foveal eccentricities with relatively lower 
MPOD further supports a possible minimum value of MPOD necessary to confer 
RGD benefits. 
 
9cpd Stimuli GD and RGD 
Significant correlations of GD and RGD with foveal MPOD measures at 9cpd 
may indicate the influence of MPOD glare attenuation on moderate to high 
spatial frequencies. Significant correlations of GD with foveal MPOD is 
demonstrated at 0o and 2o foveal eccentricity while significant correlations of 
RGD with foveal MPOD are shown at 0o, 2o and 4o of foveal eccentricity. 
Significant correlations are also seen between GD and RGD with parafoveal 
MPOD measures at 2o and 4o not seen using the 3cpd and 6cpd stimuli. The 
overall range of RGD for 9cpd stimuli at all eccentricities revealed a trend of 
increasing RGD with decreasing MPOD. The trend of increasing RGD with 
decreasing MPOD is exhibited at 6cpd stimuli and 9cpd stimuli but not 3cpd 
stimuli, may also support a spatial frequency dependence of MPOD on glare 
attenuation. Additionally, the emergence of a significant relationship between 
corresponding parafoveal MPOD with both GD and RGD out to 4o eccentricity 
using 9cpd targets suggests a spatial frequency dependence on the glare 
attenuation afforded by MP. 
 
The analysis of RGD between the highest and lowest quartiles of foveal MPOD 
shows the largest statistically significant effects. The combination of statistical 
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significance with a robust effect provides further support of a possible spatial 
frequency influence on the glare attenuation effects of MPOD.  
 
The large variability of CS and overlapping 95% confidence intervals within the 
study sample at retinal eccentricities of 4o and 6o may explain the significance of 
RGD and MPOD and the non-significance of GD and MPOD. The GD value is an 
absolute difference between CS under glare conditions and CS with no glare 
conditions.  This value will be greatly influenced by the underlying CS of the 
subject at a given retinal eccentricity.  The RGD value is a relative difference 
between CS under glare conditions and CS with no glare conditions. Specifically, 
RGD is calculated as: RGD = ( CSNo Glare - CSGlare) / (CSGlare) and may better 
identify the glare attenuation effects separate from the underlying CS at a given 
retinal eccentricity. 
 
Within our study sample, relatively similar significant correlation coefficients were 
found between both integrated and discrete measures of MPOD and RGD. 
These findings support the shared association between integrated and discrete 
MPOD measurements in regards to glare attenuation across the macula. Overall, 
foveal MPOD showed the most consistent associations with all 3 spatial 
frequency stimuli than parafoveal measures of MPOD. Only at the 9cpd stimuli 
did RGD show significant correlations with corresponding MPOD loci. Results 
from the data show a similar number of significant coefficients when either 
integrated MPOD or discrete is correlated with RGD.  
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At all three spatial frequencies, a multiple regression using integrated foveal 
MPOD and corresponding kurtosis values as predictors of resulting RGD for 
each subject was performed. In all cases, adding kurtosis as an additional 
predictor did not increase the variance explained within the regression model.  
 
Intraocular Scatter  
Intraocular correlations with foveal and AUC integrated MPOD measurements 
were non-significant. However, quartile analysis of the highest and lowest foveal 
MPOD found significant differences in intraocular scatter values. The intraocular 
scatter assessment required fixation of a central target and direct comparison of 
a flickering hemifield. The spectral composition of the glare annulus contained a 
large SW light component with a peak wavelength of 460nm closely matching the 
spectral absorption characteristics of MP. It is likely that peak MPOD is a greater 
contributor to SW light attenuation in regards to intraocular scatter than AUC 
integration MPOD values.   
 
Future Directions 
A potential follow-up study to the results of this project would be to evaluate the 
impact of scaled stimuli on relationship between glare disability and MPOD. The 
current results demonstrate decreasing correlation coefficients with increasing 
retinal eccentricity using 9cpd stimuli. It would be interesting to learn whether that 
decreased significance is a result of lower MPOD creating less glare attenuation 
and if the corresponding glare attenuation has a spatial frequency dependence. 
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The lack of significant correlations between MPOD and CS could also be 
explored further by utilizing chromatic stimuli rather than the achromatic stimuli 
reported here. The SW absorption properties of MP are well-documented and 
described in detail above. An evaluation of CS using a grating pattern generated 
on a SW-dominant background would theoretically be influenced by MPOD. 
 
A number of studies have explored the relationship between CS and 
supplementation MP with mixed results.  A few of the studies have identified a 
significant improvement in CS following supplementation (Richer et al., 1999 and 
Richer et al., 2004 and Olmedilla et al., 2003 and Kvansakul et al., 2006) and a 
few of the studies have failed to identify a significant association (Bartlett and 
Eperjesi, 2007 and Bartlett and Eperjest, 2008 and Nolan et al., 2011). It may be 
possible that differences in the findings may be a result of metabolic 
bioavailability of the L and Z from the supplement or possible differences in 
retinal transport and bindings among participants. In the absence of a SW 
component, any improvements in CS due to MP have a likely etiology in the 
Neural Hypothesis. 
 
Future directions stemming directly from this project include the isolation of a 
neural component to the CS at different retinal loci at different spatial frequency. 
A current model of neural blur () incorporates 2 components, equivalent intrinsic 
blur (int) assessed as visual acuity and optical blur (opt) assessed as higher 
order aberrations.  The model suggests the two components, intrinsic blur and 
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optical blur, are related to neural blur in the following equation:  = 1 – (opt / int).  
The resulting neural blur is the limiting component in visual function. An intriguing 
question lies in the role of MP on the resulting neural blur both from the baseline 
characteristics to results following supplementation.  
 
Intraocular scatter is highly influenced by inhomogeneities within the ocular 
media, lenticular transmission being the primary source.  The finding of 
correlation non-significance between foveal MPOD and intraocular scatter values 
is not surprising given the potential range of ocular transmission values.  A 
potential supplementation study of the influences of L only, L+Z and L+Z+MZ oral 
formulations on resulting MPOD spatial distribution correlated with repeated 
intraocular scatter values at 3, 6 and 12 months in younger subjects without 
evidence of lenticular changes. This subject sample would likely exhibit the 
highest ocular media transmission and may help to identify any improvement in 
intraocular scatter correlated to MPOD, if any is to be found.  
 
MPOD has been well-established in the literature in regard to the 3 components 
of the Optical Hypothesis when evaluated centrally.  Due to the variable nature of 
MPOD spatial distribution within the population as a whole, the parafoveal 
relationship requires further detailed investigation.  Integrated MPOD 
measurements demonstrated a significant relationship to relative glare disability 
and showed an increased association with higher spatial frequencies. This may 
influence how MPOD is currently assessed clinically and how supplementation 
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studies evaluating visual performance related to MPOD are performed.  Foveal 
MPOD measurements remained the strongest predictor of disability glare from 00 
to 40 of retinal eccentricity and, although non-significant, showed an inverse 
relationship with measured intraocular scatter values.  The spatial distribution 
profile likely remains a critical part of both the Neural and Protection Hypotheses.   
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Appendix 1 
 
 
Figure 13 
Mean contrast sensitivity values 3cpd stimuli along the horizontal meridian for the 33 subject sample as a function of 
foveal eccentricity.  Blue diamonds indicate contrast sensitivity without flanking glare and red squares represent contrast 
sensitivity with flanking glare. Error bars indicate a 95% confidence interval.  
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Figure 14 
Mean contrast sensitivity values 3cpd stimuli along the vertical meridian for the 33 subject sample as a function of foveal 
eccentricity.  Blue diamonds indicate contrast sensitivity without flanking glare and red squares represent contrast 
sensitivity with flanking glare.  Error bars indicate a 95% confidence interval. 
P a g e  | 169 
 
 
Figure 15 
Mean contrast sensitivity values 6cpd stimuli along the horizontal meridian for the 33 subject sample as a function of 
foveal eccentricity.  Blue diamonds indicate contrast sensitivity without flanking glare and red squares represent contrast 
sensitivity with flanking glare.  Error bars indicate a 95% confidence interval. 
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Figure 16 
Mean contrast sensitivity values 6cpd stimuli along the vertical meridian for the 33 subject sample 
as a function of foveal eccentricity.  Blue diamonds indicate contrast sensitivity without flanking glare and red squares 
represent contrast sensitivity with flanking glare.  Error bars indicate a 95% confidence interval. 
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Figure 17 
Mean contrast sensitivity values 9cpd stimuli along the horizontal meridian for the 33 subject sample as a function of 
foveal eccentricity.  Blue diamonds indicate contrast sensitivity without flanking glare and red squares represent contrast 
sensitivity with flanking glare.  Error bars indicate a 95% confidence interval. 
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Figure 18 
Mean contrast sensitivity values 9cpd stimuli along the vertical meridian for the 33 subject sample 
as a function of foveal eccentricity.  Blue diamonds indicate contrast sensitivity without flanking glare and red squares 
represent contrast sensitivity with flanking glare.  Error bars indicate a 95% confidence interval. 
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Figure 19 
Mean contrast sensitivity values for all targets (3,6,9cpd) along all meridians (horizontal and vertical) for the 33 subject 
sample as a function of foveal eccentricity.  Blue diamonds indicate contrast sensitivity without flanking glare for 3cpd 
stimuli, red squares indicate contrast sensitivity with flanking glare for 3cpd stimuli , green triangles indicate contrast 
sensitivity without flanking glare for 6cpd stimuli, lavender X indicates contrast sensitivity with flanking glare for 6cpd 
stimuli, blue X indicates contrast sensitivity without flanking glare for 9cpd stimuli and orange circles indicate contrast 
sensitivity with flanking glare for 9cpd stimuli. 
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Appendix 2 
 
  
Temporal Superior Nasal Inferior 
Temporal Pearson Correlation 1.000 0.962 0.964 0.957 
 
Sig. (2-tailed) ------- p<0.001 p<0.001 p<0.001 
Superior Pearson Correlation 0.962 1.000 0.955 0.965 
 Sig. (2-tailed) p<0.001 ------- p<0.001 p<0.001 
Nasal Pearson Correlation 0.964 0.955 1.000 0.968 
 Sig. (2-tailed) p<0.001 p<0.001 ------- p<0.001 
Inferior Pearson Correlation 0.957 0.965 0.968 1.000 
 Sig. (2-tailed) p<0.001 p<0.001 p<0.001 ------- 
Table 1 
Table indicating correlation and significance measures for MPOD at 2
o
 of eccentricity along the 4 principle meridians 
 
 
 
 
  
Temporal Superior Nasal Inferior 
Temporal Pearson Correlation 1.000 0.931 0.942 0.930 
 
Sig. (2-tailed) ------- p<0.001 p<0.001 p<0.001 
Superior Pearson Correlation 0.931 1.000 0.938 0.947 
 Sig. (2-tailed) p<0.001 ------- p<0.001 p<0.001 
Nasal Pearson Correlation 0.942 0.938 1.000 0.928 
 Sig. (2-tailed) p<0.001 p<0.001 ------- p<0.001 
Inferior Pearson Correlation 0.930 0.947 0.928 1.000 
 Sig. (2-tailed) p<0.001 p<0.001 p<0.001 ------- 
Table 2 
Table indicating correlation and significance measures for MPOD at 4
o
 of eccentricity along the 4 principle meridians 
 
 
 
 
  
Temporal Superior Nasal Inferior 
Temporal Pearson Correlation 1.000 0.894 0.915 0.929 
 
Sig. (2-tailed) ------- p<0.001 p<0.001 p<0.001 
Superior Pearson Correlation 0.894 1.000 0.875 0.893 
 Sig. (2-tailed) p<0.001 ------- p<0.001 p<0.001 
Nasal Pearson Correlation 0.925 0.875 1.000 0.911 
 Sig. (2-tailed) p<0.001 p<0.001 ------- p<0.001 
Inferior Pearson Correlation 0.929 0.893 0.911 1.000 
 Sig. (2-tailed) p<0.001 p<0.001 p<0.001 ------- 
Table 3 
Table indicating correlation and significance measures for MPOD at 6
o
 of eccentricity along the 4 principle meridians 
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Kurtosis Value 
Integrated 
AUC Stimuli 
Center 
Integrated AUC 
Stimuli Highest 
Sensitivity Point 
Subject 1 5.166 1.762 1.467 
Subject 2 2.554 1.879 1.577 
Subject 3 4.577 2.133 1.772 
Subject 4 4.308 1.765 1.457 
Subject 5 3.042 2.098 1.734 
Subject 6 2.175 1.912 1.598 
Subject 7 3.363 2.448 2.051 
Subject 8 1.704 1.954 1.649 
Subject 9 1.837 1.988 1.671 
Subject 10 2.271 1.781 1.501 
Subject 11 5.313 1.551 1.279 
Subject 12 5.215 1.881 1.534 
Subject 13 0.399 1.831 1.581 
Subject 14 4.312 1.498 1.251 
Subject 15 2.731 2.571 2.142 
Subject 16 5.395 1.633 1.358 
Subject 17 0.806 2.018 1.722 
Subject 18 3.302 1.505 1.255 
Subject 19 2.392 1.638 1.375 
Subject 20 7.154 1.513 1.223 
Subject 21 -0.763 1.705 1.524 
Subject 22 1.627 2.371 2.003 
Subject 23 4.603 1.666 1.392 
Subject 24 1.937 1.579 1.313 
Subject 25 2.112 2.135 1.789 
Subject 26 2.246 0.851 0.703 
Subject 27 0.825 1.245 1.051 
Subject 28 1.222 1.087 0.913 
Subject 29 3.719 1.346 1.109 
Subject 30 2.591 2.587 2.154 
Subject 31 1.049 1.693 1.436 
Subject 32 3.102 1.566 1.296 
Subject 33 -0.503 1.487 1.258 
Mean 2.781 1.778 1.489 
Std Dev 1.809 0.393 0.331 
Table 4 
Calculated values for kurtosis, integrated AUC assuming stimulus center and integrated AUC assuming stimulus point of 
highest retinal sensitivity for the 33 subject sample using MPOD values measured at 0
o
, 2
o
, 4
o
, 6
o
 and 8
o
 eccentricity. 
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3cpd   CS_0
o 
Horiz_CS_2
o
 Horiz_CS_4
o 
Horiz_CS_6
o 
Foveal MPOD 
Discrete Point 
Pearson Correlation 0.087 0.054 0.285 0.154 
 
Sig. (2-tailed) 0.629 0.765 0.108 0.391 
Foveal MPOD 
Integrated Stimulus 
Center 
Pearson Correlation 0.081 0.054 0.285 0.162 
 Sig. (2-tailed) 0.652 0.765 0.108 0.369 
Foveal MPOD 
Integrated Stimulus 
Highest Sensitivity 
Pearson Correlation 0.076 0.052 0.283 0.163 
 Sig. (2-tailed) 0.675 0.775 0.110 0.364 
Table 8 
Correlation coefficients for MPOD at 0
o
and horizontal meridian contrast sensitivity at 0
o
, 2
o
, 4
0
 and 6
o
 for 3cpd grating 
targets. 
 
 
3cpd   CS_0
o 
Vert_CS_2
o
 Vert_CS_4
o 
Vert_CS_6
o 
Peak Foveal MPOD 
Discrete Point 
Pearson Correlation 0.087 0.013 0.117 0.040 
 
Sig. (2-tailed) 0.629 0.944 0.518 0.823 
Foveal MPOD 
Integrated Stimulus 
Center 
Pearson Correlation 0.081 0.018 0.127 0.053 
 Sig. (2-tailed) 0.652 0.919 0.481 0.771 
Foveal MPOD 
Integrated Stimulus 
Highest Sensitivity 
Pearson Correlation 0.076 0.019 0.127 0.057 
 Sig. (2-tailed) 0.675 0.917 0.482 0.753 
Table 9 
Correlation coefficients for MPOD at 0
o
and vertical meridian contrast sensitivity at 0
o
, 2
o
, 4
o
 and 6
o
 for 3cpd grating 
targets. 
 
 
3cpd   CS_0
o 
CS_2
o
 CS_4
o 
CS_6
o 
Foveal MPOD 
Discrete Point 
Pearson Correlation 0.087 -0.013 0.180 0.076 
 
Sig. (2-tailed) 0.629 0.944 0.316 0.673 
Foveal MPOD 
Integrated Stimulus 
Center 
Pearson Correlation 0.081 -0.014 0.185 0.088 
 Sig. (2-tailed) 0.652 0.938 0.303 0.627 
Foveal MPOD 
Integrated Stimulus 
Highest Sensitivity 
Pearson Correlation 0.076 -0.017 0.185 0.092 
 Sig. (2-tailed) 0.675 0.924 0.304 0.611 
Table 10 
Correlation coefficients for MPOD at 0
o
and mean contrast sensitivity at 0
o
, 2
o
, 4
o 
and 6
o
 for 3cpd grating targets. 
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3cpd 
 
Horiz_CS_2
o
 
2
o
 MPOD Discrete 
Point
 Pearson Correlation -0.215 
  Sig. (2-tailed) 0.229 
2
o
 MPOD Integrated 
Stimulus Center 
 Pearson Correlation -0.222 
 Sig. (2-tailed) 0.213 
2
o
 MPOD Integrated 
Stimulus Highest 
Sensitivity
 
Pearson Correlation -0.278 
 
Sig. (2-tailed) 0.117 
Table 11 
Correlation coefficients for MPOD at 2
o
 and horizontal meridian contrast sensitivity at 2
o
 for 3cpd grating targets. 
 
 
 
 
3cpd 
 
Vert_CS_2
o
 
2
o
 MPOD Discrete 
Point
 Pearson Correlation -0.202 
  Sig. (2-tailed) 0.260 
2
o
 MPOD Integrated 
Stimulus Center 
 Pearson Correlation -0.214 
 Sig. (2-tailed) 0.232 
2
o
 MPOD Integrated 
Stimulus Highest 
Sensitivity
 
Pearson Correlation -0.276 
 
Sig. (2-tailed) 0.120 
Table 12 
Correlation coefficients for MPOD at 2
o
 and vertical meridian contrast sensitivity at 2
o
 for 3cpd grating targets. 
 
 
 
 
3cpd 
 
CS_2
o
 
2
o
 MPOD Discrete 
Point
 Pearson Correlation -0.214 
  Sig. (2-tailed) 0.232 
2
o
 MPOD Integrated 
Stimulus Center 
 Pearson Correlation -0.285 
 Sig. (2-tailed) 0.108 
2
o
 MPOD Integrated 
Stimulus Highest 
Sensitivity
 
Pearson Correlation -0.328 
 
Sig. (2-tailed) 0.062 
Table 13 
Correlation coefficients for MPOD at 2
o
 and contrast sensitivity at 2
o
 for 3cpd grating targets. 
 
 
 
P a g e  | 178 
 
3cpd   Horiz_CS_4
o
 
4
o
 MPOD Discrete 
Point
 Pearson Correlation -0.099 
  Sig. (2-tailed) 0.583 
4
o
 MPOD Integrated 
Stimulus Center 
 Pearson Correlation -0.120 
 Sig. (2-tailed) 0.506 
4
o
 MPOD Integrated 
Stimulus Highest 
Sensitivity
 
Pearson Correlation -0.105 
 
Sig. (2-tailed) 0.560 
Table 14 
Correlation coefficients for MPOD at 4
o
and horizontal meridian contrast sensitivity at 4
o
 for 3cpd grating targets. 
 
 
 
 
3cpd   Vert_CS_4
o
 
4
o
 MPOD Discrete 
Point
 Pearson Correlation -0.197 
  Sig. (2-tailed) 0.272 
4
o
 MPOD Integrated 
Stimulus Center 
 Pearson Correlation -0.228 
 Sig. (2-tailed) 0.202 
4
o
 MPOD Integrated 
Stimulus Highest 
Sensitivity
 
Pearson Correlation -0.245 
 
Sig. (2-tailed) 0.170 
Table 15 
Correlation coefficients for MPOD at 4
o
and vertical meridian contrast sensitivity at 4
o
 for 3cpd grating targets. 
 
 
 
 
 
 
3cpd   CS_4
o
 
4
o
 MPOD Discrete 
Point
 Pearson Correlation -0.129 
  Sig. (2-tailed) 0.474 
4
o
 MPOD Integrated 
Stimulus Center 
 Pearson Correlation -0.138 
 Sig. (2-tailed) 0.444 
4
o
 MPOD Integrated 
Stimulus Highest 
Sensitivity
 
Pearson Correlation -0.132 
 
Sig. (2-tailed) 0.463 
Table 16 
Correlation coefficients for MPOD at 4
o
and contrast sensitivity at 4
o
 for 3cpd grating targets. 
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3cpd   Horiz_CS_6
o
 
6
o
 MPOD Discrete 
Point
 Pearson Correlation -0.113 
  Sig. (2-tailed) 0.531 
6
o
 MPOD Integrated 
Stimulus Center 
 Pearson Correlation -0.179 
 Sig. (2-tailed) 0.319 
6
o
 MPOD Integrated 
Stimulus Highest 
Sensitivity
 
Pearson Correlation -0.057 
 
Sig. (2-tailed) 0.752 
Table 17 
Correlation coefficients for MPOD at 6
o
and horizontal meridian contrast sensitivity at 6
o
 for 3cpd grating targets. 
 
 
 
 
 
3cpd   Vert_CS_6
o
 
6
o
 MPOD Discrete 
Point
 Pearson Correlation -0.191 
  Sig. (2-tailed) 0.288 
6
o
 MPOD Integrated 
Stimulus Center 
 Pearson Correlation -0.250 
 Sig. (2-tailed) 0.160 
6
o
 MPOD Integrated 
Stimulus Highest 
Sensitivity
 
Pearson Correlation -0.139 
 
Sig. (2-tailed) 0.441 
Table 18 
Correlation coefficients for MPOD at 6
o
and vertical meridian contrast sensitivity at 6
o
 for 3cpd grating targets. 
 
 
 
 
 
3cpd   CS_6
o
 
6
o
 MPOD Discrete 
Point
 Pearson Correlation -0.148 
  Sig. (2-tailed) 0.412 
6
o
 MPOD Integrated 
Stimulus Center 
 Pearson Correlation -0.207 
 Sig. (2-tailed) 0.248 
6
o
 MPOD Integrated 
Stimulus Highest 
Sensitivity
 
Pearson Correlation -0.089 
 
Sig. (2-tailed) 0.622 
Table 19 
Correlation coefficients for MPOD at 6
o
and contrast sensitivity at 6
o
 for 3cpd grating targets. 
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 Independent Samples t-
test 
  
3cpd t-value Sig. 
CS_0
o
 0.299 0.769 
CS_2
o 
0.416 0.683 
CS_4
o 
0.475 0.641 
CS_6
o 
0.713 0.486 
Table 20 
Independent samples t-test for contrast sensitivity at 0
o
, 2
o
, 4
o
 and 6
o
 for 6cpd grating targets between the highest and 
lowest quartiles of peak foveal MPOD integrated across 1
o 
assuming stimulus point at highest retinal sensitivity. Levene’s 
Test for Equal Variances was non-significant so equal variances were assumed. 
 
 
 
 
6cpd   CS_0
o 
Horiz_CS_2
o
 Horiz_CS_4
o 
Horiz_CS_6
o 
Foveal MPOD Discrete 
Point 
Pearson Correlation 0.237 0.027 0.222 0.202 
 
Sig. (2-tailed) 0.183 0.883 0.214 0.260 
Foveal MPOD Integrated 
Stimulus Center 
Pearson Correlation 0.227 0.031 0.230 0.214 
 Sig. (2-tailed) 0.204 0.864 0.198 0.231 
Foveal MPOD Integrated 
Stimulus Highest 
Sensitivity 
Pearson Correlation 0.215 0.024 0.230 0.216 
 Sig. (2-tailed) 0.229 0.894 0.197 0.227 
Table 21 
Correlation coefficients for MPOD at 0
o
and horizontal meridian contrast sensitivity at 0
o
, 2
o
, 4
o
 and 6
o
 for 6cpd grating 
targets. 
 
 
 
6cpd   CS_0
o 
Vert_CS_2
o
 Vert_CS_4
o 
Vert_CS_6
o 
Foveal MPOD Discrete 
Point 
Pearson Correlation 0.237 0.228 0.186 0.240 
 
Sig. (2-tailed) 0.183 0.202 0.301 0.179 
Foveal MPOD Integrated 
Stimulus Center 
Pearson Correlation 0.227 0.236 0.205 0.254 
 Sig. (2-tailed) 0.204 0.186 0.253 0.154 
Foveal MPOD Integrated 
Stimulus Highest 
Sensitivity 
Pearson Correlation 0.215 0.232 0.214 0.263 
 Sig. (2-tailed) 0.229 0.194 0.232 0.140 
Table 22 
Correlation coefficients for MPOD at 0
o
and horizontal meridian contrast sensitivity at 0
o
, 2
o
, 4
o
 and 6
o
 for 6cpd grating 
targets. 
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6cpd   CS_0
0 
CS_2
0
 CS_4
0 
CS_6
0 
Foveal MPOD Discrete 
Point 
Pearson Correlation 0.237 0.192 0.213 0.228 
 
Sig. (2-tailed) 0.183 0.285 0.235 0.203 
Foveal MPOD 
Integrated Stimulus 
Center 
Pearson Correlation 0.227 0.200 0.226 0.238 
 Sig. (2-tailed) 0.204 0.265 0.206 0.183 
Foveal MPOD 
Integrated Stimulus 
Highest Sensitivity 
Pearson Correlation 0.215 0.193 0.228 0.239 
 Sig. (2-tailed) 0.229 0.281 0.201 0.180 
Table 23 
Correlation coefficients for MPOD at 0
o
and mean contrast sensitivity at 0
o
, 2
o
, 4
o
 and 6
o
 for 6cpd grating targets. 
 
 
 
6cpd 
 
Horiz_CS_2
o
 
2
o
 MPOD Discrete 
Point
 Pearson Correlation -0.234 
  Sig. (2-tailed) 0.190 
2
o
 MPOD Integrated 
Stimulus Center 
 Pearson Correlation -0.254 
 Sig. (2-tailed) 0.154 
2
o
 MPOD Integrated 
Stimulus Highest 
Sensitivity
 
Pearson Correlation -0.300 
 
Sig. (2-tailed) 0.090 
Table 24 
Correlation coefficients for MPOD at 2
o
and horizontal meridian contrast sensitivity at 2
o
 for 6cpd grating targets. 
 
 
 
 
6cpd   Vert_CS_2
o
 
2
o
 MPOD Discrete 
Point
 Pearson Correlation -0.134 
  Sig. (2-tailed) 0.456 
2
o
 MPOD Integrated 
Stimulus Center 
 Pearson Correlation -0.149 
 Sig. (2-tailed) 0.408 
2
o
 MPOD Integrated 
Stimulus Highest 
Sensitivity
 
Pearson Correlation -0.262 
 
Sig. (2-tailed) 0.141 
Table 25 
Correlation coefficients for MPOD at 2
o
and vertical meridian contrast sensitivity at 2
o
 for 6cpd grating targets. 
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6cpd 
 
CS_2
o
 
2
o
 MPOD Discrete 
Point
 Pearson Correlation -0.074 
  Sig. (2-tailed) 0.681 
2
o
 MPOD Integrated 
Stimulus Center 
 Pearson Correlation -0.180 
 Sig. (2-tailed) 0.317 
2
o
 MPOD Integrated 
Stimulus Highest 
Sensitivity
 
Pearson Correlation -0.271 
 
Sig. (2-tailed) 0.127 
Table 26 
Correlation coefficients for MPOD at 2
o
and mean contrast sensitivity at 2
o
 for 6cpd grating targets. 
 
 
 
 
6cpd 
 
Horiz_CS_4
o
 
4
o
 MPOD Discrete 
Point
 Pearson Correlation 0.001 
  Sig. (2-tailed) 0.997 
4
o
 MPOD Integrated 
Stimulus Center 
 Pearson Correlation -0.024 
 Sig. (2-tailed) 0.895 
4
o
 MPOD Integrated 
Stimulus Highest 
Sensitivity
 
Pearson Correlation -0.016 
 
Sig. (2-tailed) 0.932 
Table 27 
Correlation coefficients for MPOD at 4
o
and horizontal meridian contrast sensitivity at 4
o
 for 6cpd grating targets. 
 
 
 
 
6cpd   Vert_CS_4
o
 
4
o
 MPOD Discrete 
Point
 Pearson Correlation 0.023 
  Sig. (2-tailed) 0.897 
4
o
 MPOD Integrated 
Stimulus Center 
 Pearson Correlation -0.008 
 Sig. (2-tailed) 0.964 
4
o
 MPOD Integrated 
Stimulus Highest 
Sensitivity
 
Pearson Correlation -0.070 
 
Sig. (2-tailed) 0.699 
Table 28 
Correlation coefficients for MPOD at 4
o
and horizontal meridian contrast sensitivity at 4
o
 for 6cpd grating targets. 
 
 
P a g e  | 183 
 
6cpd   CS_4
o
 
4
o
 MPOD Discrete 
Point
 Pearson Correlation -0.023 
  Sig. (2-tailed) 0.899 
4
o
 MPOD Integrated 
Stimulus Center 
 Pearson Correlation -0.066 
 Sig. (2-tailed) 0.713 
4
o
 MPOD Integrated 
Stimulus Highest 
Sensitivity
 
Pearson Correlation -0.091 
 Sig. (2-tailed) 0.616 
Table 29 
Correlation coefficients for MPOD at 4
o
and mean contrast sensitivity at 4
o
 for 6cpd grating targets. 
 
 
 
 
6cpd 
 
Horiz_CS_6
o
 
6
o
 MPOD Discrete 
Point
 Pearson Correlation 0.024 
  Sig. (2-tailed) 0.896 
6
o
 MPOD Integrated 
Stimulus Center 
 Pearson Correlation -0.073 
 Sig. (2-tailed) 0.687 
6
o
 MPOD Integrated 
Stimulus Highest 
Sensitivity
 
Pearson Correlation 0.016 
 
Sig. (2-tailed) 0.931 
Table 30 
Correlation coefficients for MPOD at 6
o
and horizontal meridian contrast sensitivity at 6
o
 for 6cpd grating targets. 
 
 
 
 
6cpd 
 
Vert_CS_6
o
 
6
o
 MPOD Discrete 
Point
 Pearson Correlation 0.182 
  Sig. (2-tailed) 0.310 
6
o
 MPOD Integrated 
Stimulus Center 
 Pearson Correlation 0.145 
 Sig. (2-tailed) 0.421 
6
o
 MPOD Integrated 
Stimulus Highest 
Sensitivity
 
Pearson Correlation 0.205 
 
Sig. (2-tailed) 0.252 
Table 31 
Correlation coefficients for MPOD at 6
o
and vertical meridian contrast sensitivity at 6
o
 for 6cpd grating targets. 
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6cpd   CS_6
o
 
6
o
 MPOD Discrete 
Point
 Pearson Correlation 0.011 
  Sig. (2-tailed) 0.954 
6
o
 MPOD Integrated 
Stimulus Center 
 Pearson Correlation 0.074 
 Sig. (2-tailed) 0.684 
6
o
 MPOD Integrated 
Stimulus Highest 
Sensitivity
 
Pearson Correlation 0.131 
 
Sig. (2-tailed) 0.467 
Table 32 
Correlation coefficients for MPOD at 6
o
and contrast sensitivity at 6
o
 for 6cpd grating targets. 
 
 
 
 
 Independent Samples t-
test 
  
6cpd t-value Sig. 
CS_0
o 
0.995 0.355 
CS_2
o 
0.947 0.358 
CS_4
o 
1.130 0.275 
CS_6
o 
1.137 0.272 
Table 33 
Independent samples t-test for contrast sensitivity at 0
o
, 2
o
, 4
o
 and 6
o
 for 6cpd grating targets between the highest and 
lowest quartiles of peak foveal MPOD integrated across 1
o 
assuming stimulus point at highest retinal sensitivity. Levene’s 
Test for Equal Variances was non-significant so equal variances were assumed. 
 
 
 
 
9cpd   CS_0
o 
Horiz_CS_2
o
 Horiz_CS_4
o 
Horiz_CS_6
o 
Foveal MPOD Discrete 
Point 
Pearson Correlation 0.148 0.099 0.103 0.167 
 
Sig. (2-tailed) 0.412 0.583 0.567 0.354 
Foveal MPOD Integrated 
Stimulus Center 
Pearson Correlation 0.143 0.107 0.114 0.175 
 Sig. (2-tailed) 0.428 0.554 0.526 0.331 
Foveal MPOD Integrated 
Stimulus Highest 
Sensitivity 
Pearson Correlation 0.133 0.103 0.114 0.175 
 Sig. (2-tailed) 0.461 0.570 0.526 0.331 
Table 34 
Correlation coefficients for MPOD at 0
o
and horizontal meridian contrast sensitivity at 0
o
, 2
o
, 4
o
 and 6
o
 for 9cpd grating 
targets. 
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9cpd   CS_0
o 
Vert_CS_2
o
 Vert_CS_4
o 
Vert_CS_6
o 
Foveal MPOD Discrete 
Point 
Pearson Correlation 0.148 -0.188 -0.020 -0.015 
 
Sig. (2-tailed) 0.412 0.294 0.910 0.934 
Foveal MPOD Integrated 
Stimulus Center 
Pearson Correlation 0.143 -0.171 -0.005 -0.006 
 Sig. (2-tailed) 0.428 0.342 0.978 0.974 
Foveal MPOD Integrated 
Stimulus Highest 
Sensitivity 
Pearson Correlation 0.133 -0.165 -0.001 -0.001 
 Sig. (2-tailed) 0.461 0.360 0.997 0.998 
Table 35 
Correlation coefficients for MPOD at 0
o
and vertical meridian contrast sensitivity at 0
o
, 2
o
, 4
o
 and 6
o
 for 9cpd grating 
targets. 
 
 
 
9cpd   CS_0
o 
CS_2
o
 CS_4
o 
CS_6
o 
Foveal MPOD Discrete 
Point 
Pearson Correlation 0.148 -0.106 -0.021 0.067 
 
Sig. (2-tailed) 0.412 0.558 0.908 0.713 
Foveal MPOD Integrated 
Stimulus Center 
Pearson Correlation 0.143 -0.089 -0.005 0.075 
 Sig. (2-tailed) 0.428 0.622 0.979 0.678 
Foveal MPOD Integrated 
Stimulus Highest 
Sensitivity 
Pearson Correlation 0.133 -0.090 -0.004 0.077 
 Sig. (2-tailed) 0.461 0.620 0.982 0.669 
Table 36 
Correlation coefficients for MPOD at 0
o
and mean contrast sensitivity at 0
o
, 2
o
, 4
o
 and 6
o
 for 9cpd grating targets 
 
 
 
 
9cpd   Horiz_CS_2
o
 
2
o
 MPOD Discrete 
Point
 Pearson Correlation -0.156 
  Sig. (2-tailed) 0.386 
2
o
 MPOD Integrated 
Stimulus Center 
 Pearson Correlation -0.184 
 Sig. (2-tailed) 0.306 
2
o
 MPOD Integrated 
Stimulus Highest 
Sensitivity
 
Pearson Correlation -0.248 
 
Sig. (2-tailed) 0.165 
Table 37 
Correlation coefficients for MPOD at 2
o
and horizontal meridian contrast sensitivity at 2
o
 for 9cpd grating targets. 
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9cpd   Vert_CS_2
o
 
2
o
 MPOD Discrete 
Point
 Pearson Correlation -0.278 
  Sig. (2-tailed) 0.117 
2
o
 MPOD Integrated 
Stimulus Center 
 Pearson Correlation -0.290 
 Sig. (2-tailed) 0.102 
2
o
 MPOD Integrated 
Stimulus Highest 
Sensitivity
 
Pearson Correlation -0.340 
 
Sig. (2-tailed) 0.053 
Table 38 
Correlation coefficients for MPOD at 2
o
and vertical meridian contrast sensitivity at 2
o
 for 9cpd grating targets. 
 
 
 
 
9cpd   CS_2
o
 
2
o
 MPOD Discrete 
Point
 Pearson Correlation -0.220 
  Sig. (2-tailed) 0.219 
2
o
 MPOD Integrated 
Stimulus Center 
 Pearson Correlation -0.262 
 Sig. (2-tailed) 0.141 
2
o
 MPOD Integrated 
Stimulus Highest 
Sensitivity
 
Pearson Correlation -0.297 
 
Sig. (2-tailed) 0.093 
Table 39 
Correlation coefficients for MPOD at 2
o
and contrast sensitivity at 2
o
 for 9cpd grating targets. 
 
 
 
 
9cpd   Horiz_CS_4
o
 
4
o
 MPOD Discrete 
Point
 Pearson Correlation -0.163 
  Sig. (2-tailed) 0.366 
4
o
 MPOD Integrated 
Stimulus Center 
 Pearson Correlation -0.174 
 Sig. (2-tailed) 0.332 
4
o
 MPOD Integrated 
Stimulus Highest 
Sensitivity
 
Pearson Correlation -0.179 
 
Sig. (2-tailed) 0.318 
Table 40 
Correlation coefficients for MPOD at 4
o
and horizontal meridian contrast sensitivity at 4
o
 for 9cpd grating targets. 
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9cpd   Vert_CS_4
o
 
4
o
 MPOD Discrete 
Point
 Pearson Correlation -0.223 
  Sig. (2-tailed) 0.213 
4
o
 MPOD Integrated 
Stimulus Center 
 Pearson Correlation -0.294 
 Sig. (2-tailed) 0.096 
4
o
 MPOD Integrated 
Stimulus Highest 
Sensitivity
 
Pearson Correlation -0.309 
 
Sig. (2-tailed) 0.081 
Table 41 
Correlation coefficients for MPOD at 4
o
and vertical meridian contrast sensitivity at 4
o
 for 9cpd grating targets. 
 
 
 
 
9cpd   CS_4
o
 
4
o
 MPOD Discrete 
Point
 Pearson Correlation -0.271 
  Sig. (2-tailed) 0.127 
4
o
 MPOD Integrated 
Stimulus Center 
 Pearson Correlation -0.292 
 Sig. (2-tailed) 0.099 
4
o
 MPOD Integrated 
Stimulus Highest 
Sensitivity
 
Pearson Correlation -0.301 
 
Sig. (2-tailed) 0.088 
Table 42 
Correlation coefficients for MPOD at 4
o
and mean contrast sensitivity at 4
o
 for 9cpd grating targets. 
 
 
 
 
9cpd   Horiz_CS_6
o
 
6
o
 MPOD Discrete 
Point
 Pearson Correlation -0.013 
  Sig. (2-tailed) 0.943 
6
o
 MPOD Integrated 
Stimulus Center 
 Pearson Correlation -0.062 
 Sig. (2-tailed) 0.730 
6
o
 MPOD Integrated 
Stimulus Highest 
Sensitivity
 
Pearson Correlation -0.022 
 
Sig. (2-tailed) 0.902 
Table 43 
Correlation coefficients for MPOD at 6
o
and horizontal meridian contrast sensitivity at 6
o
 for 9cpd grating targets. 
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9cpd   Vert_CS_6
o
 
6
o
 MPOD Discrete 
Point
 Pearson Correlation -0.110 
  Sig. (2-tailed) 0.543 
6
o
 MPOD Integrated 
Stimulus Center 
 Pearson Correlation -0.128 
 Sig. (2-tailed) 0.479 
6
o
 MPOD Integrated 
Stimulus Highest 
Sensitivity
 
Pearson Correlation -0.055 
 
Sig. (2-tailed) 0.763 
Table 44 
Correlation coefficients for MPOD at 6
o
and vertical meridian contrast sensitivity at 6
o
 for 9cpd grating targets. 
 
 
 
 
9cpd   CS_6
o
 
6
o
 MPOD Discrete 
Point
 Pearson Correlation -0.109 
  Sig. (2-tailed) 0.547 
6
o
 MPOD Integrated 
Stimulus Center 
 Pearson Correlation -0.128 
 Sig. (2-tailed) 0.477 
6
o
 MPOD Integrated 
Stimulus Highest 
Sensitivity
 
Pearson Correlation -0.067 
 
Sig. (2-tailed) 0.710 
Table 45 
Correlation coefficients for MPOD at 6
o
and contrast sensitivity at 6
o
 for 9cpd grating targets. 
 
 
 
 
 Independent Samples t-
test 
  
9cpd t-value Sig. 
CS_0
0 
0.792 0.440 
CS_2
0 
0.669 0.494 
CS_4
0 
0.141 0.890 
CS_6
0 
0.442 0.665 
Table 46 
Independent samples t-test for contrast sensitivity at 0
o
, 2
o
, 4
o
 and, 4
o
 for 6cpd grating targets between the highest and 
lowest quartiles of peak foveal MPOD integrated across 1
0 
assuming stimulus point at highest retinal sensitivity. Levene’s 
Test for Equal Variances was non-significant so equal variances were assumed. 
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3cpd   GD_0
o
 RGD_0
o
 GD_2
o
 RGD_2
o
 GD_4
o
 RGD_4
o
 GD_6
o
 RGD_6
o
 
Peak Foveal MPOD 
Discrete Point 
Pearson 
Correlation 
-0.079 -0.205 -0.327 -0.335 -0.205 -0.261 -0.219 -0.254 
 
Sig. (2-tailed) 0.663 0.252 0.063 0.058 0.253 0.143 0.222 0.150 
Peak Foveal MPOD 
Integrated Stimulus 
Center 
Pearson 
Correlation 
-0.101 -0.217 -0.333 -0.342 -0.208 -0.266 -0.210 -0.251 
 Sig. (2-tailed) 0.575 0.226 0.058 0.056 0.245 0.134 0.241 0.155 
Peak Foveal MPOD 
Integrated Stimulus 
Highest Sensitivity 
Pearson 
Correlation 
-0.083 -0.228 -0.331 -0.340 -0.205 -0.264 -0.204 -0.249 
 Sig. (2-tailed) 0.646 0.203 0.060 0.055 0.253 0.138 0.256 0.159 
Table 47 
Correlation coefficients for MPOD at 0
o
and glare disability and relative glare disability at 0
o
, 2
o
, 4
o
 and 6
o
 for 3cpd grating targets. 
 
 
 
3cpd   GD_2
o
 RGD_2
o
 
2
o
 MPOD Discrete 
Point
 Pearson Correlation -0.240 -0.138 
  Sig. (2-tailed) 0.179 0.445 
2
o
 MPOD Integrated 
Stimulus Center 
 Pearson Correlation -0.217 -0.113 
 Sig. (2-tailed) 0.225 0.530 
2
o
 MPOD Integrated 
Stimulus Highest 
Sensitivity
 
Pearson Correlation -0.331 -0.340 
 
Sig. (2-tailed) 0.060 0.053 
Table 48 
Correlation coefficients for MPOD at 2
o 
and glare disability and relative glare disability at 2
o
 for 3cpd grating targets. 
 
 
 
 
3cpd   GD_4
o
 RGD_4
o
 
4
o
 MPOD Discrete 
Point
 Pearson Correlation -0.022 0.046 
  Sig. (2-tailed) 0.904 0.801 
4
o
 MPOD Integrated 
Stimulus Center 
 Pearson Correlation 0.052 -0.142 
 Sig. (2-tailed) 0.774 0.432 
4
o
 MPOD Integrated 
Stimulus Highest 
Sensitivity
 
Pearson Correlation 0.027 0.112 
 
Sig. (2-tailed) 0.880 0.534 
Table 49 
Correlation coefficients for MPOD at 4
o
 and glare disability and relative glare disability at 4
o
 for 3cpd grating targets. 
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3cpd   GD_6
o
 RGD_6
o
 
6
o
 MPOD Discrete 
Point
 Pearson Correlation -0.176 -0.116 
  Sig. (2-tailed) 0.326 0.521 
6
o
 MPOD Integrated 
Stimulus Center 
 Pearson Correlation -0.243 -0.166 
 Sig. (2-tailed) 0.173 0.357 
6
o
 MPOD Integrated 
Stimulus Highest 
Sensitivity
 
Pearson Correlation -0.224 -0.208 
 
Sig. (2-tailed) 0.210 0.244 
Table 50 
Correlation coefficients for MPOD at 6
o
 and glare disability and relative glare disability at 6
o
 for 3cpd grating targets. 
 
 
 
 
 
Regression Fit for 3cpd Stimuli 
Integrated Foveal MPOD F Significance 
RGD_0
o 
1.368 0.251 
RGD_2
o 
4.073 0.052 
RGD_4
o 
2.309 0.139 
RGD_6
o
 2.567 0.119 
Table 53 
Regression fit significance table for foveal MPOD integrated across 1
o
 assuming stimulus point at highest retinal 
sensitivity and relative glare disability at 0
o
, 2
o
, 4
o
 and 6
o
 using 3cpd grating targets. 
 
 
 
 
 
 
Multiple Regression Fit for 3cpd Stimuli 
Integrated Foveal MPOD and 
Kurtosis as Predictors 
F Significance 
RGD_0
o
 0.720 0.495 
RGD_2
o 
1.992 0.154 
RGD_4
o 
1.912 0.165 
RGD_6
o
 1.659 0.207 
Table 54 
Multiple regression fit significance table for foveal MPOD integrated across 1
o
 assuming stimulus point at highest retinal 
sensitivity and kurtosis values as predictors for relative glare disability at 0
o
, 2
o
, 4
o
 and 6
o
 using 3cpd grating targets. 
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6cpd   GD_2
o
 RGD_2
o
 
2
o
 MPOD Discrete 
Point
 Pearson Correlation -0.294 -0.299 
  Sig. (2-tailed) 0.096 0.091 
2
o
 MPOD Integrated 
Stimulus Center 
 Pearson Correlation -0.288 -0.298 
 Sig. (2-tailed) 0.104 0.092 
2
o
 MPOD Integrated 
Stimulus Highest 
Sensitivity
 
Pearson Correlation -0.232 -0.267 
 
Sig. (2-tailed) 0.194 0.133 
Table 56 
Correlation coefficients for MPOD at 2
o
 and glare disability and relative glare disability at 2
o
 for 6cpd grating targets. 
 
 
 
6cpd   GD_4
o
 RGD_4
o
 
4
o
 MPOD Discrete 
Point
 Pearson Correlation -0.095 -0.149 
  Sig. (2-tailed) 0.600 0.408 
4
o
 MPOD Integrated 
Stimulus Center 
 Pearson Correlation -0.115 -0.138 
 Sig. (2-tailed) 0.525 0.444 
4
o
 MPOD Integrated 
Stimulus Highest 
Sensitivity
 
Pearson Correlation -0.127 -0.151 
 
Sig. (2-tailed) 0.481 0.401 
Table 57 
Correlation coefficients for MPOD at 4
o
 and glare disability and relative glare disability at 4
o
 for 6cpd grating targets. 
 
 
 
6cpd   GD_6
o
 RGD_6
o
 
6
o
 MPOD Discrete 
Point
 Pearson Correlation 0.020 -0.053 
  Sig. (2-tailed) 0.914 0.770 
6
o
 MPOD Integrated 
Stimulus Center 
 Pearson Correlation -0.061 -0.142 
 Sig. (2-tailed) 0.735 0.431 
6
o
 MPOD Integrated 
Stimulus Highest 
Sensitivity
 
Pearson Correlation -0.017 -0.113 
 
Sig. (2-tailed) 0.924 0.530 
Table 58 
Correlation coefficients for MPOD at 6
o
 and glare disability and relative glare disability at 6
o
 for 6cpd grating targets. 
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Multiple Regression Fit for 6cpd Stimuli 
Integrated Foveal MPOD and 
Kurtosis as Predictors 
F Significance 
RGD_0
o
 3.211 0.054 
RGD_2
o 
2.207 0.128 
RGD_4
o 
1.140 0.333 
RGD_6
o
 0.503 0.610 
Table 61 
Multiple regression fit significance table for foveal MPOD integrated across 1
o
 assuming stimulus point at highest retinal 
sensitivity and kurtosis values as predictors for relative glare disability at 0
o
, 2
o
, 4
o
 and 6
o
 using 6cpd grating targets. 
 
 
 
 
9cpd   GD_6
o
 RGD_6
o
 
6
o
 MPOD Discrete 
Point
 Pearson Correlation -0.103 -0.078 
  Sig. (2-tailed) 0.567 0.667 
6
o
 MPOD Integrated 
Stimulus Center 
 Pearson Correlation -0.141 -0.124 
 Sig. (2-tailed) 0.432 0.493 
6
o
 MPOD Integrated 
Stimulus Highest 
Sensitivity
 
Pearson Correlation -0.087 -0.126 
 
Sig. (2-tailed) 0.629 0.485 
Table 65 
Correlation coefficients for MPOD at 6
o
 and glare disability and relative glare disability at 6
o
 for 9cpd grating targets. 
